Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,A1BG,Alpha-1B-glycoprotein,20568,163,1.91 [0.77-4.72],0.1615848785530374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AAMDC,Mth938 domain-containing protein,19981,164,1.14 [0.86-1.51],0.377441920588923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AARSD1,Alanyl-tRNA editing protein Aarsd1,23599,177,1.16 [0.92-1.47],0.2158340798996111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABCA2,ATP-binding cassette sub-family A member 2,19847,157,0.95 [0.62-1.48],0.8340721767814423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABHD14B,Protein ABHD14B,23436,174,1.25 [0.99-1.58],0.0631828286163911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABL1,Tyrosine-protein kinase ABL1,23599,177,1.15 [0.95-1.39],0.1585648774516823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABO,Histo-blood group ABO system transferase,20572,165,1.04 [0.93-1.15],0.498187224123465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABRAXAS2,BRISC complex subunit Abraxas 2,19847,157,1.13 [0.90-1.43],0.2914246045046101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23155,169,1.12 [0.95-1.32],0.1829948154434252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20186,161,1.25 [1.06-1.47],0.0081485940141065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",20545,162,1.10 [0.93-1.30],0.2545166983987467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAN,Aggrecan core protein,23467,172,1.08 [0.66-1.78],0.7582795184588302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE,Angiotensin-converting enzyme,20572,165,1.13 [0.66-1.95],0.6491951663521692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE2,Angiotensin-converting enzyme 2,23281,173,1.07 [0.83-1.37],0.6158515642909035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACHE,Acetylcholinesterase,20082,158,0.97 [0.62-1.53],0.9008460563730414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOT13,Acyl-coenzyme A thioesterase 13,20481,163,1.11 [0.98-1.27],0.1068899736473847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,23713,172,1.23 [0.96-1.58],0.1088870914438194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19940,158,0.85 [0.60-1.20],0.3539749254236168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP5,Tartrate-resistant acid phosphatase type 5,23811,178,0.97 [0.65-1.44],0.8701864199335165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP6,Lysophosphatidic acid phosphatase type 6,23892,177,0.97 [0.80-1.18],0.7638562831853355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRBP,Acrosin-binding protein,20474,161,1.09 [0.75-1.57],0.6463794250566727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRV1,Acrosomal protein SP-10,19940,158,1.07 [0.93-1.23],0.3613520988616258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19847,157,1.08 [0.72-1.63],0.7015812929234972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTA2,"Actin, aortic smooth muscle",23281,173,1.21 [0.91-1.60],0.1848427035348641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN2,Alpha-actinin-2,19847,157,1.39 [1.14-1.70],0.0012513044182198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN4,Alpha-actinin-4,23300,174,1.35 [0.97-1.89],0.0772214477314716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACVRL1,Serine/threonine-protein kinase receptor R3,23464,174,1.11 [0.66-1.88],0.6946730907173275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY1,Aminoacylase-1,23713,172,0.97 [0.78-1.22],0.8229993792336555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19847,157,0.91 [0.69-1.22],0.5354661843628479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACYP1,Acylphosphatase-1,20014,158,1.23 [0.97-1.54],0.0815002643709014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA,Adenosine deaminase,23989,179,1.22 [0.86-1.72],0.2580919274588195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA2,Adenosine deaminase 2,23592,175,0.99 [0.73-1.35],0.9681272214610048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19940,158,1.61 [1.08-2.40],0.0182271917846273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,23281,173,1.11 [0.72-1.71],0.6289105812087592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,23507,174,1.09 [0.75-1.58],0.6485340405306113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,23989,179,1.23 [0.83-1.81],0.3032886421465383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23889,177,1.03 [0.65-1.61],0.9101001363375286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,20481,163,0.96 [0.58-1.59],0.8800190013992529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19940,158,0.99 [0.61-1.61],0.9620076495108764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24010,179,0.76 [0.44-1.32],0.3365093001746407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,23599,177,1.01 [0.73-1.39],0.965485514068703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,23281,173,1.29 [0.94-1.78],0.1177395057200781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19940,158,0.99 [0.65-1.53],0.976528902361384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,23774,174,0.64 [0.48-0.85],0.0022583959484434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL2,ADAMTS-like protein 2,20552,162,1.16 [0.75-1.79],0.5163181223749107
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL4,ADAMTS-like protein 4,19981,164,0.68 [0.37-1.26],0.2190417327170274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL5,ADAMTS-like protein 5,20545,162,0.83 [0.57-1.21],0.3400481500312788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23155,169,1.05 [0.71-1.55],0.7949421150131284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADD1,Alpha-adducin,20082,158,1.21 [0.97-1.50],0.0853912484284078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRB3,Adhesion G protein-coupled receptor B3,23464,174,0.97 [0.65-1.45],0.8722738555646087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRD1,Adhesion G-protein coupled receptor D1,20082,158,1.15 [0.79-1.67],0.4641122306693076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE1,Adhesion G protein-coupled receptor E1,20481,163,0.97 [0.74-1.28],0.8372697997398658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE2,Adhesion G protein-coupled receptor E2,23798,178,0.94 [0.59-1.50],0.8012601850824078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE5,Adhesion G protein-coupled receptor E5,23895,178,0.84 [0.54-1.30],0.4259801921075226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRF5,Adhesion G protein-coupled receptor F5,20545,162,1.20 [0.68-2.10],0.5345224246794456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG1,Adhesion G-protein coupled receptor G1,23599,177,1.05 [0.90-1.23],0.5385059427281782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG2,Adhesion G-protein coupled receptor G2,23713,172,1.26 [0.76-2.10],0.3651899273126807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRV1,Adhesion G-protein coupled receptor V1,19888,158,1.04 [0.84-1.29],0.701612748379913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH1B,All-trans-retinol dehydrogenase,20082,158,1.13 [0.92-1.38],0.2424393171277982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,23281,173,1.05 [0.89-1.24],0.5890078493224975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADIPOQ,Adiponectin,20568,163,1.22 [0.98-1.51],0.0753468558825514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADM,Pro-adrenomedullin,23920,179,1.28 [0.77-2.13],0.3474599414847478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADRA2A,Alpha-2A adrenergic receptor,19847,157,1.06 [0.87-1.30],0.558435143361645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFAP1,Actin filament-associated protein 1,20082,158,1.07 [0.90-1.29],0.4411573523151193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFM,Afamin,20568,163,0.92 [0.44-1.93],0.8169174058167906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFP,Alpha-fetoprotein,23421,174,0.88 [0.71-1.08],0.2168668139538331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGBL2,Cytosolic carboxypeptidase 2,19888,158,0.89 [0.76-1.04],0.1417648056231693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGER,Advanced glycosylation end product-specific receptor,23644,178,0.90 [0.65-1.24],0.5112536250426585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR2,Anterior gradient protein 2 homolog,23016,175,1.05 [0.92-1.20],0.4816860944375406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR3,Anterior gradient protein 3,23118,169,0.83 [0.65-1.05],0.1214995900630691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRN,Agrin,23798,178,1.42 [1.00-2.01],0.0499234411996663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRP,Agouti-related protein,23989,179,1.22 [0.94-1.58],0.1302226610748897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGT,Angiotensinogen,20572,165,1.60 [0.87-2.93],0.1272265686045717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGXT,Serine--pyruvate aminotransferase,23713,172,0.98 [0.81-1.17],0.7912069330544186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHCY,Adenosylhomocysteinase,23713,172,1.11 [0.91-1.36],0.282821765223984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK,Neuroblast differentiation-associated protein AHNAK,19981,164,0.61 [0.37-1.01],0.0541649416848189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK2,Protein AHNAK2,19981,164,1.25 [0.79-1.99],0.342891057375441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,20474,161,1.07 [0.86-1.33],0.519619858413955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSG,Alpha-2-HS-glycoprotein,20572,165,0.77 [0.44-1.32],0.3413732384695366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSP,Alpha-hemoglobin-stabilizing protein,23678,175,1.02 [0.87-1.21],0.7844242332037611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIDA,"Axin interactor, dorsalization-associated protein",19997,159,0.88 [0.72-1.08],0.21161242834529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1,Allograft inflammatory factor 1,23155,169,1.28 [0.99-1.65],0.0565336188068586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1L,Allograft inflammatory factor 1-like,19981,164,1.11 [0.86-1.43],0.4413536859535537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23566,176,1.11 [0.98-1.26],0.0858268989738788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK1,Adenylate kinase isoenzyme 1,23713,172,1.13 [0.92-1.40],0.2385814097240926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK2,"Adenylate kinase 2, mitochondrial",20496,162,1.07 [0.93-1.24],0.3164974142497486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKAP12,A-kinase anchor protein 12,20082,158,0.93 [0.44-1.98],0.8449084314447248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B1,Aldo-keto reductase family 1 member B1,23155,169,1.16 [0.97-1.40],0.1023496108389072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B10,Aldo-keto reductase family 1 member B10,19997,159,0.95 [0.74-1.23],0.7058414720568617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1C4,Aldo-keto reductase family 1 member C4,23281,173,1.08 [0.84-1.38],0.5463446703455989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19940,158,0.99 [0.78-1.24],0.9012349258450484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT1S1,Proline-rich AKT1 substrate 1,23189,175,1.14 [0.93-1.40],0.1992693139864275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT2,RAC-beta serine/threonine-protein kinase,20505,164,1.11 [0.98-1.24],0.0965024600680404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT3,RAC-gamma serine/threonine-protein kinase,23047,168,1.23 [0.97-1.56],0.0811299935916421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALCAM,CD166 antigen,24010,179,1.16 [0.59-2.29],0.6631175805590965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH1A1,Retinal dehydrogenase 1,23722,175,1.00 [0.77-1.28],0.9774143593267598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH2,"Aldehyde dehydrogenase, mitochondrial",20474,161,0.93 [0.68-1.28],0.6639815355306333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",23642,176,1.18 [0.99-1.42],0.0650153630363118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",20505,164,1.31 [0.98-1.76],0.0683239137505984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALMS1,Alstrom syndrome protein 1,20186,161,0.79 [0.54-1.16],0.2271692249775406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPI,Intestinal-type alkaline phosphatase,19940,158,0.95 [0.84-1.08],0.4466237070685398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPP,"Alkaline phosphatase, placental type",23599,177,0.98 [0.86-1.11],0.7606062590344936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBN,Ameloblastin,23300,174,0.82 [0.47-1.42],0.474289599901283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBP,Protein AMBP,23884,179,1.25 [0.65-2.41],0.4961139437670091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,20552,162,0.79 [0.45-1.40],0.4231741299035861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMFR,E3 ubiquitin-protein ligase AMFR,23189,175,1.01 [0.81-1.24],0.9529846971882684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO1,Amphoterin-induced protein 1,19997,159,0.86 [0.62-1.21],0.3859456380806487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO2,Amphoterin-induced protein 2,23599,177,1.30 [0.74-2.29],0.3547833098028842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMN,Protein amnionless,23300,174,1.05 [0.79-1.39],0.7455642146888308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOT,Angiomotin,20082,158,0.80 [0.53-1.22],0.3012295349851684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOTL2,Angiomotin-like protein 2,20385,161,1.25 [0.96-1.63],0.0997192296895086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMPD3,AMP deaminase 3,20496,162,1.05 [0.85-1.29],0.6726790390547411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19298,151,0.91 [0.66-1.26],0.5785935331866722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2A,Pancreatic alpha-amylase,22829,166,0.94 [0.71-1.26],0.6909338233133802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2B,Alpha-amylase 2B,22115,162,0.90 [0.68-1.20],0.4883678223595791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANG,Angiogenin,23672,175,1.26 [0.85-1.87],0.2420625266830284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT1,Angiopoietin-1,23622,178,1.12 [0.95-1.32],0.1652036889015634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT2,Angiopoietin-2,23920,179,1.44 [1.03-2.01],0.0330551581070211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL1,Angiopoietin-related protein 1,23339,170,1.62 [1.02-2.59],0.0429469952332595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL2,Angiopoietin-related protein 2,23716,178,0.87 [0.62-1.22],0.4146902266551694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL3,Angiopoietin-related protein 3,23751,176,1.17 [0.79-1.72],0.4402354452120274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL4,Angiopoietin-related protein 4,23762,178,1.17 [0.87-1.57],0.2977409310869308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL7,Angiopoietin-related protein 7,23920,179,1.14 [0.79-1.65],0.4738756154445245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANK2,Ankyrin-2,19847,157,0.99 [0.79-1.23],0.8944025144811905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19940,158,1.07 [0.88-1.29],0.4871355549642224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRA2,Ankyrin repeat family A protein 2,19825,157,1.02 [0.77-1.35],0.8910172970693044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRD54,Ankyrin repeat domain-containing protein 54,23155,169,1.00 [0.79-1.27],0.9757631340327296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19981,164,1.02 [0.69-1.50],0.9321946484897932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANPEP,Aminopeptidase N,23790,176,1.58 [1.00-2.51],0.0521893701417911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA1,Annexin A1,19979,157,1.18 [0.87-1.61],0.2816096412997397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA10,Annexin A10,23189,175,1.02 [0.87-1.20],0.7886911124521319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA11,Annexin A11,23642,176,1.15 [0.93-1.42],0.1852684376673115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA2,Annexin A2,19686,163,1.06 [0.86-1.30],0.5924813387569728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA3,Annexin A3,23889,177,1.20 [0.99-1.44],0.056964146035525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA4,Annexin A4,23611,171,1.15 [0.96-1.38],0.1266900832128016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA5,Annexin A5,23104,174,1.26 [0.81-1.95],0.3007278159370252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC1,Amiloride-sensitive amine oxidase [copper-containing],23300,174,1.19 [0.97-1.46],0.093715642651058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC3,Membrane primary amine oxidase,23824,176,1.36 [0.86-2.15],0.1892018274361624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP1G2,AP-1 complex subunit gamma-like 2,20474,161,1.05 [0.87-1.26],0.6411889167970304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP2B1,AP-2 complex subunit beta,19997,159,1.07 [0.79-1.46],0.6602002377629063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3B1,AP-3 complex subunit beta-1,20481,163,1.18 [0.97-1.42],0.0925231448548792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3S2,AP-3 complex subunit sigma-2,20496,162,1.32 [0.99-1.77],0.0603138931281852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,23599,177,1.19 [0.92-1.54],0.1963695303801028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APCS,Serum amyloid P-component,20386,163,1.29 [0.81-2.06],0.2876794762735464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,23855,176,1.15 [0.93-1.43],0.2036915149528629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APLP1,Amyloid-like protein 1,23713,172,0.75 [0.57-0.98],0.0374114725717814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA1,Apolipoprotein A-I,20568,163,1.09 [0.64-1.87],0.7463596083485688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA2,Apolipoprotein A-II,20572,165,0.75 [0.56-1.02],0.0674353773266391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA4,Apolipoprotein A-IV,20568,163,0.74 [0.47-1.18],0.2084649459529084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOB,Apolipoprotein B-100,20572,165,1.21 [0.63-2.33],0.5748737646775136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOBR,Apolipoprotein B receptor,19981,164,1.04 [0.73-1.47],0.8455035202316913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOC1,Apolipoprotein C-I,20535,163,1.08 [0.73-1.59],0.7066413512112462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOD,Apolipoprotein D,19673,155,1.04 [0.72-1.50],0.8299999459023955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOE,Apolipoprotein E,20568,163,1.10 [0.91-1.33],0.3195252215529974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOF,Apolipoprotein F,20572,165,1.07 [0.58-1.98],0.828080410943941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOH,Beta-2-glycoprotein 1,23722,175,1.14 [0.80-1.63],0.4800900284167489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOL1,Apolipoprotein L1,20572,165,0.99 [0.74-1.31],0.9215744324846769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOM,Apolipoprotein M,23789,176,1.31 [0.82-2.08],0.2547781520565619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APP,Amyloid-beta precursor protein,23685,174,1.13 [0.92-1.38],0.2472063391509714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APPL2,DCC-interacting protein 13-beta,20082,158,1.08 [0.94-1.24],0.2912364003986975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APRT,Adenine phosphoribosyltransferase,23463,174,1.29 [0.96-1.73],0.0895804158958606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARAF,Serine/threonine-protein kinase A-Raf,20186,161,0.98 [0.78-1.22],0.832984765820744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AREG,Amphiregulin,23599,177,1.57 [1.16-2.12],0.0035379984736437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARF6,ADP-ribosylation factor 6,20481,163,1.14 [0.99-1.32],0.0617766292144901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARFIP1,Arfaptin-1,20505,164,1.15 [0.93-1.42],0.2111787151644527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG1,Arginase-1,23553,175,0.93 [0.72-1.20],0.5612154037402166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG2,"Arginase-2, mitochondrial",20474,161,0.85 [0.57-1.26],0.4179334042722274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP1,Rho GTPase-activating protein 1,23155,169,1.29 [0.96-1.74],0.086369409986922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP25,Rho GTPase-activating protein 25,23155,169,1.24 [1.01-1.52],0.0363218792703132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP30,Rho GTPase-activating protein 30,20186,161,0.68 [0.42-1.09],0.1123037971651234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP45,Rho GTPase-activating protein 45,20082,158,1.07 [0.89-1.29],0.4779002535602422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP5,Rho GTPase-activating protein 5,19825,157,1.16 [0.97-1.39],0.1069917715112447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF1,Rho guanine nucleotide exchange factor 1,20496,162,1.15 [0.97-1.37],0.0971758905712501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF10,Rho guanine nucleotide exchange factor 10,20505,164,1.02 [0.87-1.19],0.822910749222182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF12,Rho guanine nucleotide exchange factor 12,23685,176,1.06 [0.93-1.21],0.3674649544911813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF5,Rho guanine nucleotide exchange factor 5,19888,158,0.91 [0.73-1.14],0.4071779709983978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID3A,AT-rich interactive domain-containing protein 3A,19888,158,0.98 [0.67-1.44],0.9194194408885648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID4B,AT-rich interactive domain-containing protein 4B,23189,175,0.92 [0.66-1.29],0.636677020467102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL13B,ADP-ribosylation factor-like protein 13B,19847,157,1.08 [0.87-1.34],0.4666639905441435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19847,157,1.28 [0.89-1.83],0.1896372494634862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARMCX2,Armadillo repeat-containing X-linked protein 2,19888,158,0.89 [0.66-1.19],0.4239232127699681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNT,Aryl hydrocarbon receptor nuclear translocator,23300,174,1.00 [0.70-1.44],0.9792616033547348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19847,157,1.06 [0.80-1.41],0.6941287577973099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSA,Arylsulfatase A,23722,175,1.32 [1.00-1.76],0.0507029175544517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSB,Arylsulfatase B,23599,177,1.11 [0.88-1.40],0.3909237533114476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART3,Ecto-ADP-ribosyltransferase 3,23824,176,0.53 [0.37-0.76],0.0005596941793227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART5,Ecto-ADP-ribosyltransferase 5,19888,158,0.72 [0.52-1.00],0.0505531483064562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARTN,Artemin,23300,174,1.20 [0.93-1.53],0.1542787751398789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH1,Acid ceramidase,20367,161,1.17 [0.86-1.58],0.3147689705132115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH2,Neutral ceramidase,23507,174,0.97 [0.76-1.25],0.8341774713969314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR1,Asialoglycoprotein receptor 1,23507,174,1.22 [0.79-1.88],0.3756543582684003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR2,Asialoglycoprotein receptor 2,20572,165,0.93 [0.53-1.63],0.7981353689945112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPN,Asporin,20545,162,0.88 [0.51-1.54],0.6609689145472525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPSCR1,Tether containing UBX domain for GLUT4,20505,164,1.15 [0.92-1.44],0.2142851898295776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19981,164,1.06 [0.91-1.22],0.4785182318764058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASS1,Argininosuccinate synthase,19847,157,0.92 [0.75-1.13],0.4271927635386293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF2,Cyclic AMP-dependent transcription factor ATF-2,23189,175,0.88 [0.69-1.11],0.2812223538591802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF4,Cyclic AMP-dependent transcription factor ATF-4,19825,157,1.02 [0.65-1.62],0.9165816069946622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG16L1,Autophagy-related protein 16-1,20481,163,1.07 [0.89-1.27],0.4778425584272269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG4A,Cysteine protease ATG4A,23155,169,1.22 [0.98-1.52],0.0803697915892414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATOX1,Copper transport protein ATOX1,23774,174,1.16 [0.96-1.40],0.1277844142502894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19847,157,0.70 [0.47-1.05],0.0853726806012986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19847,157,1.06 [0.66-1.70],0.8177728763978286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19847,157,0.95 [0.63-1.44],0.8248527545207842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B4,Protein ATP1B4,19825,157,0.98 [0.67-1.42],0.9091587389977412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19847,157,0.99 [0.78-1.27],0.9556092492207914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19847,157,0.71 [0.49-1.03],0.0721931617542623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5IF1,"ATPase inhibitor, mitochondrial",23798,178,1.11 [0.99-1.26],0.0796764270524779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5PO,"ATP synthase subunit O, mitochondrial",23189,175,1.24 [0.94-1.63],0.129980770240775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6AP2,Renin receptor,23155,169,0.94 [0.66-1.35],0.7393626749621823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1D,V-type proton ATPase subunit D,23599,177,1.02 [0.61-1.70],0.9446776361962482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1F,V-type proton ATPase subunit F,23156,175,1.08 [0.88-1.32],0.4503014202432104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G1,V-type proton ATPase subunit G 1,19981,164,1.20 [0.98-1.46],0.0726913077787575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G2,V-type proton ATPase subunit G 2,19847,157,1.05 [0.90-1.23],0.5372176899779282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRAID,All-trans retinoic acid-induced differentiation factor,20481,163,1.30 [0.87-1.92],0.1969951697731597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRN,"Attractin, Isoform 2",20568,163,0.90 [0.37-2.21],0.8164993287197833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN10,Ataxin-10,23189,175,1.08 [0.90-1.31],0.3974016297995093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2,Ataxin-2,19888,158,0.97 [0.83-1.13],0.6678900964595423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2L,Ataxin-2-like protein,20505,164,1.44 [1.12-1.86],0.0040147464944707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN3,Ataxin-3,20496,162,1.16 [0.92-1.48],0.2120195497255129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXIN1,Axin-1,23685,176,1.10 [0.95-1.26],0.1912764619818148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXL,Tyrosine-protein kinase receptor UFO,23824,176,0.97 [0.60-1.58],0.9086600809685396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZI2,5-azacytidine-induced protein 2,20505,164,1.07 [0.82-1.39],0.6249880186661836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZU1,Azurocidin,23044,169,1.13 [0.97-1.33],0.122784936547514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B2M,Beta-2-microglobulin,20568,163,1.22 [0.83-1.81],0.3089454706414094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19847,157,1.76 [0.94-3.30],0.0750781287238664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19981,164,1.22 [0.81-1.83],0.3426791172787096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GALT1,"Beta-1,4-galactosyltransferase 1",23798,178,1.29 [0.81-2.07],0.2854689821347759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GAT1,"Beta-1,4-glucuronyltransferase 1",23722,175,0.92 [0.53-1.60],0.771994129939219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BABAM1,BRISC and BRCA1-A complex member 1,19940,158,1.13 [0.68-1.87],0.63079436046352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BACH1,Transcription regulator protein BACH1,23685,176,1.06 [0.88-1.26],0.536943559130457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG3,BAG family molecular chaperone regulator 3,23464,174,1.05 [0.75-1.46],0.7898502823357183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG4,BAG family molecular chaperone regulator 4,19940,158,1.09 [0.81-1.47],0.5524990918999516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG6,Large proline-rich protein BAG6,23281,173,1.26 [0.88-1.81],0.2055869879606847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23155,169,1.01 [0.81-1.24],0.958143214475024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAMBI,BMP and activin membrane-bound inhibitor homolog,23155,169,0.96 [0.60-1.54],0.8561484854940887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BANK1,B-cell scaffold protein with ankyrin repeats,23685,176,1.03 [0.91-1.17],0.6117237983625576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAP18,Chromatin complexes subunit BAP18,20496,162,1.07 [0.88-1.31],0.4974695959629009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BATF,Basic leucine zipper transcriptional factor ATF-like,19997,159,0.90 [0.72-1.11],0.3047846437580946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAX,Apoptosis regulator BAX,23146,175,1.07 [0.92-1.24],0.3636969382185555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAM,Basal cell adhesion molecule,23722,175,1.49 [0.88-2.52],0.1376057171205856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAN,Brevican core protein,23507,174,0.74 [0.50-1.09],0.1254104440158537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20545,162,0.88 [0.53-1.46],0.6219387873286806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19888,158,1.02 [0.76-1.35],0.9161694286282794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCHE,Cholinesterase,20189,162,0.86 [0.49-1.50],0.5887509307925638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2,Apoptosis regulator Bcl-2,20481,163,1.06 [0.82-1.38],0.6516114242674245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L1,Bcl-2-like protein 1,20496,162,1.12 [0.96-1.30],0.1467104600327183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",23685,176,1.18 [0.84-1.65],0.334262439825388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L15,Bcl-2-like protein 15,19940,158,0.86 [0.65-1.14],0.2921013537566994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7A,B-cell CLL/lymphoma 7 protein family member A,19825,157,1.23 [1.01-1.49],0.0416283513819622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7B,B-cell CLL/lymphoma 7 protein family member B,20474,161,0.83 [0.58-1.19],0.3172474056002388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCR,Breakpoint cluster region protein,23685,176,1.08 [0.93-1.24],0.3228046932322727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BDNF,Brain-derived neurotrophic factor,20552,162,1.13 [0.94-1.36],0.1818585963713743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BECN1,Beclin-1,19981,164,1.14 [0.89-1.46],0.2996815532231388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BEX3,Protein BEX3,19825,157,0.83 [0.57-1.21],0.3445306890609948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGLAP,Osteocalcin,20552,162,1.02 [0.85-1.22],0.8489877842219452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGN,Biglycan,23119,169,0.84 [0.74-0.95],0.0049780834612332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHLHE40,Class E basic helix-loop-helix protein 40,19888,158,1.04 [0.84-1.29],0.7155228887347365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19847,157,1.23 [0.68-2.22],0.4954871854305179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BID,BH3-interacting domain death agonist,23685,176,1.14 [0.94-1.38],0.1731867303150939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIN2,Bridging integrator 2,23722,175,1.04 [0.90-1.21],0.6171915442261497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIRC2,Baculoviral IAP repeat-containing protein 2,23155,169,1.13 [0.92-1.40],0.252291328591686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLMH,Bleomycin hydrolase,24010,179,1.10 [0.72-1.69],0.6477276515608595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLNK,B-cell linker protein,19940,158,1.24 [0.89-1.72],0.199747164291983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19888,158,0.98 [0.80-1.21],0.8596907776682594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,20496,162,1.22 [0.86-1.74],0.2623056460881914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLVRB,Flavin reductase,23722,175,1.04 [0.86-1.27],0.6702606927867387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP10,Bone morphogenetic protein 10,20082,158,1.22 [0.71-2.09],0.4818196487478343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP4,Bone morphogenetic protein 4,23464,174,1.00 [0.75-1.34],0.9860049031598488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP6,Bone morphogenetic protein 6,23244,173,1.02 [0.72-1.43],0.9185188901974494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMPER,BMP-binding endothelial regulator protein,20082,158,1.10 [0.56-2.15],0.7895693672663561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,20545,162,1.23 [0.81-1.86],0.3355947714491775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19940,158,1.08 [0.77-1.52],0.646226235218931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOC,Brother of CDO,23281,173,1.37 [0.76-2.44],0.2928939530494562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA1,BolA-like protein 1,19888,158,1.18 [0.91-1.54],0.2185350494063939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA2_BOLA2B,BolA-like protein 2,19981,164,1.07 [0.80-1.42],0.6539705146134358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFA2,BPI fold-containing family A member 2,19308,158,0.94 [0.81-1.09],0.3964860091975315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB1,BPI fold-containing family B member 1,23674,179,0.92 [0.75-1.13],0.4437911671419156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB2,BPI fold-containing family B member 2,20508,161,1.26 [1.01-1.58],0.0442587216749331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRAP,BRCA1-associated protein,20280,162,1.05 [0.91-1.21],0.4835672716811077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD1,Bromodomain-containing protein 1,20186,161,0.77 [0.45-1.33],0.3448492293060325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD2,Bromodomain-containing protein 2,19888,158,0.88 [0.55-1.41],0.6080766041237096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD3,Bromodomain-containing protein 3,19847,157,0.94 [0.67-1.31],0.7149806260440132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRDT,Bromodomain testis-specific protein,19847,157,1.61 [1.10-2.36],0.0143653600393233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRK1,Protein BRICK1,23189,175,1.30 [0.97-1.74],0.081944263002921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRME1,Break repair meiotic recombinase recruitment factor 1,19888,158,1.36 [1.03-1.81],0.032236780995367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRSK2,Serine/threonine-protein kinase BRSK2,20505,164,1.07 [0.72-1.60],0.7231814218339624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSG,Basigin,23950,178,0.98 [0.51-1.86],0.9388036284723098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSND,Barttin,19825,157,1.13 [0.75-1.71],0.5564449382537278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,23926,178,0.93 [0.72-1.22],0.6156081663889279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST2,Bone marrow stromal antigen 2,23926,178,1.19 [0.93-1.52],0.1629424607938165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTC,Probetacellulin,23155,169,1.25 [1.06-1.47],0.0070590846170559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTD,Biotinidase,20568,163,0.71 [0.35-1.46],0.352637260019816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTLA,B- and T-lymphocyte attenuator,19825,157,1.06 [0.90-1.24],0.4913700366200859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN1A1,Butyrophilin subfamily 1 member A1,20435,161,1.30 [0.95-1.77],0.1026394722849666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN2A1,Butyrophilin subfamily 2 member A1,23798,178,1.04 [0.64-1.70],0.8771042435270646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN3A2,Butyrophilin subfamily 3 member A2,23685,176,1.26 [0.90-1.76],0.1787120720144432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTNL10,Butyrophilin-like protein 10,19825,157,1.09 [0.76-1.55],0.6452171841202596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C19orf12,Protein C19orf12,23189,175,0.97 [0.79-1.21],0.8097570452362357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1GALT1C1,C1GALT1-specific chaperone 1,19847,157,0.90 [0.55-1.47],0.6847587741820593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QA,Complement C1q subcomponent subunit A,23877,177,1.36 [0.76-2.44],0.2989900732267902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",20505,164,0.99 [0.80-1.24],0.939008006289278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QL2,Complement C1q-like protein 2,19940,158,0.71 [0.49-1.04],0.0774254540017149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23824,176,1.21 [0.89-1.64],0.225137654210862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20082,158,0.94 [0.62-1.43],0.7818215197611729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,20505,164,0.81 [0.49-1.34],0.4057277712756452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20051,158,0.91 [0.67-1.24],0.5554002008532959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1R,Complement C1r subcomponent,20568,163,1.34 [0.67-2.67],0.4047908220294222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1RL,Complement C1r subcomponent-like protein,20528,163,1.79 [0.82-3.92],0.1451971187838948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1S,Complement C1s subcomponent,20568,163,1.48 [0.74-2.97],0.2702362152791463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2,Complement C2,23789,176,1.76 [0.91-3.42],0.0926563087129753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2CD2L,Phospholipid transfer protein C2CD2L,23156,175,0.80 [0.57-1.13],0.2066364405597668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2orf69,UPF0565 protein C2orf69,19997,159,0.99 [0.76-1.29],0.9677135003988508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C3,Complement C3,19520,154,1.24 [0.91-1.68],0.1667360458009063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C4BPB,C4b-binding protein beta chain,23774,174,1.11 [0.78-1.57],0.5598622387678146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C5,Complement C5,20568,163,1.30 [0.48-3.53],0.603164068137464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7,Complement component C7,20073,159,1.68 [1.05-2.69],0.03148028692543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7orf50,Uncharacterized protein C7orf50,20496,162,1.09 [0.61-1.95],0.7765911882575033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C8B,Complement component C8 beta chain,20568,163,1.39 [0.85-2.29],0.1914988598142549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9,Complement component C9,20572,165,1.19 [0.91-1.56],0.2043150142531108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9orf40,Uncharacterized protein C9orf40,20481,163,0.99 [0.82-1.20],0.9461780453726168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA1,Carbonic anhydrase 1,23219,171,0.98 [0.77-1.24],0.8573660302832125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA11,Carbonic anhydrase-related protein 11,23155,169,0.94 [0.58-1.51],0.7874869996845522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA12,Carbonic anhydrase 12,23599,177,0.86 [0.56-1.30],0.4639293655715124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA13,Carbonic anhydrase 13,23437,170,1.07 [0.94-1.22],0.3257683454633073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA14,Carbonic anhydrase 14,23920,179,0.59 [0.41-0.84],0.0039218010137596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA2,Carbonic anhydrase 2,23643,175,1.04 [0.86-1.26],0.6989407850664457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA3,Carbonic anhydrase 3,23976,179,1.46 [1.20-1.79],0.0002135244939694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA4,Carbonic anhydrase 4,24010,179,0.82 [0.48-1.41],0.4774796416624824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA5A,"Carbonic anhydrase 5A, mitochondrial",23281,173,0.94 [0.80-1.09],0.3951954405162384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA6,Carbonic anhydrase 6,23650,175,0.84 [0.68-1.04],0.1126703725751953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA7,Carbonic anhydrase 7,20186,161,0.97 [0.62-1.53],0.9002915303233308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA8,Carbonic anhydrase-related protein,19940,158,0.82 [0.42-1.59],0.5565900606694877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA9,Carbonic anhydrase 9,23920,179,0.96 [0.72-1.28],0.7843462393794622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CABP2,Calcium-binding protein 2,19997,159,1.00 [0.79-1.27],0.9998115830572132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19888,158,0.98 [0.60-1.59],0.923737759183239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19847,157,0.72 [0.51-1.04],0.0779605148345956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19888,158,0.91 [0.70-1.19],0.5004303969361239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,20505,164,1.14 [0.96-1.36],0.1365156675921138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACYBP,Calcyclin-binding protein,20050,158,1.11 [0.95-1.28],0.1909858791479242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CADPS,Calcium-dependent secretion activator 1,19997,159,0.77 [0.50-1.19],0.2431062928619913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB1,Calbindin,23599,177,1.07 [0.79-1.44],0.6650301021312984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB2,Calretinin,23189,175,1.20 [0.77-1.87],0.4202830880030592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCA,Calcitonin,23474,174,1.17 [0.97-1.40],0.1008121793257904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCB,Calcitonin gene-related peptide 2,20496,162,1.38 [1.01-1.88],0.0455252572039577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,23849,177,1.03 [0.91-1.18],0.6251268027532256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19981,164,1.08 [0.88-1.31],0.4659301097588804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALY,Neuron-specific vesicular protein calcyon,19847,157,1.10 [0.75-1.60],0.6292272351536801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23155,169,1.19 [0.89-1.59],0.2395933699301464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19997,159,0.95 [0.71-1.27],0.7440073769643532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,20505,164,1.05 [0.91-1.20],0.5285914506215751
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CANT1,Soluble calcium-activated nucleotidase 1,23633,172,1.11 [0.57-2.18],0.7507620631168881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPG,Macrophage-capping protein,23549,177,1.13 [0.91-1.41],0.2662080970952121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPN3,Calpain-3,20474,161,1.64 [1.27-2.14],0.0002004649151927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPS,Calcyphosin,20496,162,1.04 [0.90-1.19],0.6326703648436838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CARHSP1,Calcium-regulated heat-stable protein 1,23189,175,0.94 [0.72-1.23],0.6648681150117144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASC3,Protein CASC3,19997,159,1.14 [0.80-1.62],0.4637728479593247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP1,Caspase-1,23189,175,0.91 [0.74-1.11],0.3342876032341221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP10,Caspase-10,23189,175,1.02 [0.85-1.23],0.8295994446732997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP2,Caspase-2,23685,176,1.14 [0.94-1.37],0.1946986005944222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP3,Caspase-3,24010,179,1.12 [0.96-1.30],0.1504823534742782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP4,Caspase-4,20186,161,0.90 [0.82-1.00],0.0569054288461727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP7,Caspase-7,20496,162,1.15 [0.96-1.37],0.1203332599790891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP8,Caspase-8,23856,177,1.17 [0.96-1.43],0.120781976656905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP9,Caspase-9,19940,158,1.13 [0.90-1.43],0.3011486281883121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASQ2,Calsequestrin-2,19847,157,1.11 [0.82-1.48],0.5046101313549591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAT,Catalase,20275,164,1.11 [0.85-1.46],0.4361425628242252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLIF,Cobalamin binding intrinsic factor,23682,172,0.98 [0.82-1.17],0.8200120060750401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN1,Cerebellin-1,19888,158,0.99 [0.83-1.17],0.8767450448687878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN4,Cerebellin-4,23920,179,0.91 [0.60-1.37],0.6424560277208997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBS,Cystathionine beta-synthase,19981,164,0.91 [0.67-1.25],0.5722559622961829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBX2,Chromobox protein homolog 2,19847,157,0.69 [0.42-1.14],0.1450173852930767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,23507,174,1.10 [0.92-1.31],0.3130891557028236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCAR2,Cell cycle and apoptosis regulator protein 2,20496,162,0.72 [0.49-1.04],0.0829357988457125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC134,Coiled-coil domain-containing protein 134,20474,161,0.91 [0.66-1.25],0.547372778570772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC28A,Coiled-coil domain-containing protein 28A,19997,159,0.87 [0.52-1.45],0.583165522359126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC50,Coiled-coil domain-containing protein 50,20505,164,1.09 [0.91-1.31],0.3345921004042279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC80,Coiled-coil domain-containing protein 80,23713,172,1.70 [1.19-2.41],0.0031402919551248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19981,164,0.82 [0.64-1.05],0.1182704852479939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL11,Eotaxin,23989,179,0.93 [0.66-1.33],0.7071382060633897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL13,C-C motif chemokine 13,23955,179,1.12 [0.92-1.35],0.2599608579310344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL14,C-C motif chemokine 14,23672,175,1.53 [1.16-2.01],0.0022706239782143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL15,C-C motif chemokine 15,24010,179,1.09 [0.81-1.47],0.5659022364320097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL16,C-C motif chemokine 16,24010,179,0.82 [0.64-1.04],0.1012656302690368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL17,C-C motif chemokine 17,23637,177,1.14 [0.99-1.31],0.0726998473591321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL18,C-C motif chemokine 18,23414,174,1.14 [0.96-1.35],0.123478663711716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL19,C-C motif chemokine 19,23926,178,1.12 [1.02-1.23],0.0157021396335177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL2,C-C motif chemokine 2,23464,174,0.98 [0.76-1.27],0.8703362529819231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL20,C-C motif chemokine 20,23989,179,0.99 [0.85-1.15],0.8852659848171831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL21,C-C motif chemokine 21,23798,178,1.48 [1.13-1.95],0.0041837905334688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL22,C-C motif chemokine 22,23443,176,1.11 [0.86-1.42],0.4332655118596571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL23,C-C motif chemokine 23,23798,178,1.33 [0.97-1.82],0.0721439834468497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL24,C-C motif chemokine 24,23762,178,0.97 [0.83-1.14],0.728385905348705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL25,C-C motif chemokine 25,23989,179,0.87 [0.66-1.14],0.3054174290861314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL26,C-C motif chemokine 26,23685,176,1.02 [0.89-1.18],0.7305756299085588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL27,C-C motif chemokine 27,23713,172,0.97 [0.78-1.21],0.7974342393641112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL28,C-C motif chemokine 28,23604,176,1.14 [0.91-1.41],0.2519010264574854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL3,C-C motif chemokine 3,23685,176,1.12 [0.91-1.37],0.2953630016527089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL4,C-C motif chemokine 4,23720,177,1.13 [0.95-1.36],0.1725417521146572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL5,C-C motif chemokine 5,23824,176,1.16 [1.02-1.32],0.0231495223595189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL7,C-C motif chemokine 7,23685,176,1.41 [1.18-1.69],0.0001449397046249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL8,C-C motif chemokine 8,23884,179,1.23 [0.99-1.53],0.0627775617266093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN1,CCN family member 1,23563,177,1.20 [0.99-1.44],0.0617899321458094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN2,CCN family member 2,23683,178,1.34 [1.06-1.69],0.0145741470950553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN3,CCN family member 3,23965,179,1.70 [1.19-2.43],0.0033212785975324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN4,CCN family member 4,23920,179,1.32 [0.95-1.83],0.099343412929324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN5,CCN family member 5,23722,175,1.04 [0.73-1.48],0.843385888158876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCND2,G1/S-specific cyclin-D2,20186,161,0.66 [0.49-0.89],0.0069190204054029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCNE1,G1/S-specific cyclin-E1,19940,158,0.80 [0.63-1.02],0.068516151494839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCS,Copper chaperone for superoxide dismutase,23507,174,1.18 [0.89-1.57],0.2412448337214267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCT5,T-complex protein 1 subunit epsilon,23155,169,1.13 [0.84-1.52],0.4115585914514982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD101,Immunoglobulin superfamily member 2,20481,163,1.05 [0.75-1.48],0.7767281224678868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD109,CD109 antigen,23722,175,0.91 [0.61-1.36],0.6552232365697499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD14,Monocyte differentiation antigen CD14,23273,172,1.18 [0.85-1.63],0.327239395609364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD160,CD160 antigen,23989,179,0.85 [0.64-1.13],0.2583207887955712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD163,Scavenger receptor cysteine-rich type 1 protein M130,23824,176,1.07 [0.79-1.46],0.646169104482208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164,Sialomucin core protein 24,23722,175,1.26 [0.82-1.93],0.2978542364774095
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164L2,CD164 sialomucin-like 2 protein,19997,159,0.93 [0.61-1.43],0.7410078742098658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD177,CD177 antigen,23680,175,0.94 [0.86-1.04],0.2415965711081071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD1C,T-cell surface glycoprotein CD1c,23774,174,0.87 [0.51-1.49],0.6188169612717669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2,T-cell surface antigen CD2,19847,157,1.04 [0.71-1.53],0.8508648317926821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200,OX-2 membrane glycoprotein,23685,176,1.15 [0.71-1.86],0.5665443688842133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200R1,Cell surface glycoprotein CD200 receptor 1,23605,176,0.95 [0.65-1.38],0.7784429841767582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD207,C-type lectin domain family 4 member K,23177,172,1.09 [0.77-1.54],0.6270892855847243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD209,CD209 antigen,23778,178,0.93 [0.66-1.31],0.69173871765366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD22,B-cell receptor CD22,23989,179,0.99 [0.73-1.35],0.948393689366175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD226,CD226 antigen,19940,158,1.05 [0.73-1.51],0.7722712671297215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD244,Natural killer cell receptor 2B4,23989,179,1.32 [0.82-2.11],0.2496575478227109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD248,Endosialin,20552,162,0.64 [0.44-0.93],0.0184224255261617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD27,CD27 antigen,23774,174,1.18 [0.87-1.61],0.2955298564938134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD274,Programmed cell death 1 ligand 1,23507,174,1.09 [0.73-1.62],0.672522429716562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD276,CD276 antigen,23679,178,1.90 [1.30-2.78],0.0009118663395648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD28,T-cell-specific surface glycoprotein CD28,23155,169,1.10 [0.76-1.58],0.6161699972841292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2AP,CD2-associated protein,23713,172,1.09 [0.89-1.35],0.4009318166376087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300A,CMRF35-like molecule 8,20082,158,0.96 [0.58-1.59],0.8820080807457454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300C,CMRF35-like molecule 6,23926,178,1.00 [0.69-1.46],0.9993720666333922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300E,CMRF35-like molecule 2,23856,179,1.20 [0.88-1.64],0.2491140605781866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LF,CMRF35-like molecule 1,23920,179,0.94 [0.76-1.16],0.5629261445405342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LG,CMRF35-like molecule 9,23722,175,0.85 [0.59-1.22],0.3756460243163616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD302,CD302 antigen,23599,177,1.21 [0.79-1.84],0.3802929335605101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD33,Myeloid cell surface antigen CD33,23774,174,1.15 [0.97-1.37],0.1131030715366789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD34,Hematopoietic progenitor cell antigen CD34,23854,178,0.81 [0.47-1.42],0.4664926303625913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD36,Platelet glycoprotein 4,19940,158,1.16 [0.84-1.61],0.3667355536305933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,23599,177,0.84 [0.56-1.26],0.3989549597241536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3D,T-cell surface glycoprotein CD3 delta chain,19888,158,1.03 [0.67-1.58],0.8975740390480292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3E,T-cell surface glycoprotein CD3 epsilon chain,20186,161,1.12 [0.76-1.64],0.5755569658989694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3G,T-cell surface glycoprotein CD3 gamma chain,19940,158,0.97 [0.80-1.16],0.7262463970562575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD4,T-cell surface glycoprotein CD4,23647,176,1.17 [0.76-1.82],0.4727685421565188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40,Tumor necrosis factor receptor superfamily member 5,23684,177,1.28 [0.99-1.64],0.0610948141837497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40LG,CD40 ligand,23989,179,1.17 [0.99-1.38],0.0682357060792353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD46,Membrane cofactor protein,23600,174,1.49 [0.95-2.33],0.0795788519263143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD48,CD48 antigen,23762,178,0.94 [0.61-1.46],0.7992584456161673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5,T-cell surface glycoprotein CD5,23884,179,1.15 [0.80-1.65],0.4478509083350075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD55,Complement decay-accelerating factor,22902,167,1.07 [0.64-1.81],0.7878375588215044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD58,Lymphocyte function-associated antigen 3,23634,178,1.05 [0.49-2.23],0.906900345474363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD59,CD59 glycoprotein,22883,174,0.81 [0.44-1.50],0.5066164988914752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5L,CD5 antigen-like,20465,163,1.15 [0.85-1.57],0.3619411583768784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD6,T-cell differentiation antigen CD6,23950,178,0.94 [0.73-1.21],0.6354931541801035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD63,CD63 antigen,23464,174,1.24 [0.95-1.61],0.1216665729358771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD69,Early activation antigen CD69,23592,171,1.09 [0.94-1.28],0.2580677790409481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD7,T-cell antigen CD7,19906,157,0.89 [0.62-1.28],0.5336761946861975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD70,CD70 antigen,23685,176,0.90 [0.67-1.22],0.4999113186836214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD72,B-cell differentiation antigen CD72,20082,158,1.11 [0.78-1.58],0.5715289656443738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD74,HLA class II histocompatibility antigen gamma chain,23926,178,1.31 [0.90-1.90],0.160444002602334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD79B,B-cell antigen receptor complex-associated protein beta chain,23989,179,1.10 [0.83-1.46],0.5047008553686396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD80,T-lymphocyte activation antigen CD80,20545,162,1.37 [0.90-2.10],0.1433567385918881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD82,CD82 antigen,20186,161,1.38 [1.05-1.82],0.0220932182511711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD83,CD83 antigen,23685,176,1.23 [0.84-1.81],0.2832068467067092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD84,SLAM family member 5,23685,176,1.49 [0.98-2.27],0.0602957679156778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD86,T-lymphocyte activation antigen CD86,20481,163,0.93 [0.56-1.52],0.761776156970011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD8A,T-cell surface glycoprotein CD8 alpha chain,23926,178,0.98 [0.76-1.27],0.894416338731385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD93,Complement component C1q receptor,22840,169,0.99 [0.63-1.54],0.951726990844263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99,CD99 antigen,23722,175,1.15 [0.59-2.26],0.6775097927418736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99L2,CD99 antigen-like protein 2,23722,175,1.38 [0.80-2.36],0.2441788848918145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDA,Cytidine deaminase,20509,162,1.10 [0.81-1.48],0.5496019290889309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDAN1,Codanin-1,20496,162,0.65 [0.32-1.34],0.2456445421097579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC123,Cell division cycle protein 123 homolog,19825,157,1.15 [0.93-1.42],0.2013940206775352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC25A,M-phase inducer phosphatase 1,19825,157,0.94 [0.63-1.42],0.7782532964832778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC26,Anaphase-promoting complex subunit CDC26,20437,163,1.16 [0.94-1.43],0.176621394543528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC27,Cell division cycle protein 27 homolog,23155,169,0.96 [0.76-1.21],0.7256992471738388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC37,Hsp90 co-chaperone Cdc37,23774,174,1.14 [0.97-1.34],0.1019488592376211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC42BPB,Serine/threonine-protein kinase MRCK beta,20481,163,1.05 [0.91-1.21],0.5071941181231088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDCP1,CUB domain-containing protein 1,23507,174,1.15 [0.91-1.45],0.247966801359546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH1,Cadherin-1,22943,169,1.09 [0.78-1.52],0.6269993357676915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH15,Cadherin-15,23893,178,1.09 [0.90-1.31],0.3684824579132575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH17,Cadherin-17,23713,172,1.02 [0.84-1.24],0.8641339064845776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH2,Cadherin-2,23713,172,1.09 [0.74-1.60],0.6578174107636321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH22,Cadherin-22,20186,161,0.67 [0.37-1.20],0.1777292864152606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH23,Cadherin-23,20496,162,0.69 [0.38-1.24],0.2114825222937769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH3,Cadherin-3,23926,178,1.18 [0.83-1.69],0.362820159625097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH4,Cadherin-4,19888,158,0.87 [0.61-1.23],0.4251927944426261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH5,Cadherin-5,24010,179,0.85 [0.54-1.32],0.4713278216193072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH6,Cadherin-6,23713,172,1.00 [0.70-1.43],0.9841810671971508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR1,Cadherin-related family member 1,23189,175,1.01 [0.73-1.39],0.9493977511883732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR2,Cadherin-related family member 2,23599,177,1.19 [0.97-1.47],0.0945470004197579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR5,Cadherin-related family member 5,23713,172,1.15 [0.81-1.64],0.4398098620324724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK1,Cyclin-dependent kinase 1,19825,157,0.99 [0.65-1.50],0.9446327368983736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,20505,164,1.20 [0.96-1.50],0.1179726310292004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKL5,Cyclin-dependent kinase-like 5,19888,158,0.85 [0.61-1.18],0.3333515443469688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN1A,Cyclin-dependent kinase inhibitor 1,23599,177,1.07 [0.95-1.21],0.2817023100058396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,23599,177,1.11 [0.96-1.28],0.1775740420695679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDNF,Cerebral dopamine neurotrophic factor,23599,177,1.09 [0.74-1.62],0.6506618588832368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,23715,178,1.36 [0.81-2.30],0.2430063820535481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDSN,Corneodesmosin,23920,178,1.02 [0.76-1.39],0.8835176381600048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,23738,174,1.00 [0.54-1.87],0.9901330720075444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20481,163,0.86 [0.72-1.04],0.1121362809637723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20186,161,1.04 [0.85-1.28],0.697171091858053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,20481,163,1.00 [0.69-1.45],0.9864981496906609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20186,161,1.02 [0.73-1.43],0.9027139598483264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,23685,176,1.12 [0.96-1.30],0.1423539072928723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23155,169,0.93 [0.69-1.25],0.6224794330312551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22864,167,1.02 [0.81-1.27],0.8872881017451456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20552,162,1.29 [0.94-1.77],0.1082069136654871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,23281,173,1.28 [0.99-1.65],0.0573490369938101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPA,CCAAT/enhancer-binding protein alpha,19940,158,0.93 [0.60-1.45],0.748757234287218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPB,CCAAT/enhancer-binding protein beta,23281,173,1.07 [0.76-1.52],0.6965261704162183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA2A,Chymotrypsin-like elastase family member 2A,20552,162,1.02 [0.80-1.28],0.8996582731144486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA3A,Chymotrypsin-like elastase family member 3A,23973,179,1.10 [0.89-1.37],0.3832524686213154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20082,158,1.09 [0.64-1.84],0.756457853940723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEMIP2,Cell surface hyaluronidase,19940,158,0.95 [0.58-1.57],0.8551515684156167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEND1,Cell cycle exit and neuronal differentiation protein 1,19888,158,1.23 [1.01-1.49],0.0365726623170255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPF,Centromere protein F,20186,161,0.94 [0.71-1.24],0.6509470920424061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPJ,Centromere protein J,20186,161,0.79 [0.62-1.02],0.0685371357769871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP112,Centrosomal protein of 112 kDa,19847,157,0.85 [0.57-1.25],0.4090142113796273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP152,Centrosomal protein of 152 kDa,19825,157,1.07 [0.76-1.51],0.7044665256838988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP164,Centrosomal protein of 164 kDa,23300,174,1.09 [0.90-1.32],0.370321677262259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP170,Centrosomal protein of 170 kDa,19981,164,1.05 [0.86-1.27],0.6490376343163518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP20,Centrosomal protein 20,23155,169,1.09 [0.91-1.30],0.3696276923051822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP290,Centrosomal protein of 290 kDa,20186,161,0.52 [0.36-0.75],0.00056867034023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP350,Centrosome-associated protein 350,19825,157,1.12 [0.75-1.67],0.5797111481830959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP43,Centrosomal protein 43,23099,173,1.10 [0.91-1.33],0.3469984489010385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP85,Centrosomal protein of 85 kDa,23155,169,1.03 [0.84-1.27],0.7732113020632239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CERT,Ceramide transfer protein,23189,175,1.15 [0.93-1.43],0.2037608047615222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES1,Liver carboxylesterase 1,23781,178,1.07 [0.91-1.25],0.4252853966185945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES2,Cocaine esterase,23599,177,0.86 [0.67-1.10],0.2276803473153613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES3,Carboxylesterase 3,23599,177,1.12 [0.94-1.33],0.2179805014360543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN2,Centrin-2,23189,175,1.06 [0.87-1.28],0.5838487507384625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN3,Centrin-3,20481,163,1.07 [0.88-1.30],0.4838617310453984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFB,Complement factor B,20212,159,1.35 [0.85-2.16],0.205090070691342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFC1,Cryptic protein,23155,169,0.68 [0.49-0.94],0.0195021868099294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFD,Complement factor D,20568,163,0.98 [0.47-2.06],0.9588622295392648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFH,Complement factor H,19391,152,1.35 [0.69-2.66],0.3796751829774794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR2,Complement factor H-related protein 2,20423,162,1.08 [0.82-1.41],0.5999258196009316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR4,Complement factor H-related protein 4,20526,163,1.32 [1.06-1.65],0.0139571071463338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR5,Complement factor H-related protein 5,20311,164,1.22 [0.84-1.77],0.289230135110134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFI,Complement factor I,20568,163,1.73 [0.80-3.72],0.1607708904605836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFP,Properdin,20568,163,1.16 [0.62-2.15],0.6412959504887756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGA,Glycoprotein hormones alpha chain,23722,175,1.04 [0.85-1.29],0.6897610247527619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,20572,165,1.27 [0.84-1.92],0.2486739446181191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGN,Cingulin,19997,159,1.12 [0.76-1.63],0.5712575796555823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGREF1,Cell growth regulator with EF hand domain protein 1,23713,172,0.91 [0.66-1.25],0.5520103631050843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23155,169,1.15 [0.92-1.45],0.2091409073342263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAD,Chondroadherin,20082,158,0.88 [0.64-1.23],0.463296606132161
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",20496,162,1.45 [1.06-1.98],0.0205360620991459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD6,MICOS complex subunit MIC25,20474,161,1.09 [0.64-1.85],0.7443643930476613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHEK2,Serine/threonine-protein kinase Chk2,23281,173,0.81 [0.53-1.23],0.3291151184796092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGA,Chromogranin-A,20552,162,1.19 [1.02-1.38],0.0278768362615795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGB,Secretogranin-1,23860,178,0.81 [0.58-1.11],0.1867392807016084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHI3L1,Chitinase-3-like protein 1,23217,172,1.03 [0.88-1.21],0.6780672172996218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHIT1,Chitotriosidase-1,23820,178,1.01 [0.93-1.10],0.782628033891845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHL1,Neural cell adhesion molecule L1-like protein,23786,176,1.25 [0.81-1.93],0.3065186933176923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHM,Rab proteins geranylgeranyltransferase component A 1,19997,159,1.01 [0.78-1.30],0.9461883356570188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP1A,Charged multivesicular body protein 1a,23507,174,1.14 [0.96-1.35],0.1337900098476185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP6,Charged multivesicular body protein 6,20545,162,1.10 [0.85-1.43],0.4729592296375109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHP1,Calcineurin B homologous protein 1,19888,158,0.85 [0.67-1.07],0.1705027643696882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL1,Chordin-like protein 1,23762,178,1.49 [1.00-2.22],0.0528178952485796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL2,Chordin-like protein 2,23713,172,0.88 [0.65-1.18],0.3800828851266534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRM1,Muscarinic acetylcholine receptor M1,19997,159,0.66 [0.40-1.07],0.0934624615235681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIAPIN1,Anamorsin,23774,174,1.24 [1.00-1.54],0.0471157363699689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CILP,Cartilage intermediate layer protein 1,20552,162,1.10 [0.83-1.46],0.5042158787072636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CINP,Cyclin-dependent kinase 2-interacting protein,20186,161,0.86 [0.59-1.26],0.4384097219533388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIRBP,Cold-inducible RNA-binding protein,20481,163,1.13 [0.97-1.33],0.1220879981268476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIT,Citron Rho-interacting kinase,19997,159,0.69 [0.48-1.00],0.0530229140209542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKAP4,Cytoskeleton-associated protein 4,23872,177,1.09 [0.69-1.73],0.7068229400120042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKB,Creatine kinase B-type,20552,162,1.13 [0.87-1.47],0.3623372323489399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",23603,177,0.95 [0.78-1.16],0.6348248774504133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLASP1,CLIP-associating protein 1,19825,157,1.12 [0.93-1.35],0.2386403581021866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLC,Galectin-10,23676,172,0.92 [0.75-1.13],0.4291917424279982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC10A,C-type lectin domain family 10 member A,23507,174,0.95 [0.65-1.38],0.7816192006595597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC11A,C-type lectin domain family 11 member A,23689,175,0.94 [0.71-1.24],0.6637167950362617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC12A,C-type lectin domain family 12 member A,19940,158,0.66 [0.30-1.46],0.3033332082142878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC14A,C-type lectin domain family 14 member A,23722,175,0.95 [0.63-1.45],0.8140740571377774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1A,C-type lectin domain family 1 member A,23281,173,1.12 [0.75-1.67],0.5774948286790945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1B,C-type lectin domain family 1 member B,23926,178,1.09 [0.95-1.25],0.2186211228363062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC2L,C-type lectin domain family 2 member L,19997,159,0.91 [0.66-1.25],0.5585049913117419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC3B,Tetranectin,20105,159,0.83 [0.40-1.74],0.6280063159596445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4A,C-type lectin domain family 4 member A,23685,176,0.73 [0.51-1.04],0.0809025274000145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4C,C-type lectin domain family 4 member C,23685,176,0.81 [0.62-1.07],0.1365368805282865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4D,C-type lectin domain family 4 member D,23685,176,1.24 [1.01-1.53],0.0426478432893643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4G,C-type lectin domain family 4 member G,23685,176,1.69 [1.14-2.51],0.0087335735478681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4M,C-type lectin domain family 4 member M,20522,162,0.92 [0.68-1.25],0.6006394960371356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC5A,C-type lectin domain family 5 member A,23634,171,1.62 [1.06-2.48],0.0248043675380777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC6A,C-type lectin domain family 6 member A,23155,169,1.00 [0.75-1.33],0.9822800300796738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC7A,C-type lectin domain family 7 member A,23989,179,1.18 [0.92-1.51],0.1913884055587597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLGN,Calmegin,19997,159,1.02 [0.73-1.42],0.9218175955222484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIC5,Chloride intracellular channel protein 5,19997,159,0.74 [0.44-1.27],0.2778244188085315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLINT1,Clathrin interactor 1,19825,157,1.07 [0.79-1.45],0.6556210562602676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIP2,CAP-Gly domain-containing linker protein 2,23685,176,1.07 [0.95-1.21],0.2467978481121366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLMP,CXADR-like membrane protein,23920,179,1.19 [0.66-2.15],0.5587496026828529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLNS1A,Methylosome subunit pICln,19997,159,0.86 [0.54-1.36],0.5092348915650733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",23474,174,1.09 [0.95-1.25],0.231755985834156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPS,Colipase,23678,175,0.96 [0.80-1.16],0.6830513195841882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSPN,Claspin,23156,175,1.12 [0.81-1.56],0.4891872722669206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN1,Calsyntenin-1,23189,175,0.98 [0.75-1.28],0.8903921042465883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN2,Calsyntenin-2,23989,179,1.05 [0.76-1.46],0.7514565632750783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN3,Calsyntenin-3,20496,162,0.87 [0.52-1.44],0.5791822923062009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLTA,Clathrin light chain A,23281,173,1.34 [1.03-1.73],0.0278795513368114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLU,Clusterin,20568,163,1.06 [0.65-1.72],0.8125435169352256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLUL1,Clusterin-like protein 1,23670,172,1.05 [0.78-1.42],0.7453691404389432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMC1,COX assembly mitochondrial protein homolog,20545,162,1.13 [0.96-1.33],0.1396704823884732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMIP,C-Maf-inducing protein,20474,161,1.08 [0.90-1.29],0.3994467943041907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNDP1,Beta-Ala-His dipeptidase,23824,176,0.97 [0.73-1.29],0.8131872315916526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19888,158,0.98 [0.73-1.31],0.8848836111154851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19947,164,1.14 [0.94-1.38],0.1694550456127376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY2,Protein canopy homolog 2,23281,173,1.17 [0.97-1.41],0.1075682777444458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY4,Protein canopy homolog 4,23599,177,1.20 [1.01-1.44],0.0373506699035703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNST,Consortin,23713,172,1.07 [0.94-1.21],0.2869305062973929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTF,Ciliary neurotrophic factor,19888,158,0.76 [0.49-1.20],0.2387090883414072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN1,Contactin-1,24010,179,0.86 [0.53-1.39],0.5312872044096986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN2,Contactin-2,23920,179,1.26 [0.94-1.68],0.1289667569620822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN3,Contactin-3,23722,175,0.80 [0.50-1.29],0.3678043494390799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN4,Contactin-4,23722,175,1.06 [0.60-1.87],0.8386937413586532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN5,Contactin-5,23775,178,0.83 [0.58-1.19],0.3042279259237008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP2,Contactin-associated protein-like 2,23685,176,0.84 [0.61-1.16],0.2999932385791458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP4,Contactin-associated protein-like 4,19997,159,0.84 [0.70-1.01],0.0647974062084399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COCH,Cochlin,20545,162,0.97 [0.70-1.34],0.8469731788164848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL15A1,Collagen alpha-1(XV) chain,20552,162,1.13 [0.65-1.96],0.6706783657442017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL18A1,Collagen alpha-1(XVIII) chain,23815,178,0.93 [0.53-1.64],0.80421986599368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL1A1,Collagen alpha-1(I) chain,24010,179,1.13 [0.65-1.97],0.6553765500298876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL24A1,Collagen alpha-1(XXIV) chain,20481,163,1.12 [0.86-1.47],0.398708620309447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL28A1,Collagen alpha-1(XXVIII) chain,19997,159,0.99 [0.82-1.20],0.933872781825856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL2A1,Collagen alpha-1(II) chain,19981,164,1.06 [0.88-1.28],0.5519045514865815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL3A1,Collagen alpha-1(III) chain,20552,162,1.00 [0.53-1.89],0.9941143914312972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A1,Collagen alpha-1(IV) chain,23713,172,0.99 [0.70-1.41],0.9585384128954996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A4,Collagen alpha-4(IV) chain,20154,161,1.00 [0.75-1.33],0.9798526467851788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL5A1,Collagen alpha-1(V) chain,20082,158,1.14 [0.78-1.67],0.4974924670542803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL6A3,Collagen alpha-3(VI) chain,24010,179,1.48 [1.05-2.09],0.0265806611542986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A1,Collagen alpha-1(IX) chain,23685,176,0.94 [0.70-1.28],0.7132597102219728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A2,Collagen alpha-2(IX) chain,20186,161,1.10 [0.79-1.52],0.5857726524542284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COLEC12,Collectin-12,23679,178,1.16 [0.71-1.88],0.5496225941858833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD1,COMM domain-containing protein 1,19981,164,1.11 [0.87-1.41],0.4229810378412622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD9,COMM domain-containing protein 9,20474,161,1.02 [0.70-1.49],0.910163561396948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMP,Cartilage oligomeric matrix protein,23480,174,1.34 [0.89-2.00],0.1571752998215246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMT,Catechol O-methyltransferase,23020,169,1.21 [1.02-1.42],0.0257524237234491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPB2,Coatomer subunit beta',19847,157,0.93 [0.65-1.34],0.7065092454302369
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPE,Coatomer subunit epsilon,23189,175,0.84 [0.61-1.16],0.2840588135720128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19981,164,0.92 [0.64-1.33],0.6588061094220514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO1A,Coronin-1A,23263,172,1.07 [0.93-1.24],0.3606658841634877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO6,Coronin-6,19888,158,1.75 [1.29-2.37],0.0003142649121921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",23599,177,1.15 [0.96-1.39],0.1340455752098447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX6B1,Cytochrome c oxidase subunit 6B1,20545,162,1.68 [1.10-2.57],0.0160183921499232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA1,Carboxypeptidase A1,24010,179,0.91 [0.74-1.11],0.3466455869054323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA2,Carboxypeptidase A2,23857,177,0.88 [0.72-1.07],0.2012922667200872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA4,Carboxypeptidase A4,19692,155,1.10 [0.76-1.58],0.6113966273495893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB1,Carboxypeptidase B,24010,179,0.88 [0.71-1.10],0.2588700016706016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB2,Carboxypeptidase B2,20535,163,1.47 [0.76-2.86],0.2545052842476154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPE,Carboxypeptidase E,23725,177,0.89 [0.64-1.23],0.4695881210284471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPLX2,Complexin-2,19825,157,1.19 [0.78-1.82],0.4090149959121705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPM,Carboxypeptidase M,23806,177,0.85 [0.58-1.26],0.428539689271155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19940,158,0.91 [0.51-1.63],0.7595517194634497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPPED1,Serine/threonine-protein phosphatase CPPED1,23926,178,1.08 [0.88-1.31],0.4575940800108531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPQ,Carboxypeptidase Q,20518,162,1.61 [1.06-2.45],0.0249597342518421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPTP,Ceramide-1-phosphate transfer protein,19847,157,1.16 [0.80-1.67],0.4306317524099241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPVL,Probable serine carboxypeptidase CPVL,23872,179,1.17 [0.84-1.61],0.3576167067266504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM1,Probable carboxypeptidase X1,23774,174,1.15 [0.95-1.39],0.1579898964022296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM2,Inactive carboxypeptidase-like protein X2,20545,162,1.35 [0.76-2.39],0.3059536190957799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR1,Complement receptor type 1,20497,165,1.22 [0.80-1.87],0.3488136221120194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR2,Complement receptor type 2,23824,176,1.35 [1.02-1.78],0.0358411819752236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23155,169,1.05 [0.89-1.23],0.5694533721103655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRADD,Death domain-containing protein CRADD,23474,174,1.25 [1.04-1.49],0.0176784609405949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREB3,Cyclic AMP-responsive element-binding protein 3,19825,157,0.93 [0.69-1.24],0.6104664038909144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREBZF,CREB/ATF bZIP transcription factor,19825,157,0.82 [0.44-1.51],0.5194180761412541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREG1,Protein CREG1,23398,173,1.27 [0.93-1.74],0.1374459125583985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD1,Protein disulfide isomerase CRELD1,20082,158,0.78 [0.51-1.19],0.2503424483523533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD2,Protein disulfide isomerase CRELD2,23762,178,1.25 [0.97-1.60],0.0815193747599824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRH,Corticoliberin,23118,169,0.95 [0.81-1.12],0.5665045190853271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHBP,Corticotropin-releasing factor-binding protein,23679,178,0.84 [0.51-1.36],0.4685447807902027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHR1,Corticotropin-releasing factor receptor 1,23281,173,0.88 [0.69-1.12],0.3045449013183541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIM1,Cysteine-rich motor neuron 1 protein,23798,178,0.91 [0.47-1.77],0.7881378991578447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIP2,Cysteine-rich protein 2,23507,174,0.87 [0.59-1.27],0.4679679780386978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP2,Cysteine-rich secretory protein 2,23920,179,1.13 [0.88-1.46],0.3364765405235217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP3,Cysteine-rich secretory protein 3,20380,162,0.87 [0.50-1.51],0.6120834329566309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRKL,Crk-like protein,23717,178,1.13 [1.00-1.29],0.0537456757087646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRLF1,Cytokine receptor-like factor 1,23798,178,1.15 [0.67-1.95],0.6152170202315072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRNN,Cornulin,23046,169,1.13 [0.92-1.38],0.2456712958720462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAC1,Cartilage acidic protein 1,24010,179,0.87 [0.57-1.33],0.5309530550353894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAM,Cytotoxic and regulatory T-cell molecule,23507,174,1.27 [0.98-1.65],0.0673636414550781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAP,Cartilage-associated protein,19997,159,0.75 [0.52-1.08],0.1219562608103192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRX,Cone-rod homeobox protein,23281,173,0.87 [0.75-1.02],0.0879800564734602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB1,Beta-crystallin B1,20545,162,1.20 [0.96-1.50],0.1182377497663658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB2,Beta-crystallin B2,20496,162,0.95 [0.76-1.18],0.6338220925518105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYGD,Gamma-crystallin D,20496,162,1.04 [0.89-1.22],0.5997400153833411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYM,Ketimine reductase mu-crystallin,19888,158,1.14 [0.95-1.38],0.163093010796562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYZL1,Quinone oxidoreductase-like protein 1,19981,164,1.10 [0.93-1.31],0.2466184519810247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSDE1,Cold shock domain-containing protein E1,19847,157,0.98 [0.86-1.12],0.7630009833255857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1,Macrophage colony-stimulating factor 1,23798,178,1.40 [0.87-2.27],0.1673769663117212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1R,Macrophage colony-stimulating factor 1 receptor,20572,165,1.10 [0.76-1.59],0.6036505697987018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2,Granulocyte-macrophage colony-stimulating factor,19847,157,0.98 [0.65-1.50],0.9429696237260852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,23507,174,0.98 [0.79-1.22],0.8495770661193675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RB,Cytokine receptor common subunit beta,19940,158,0.94 [0.66-1.36],0.7562162875076706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3,Granulocyte colony-stimulating factor,23300,174,0.96 [0.73-1.27],0.7737421165349212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3R,Granulocyte colony-stimulating factor receptor,19940,158,0.93 [0.55-1.59],0.8028417805937013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSH1,Chorionic somatomammotropin hormone 1,20572,165,1.15 [0.69-1.92],0.5939359584431934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK1D,Casein kinase I isoform delta,19940,158,0.93 [0.73-1.19],0.5658794559342166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK2A1,Casein kinase II subunit alpha,20505,164,1.40 [1.01-1.94],0.042048134992934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG4,Chondroitin sulfate proteoglycan 4,20552,162,0.94 [0.60-1.49],0.7993378546916629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG5,Chondroitin sulfate proteoglycan 5,19888,158,1.10 [0.82-1.48],0.5237211348353119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSRP3,Cysteine and glycine-rich protein 3,19847,157,1.30 [1.15-1.47],2.214079353333348e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST1,Cystatin-SN,17865,142,0.98 [0.83-1.15],0.8010720190087569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST3,Cystatin-C,23780,176,1.53 [0.99-2.37],0.0558601642312371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST5,Cystatin-D,23214,174,0.94 [0.74-1.20],0.6409044615590023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST6,Cystatin-M,23099,172,1.18 [0.90-1.54],0.2410234393483305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST7,Cystatin-F,23720,177,1.08 [0.95-1.23],0.2588622118776064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSTB,Cystatin-B,23399,178,1.24 [0.92-1.67],0.1554676055001202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTAG1A_CTAG1B,Cancer/testis antigen 1,20149,161,0.94 [0.69-1.28],0.6907071631045062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTBS,Di-N-acetylchitobiase,20280,164,0.87 [0.50-1.51],0.6269664052630233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTF1,Cardiotrophin-1,23281,173,1.11 [0.95-1.29],0.1964189540008056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTHRC1,Collagen triple helix repeat-containing protein 1,20552,162,1.76 [1.06-2.93],0.0297412920999325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTLA4,Cytotoxic T-lymphocyte protein 4,20552,162,1.03 [0.63-1.68],0.8971725558040149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTNNA1,Catenin alpha-1,19888,158,0.74 [0.43-1.27],0.2801818037175888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRB1,Chymotrypsinogen B,23722,175,0.95 [0.75-1.19],0.6359908288799185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRC,Chymotrypsin-C,23679,178,0.93 [0.76-1.14],0.4871496237096238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRL,Chymotrypsin-like protease CTRL-1,20496,162,1.01 [0.81-1.25],0.936010544402971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSB,Cathepsin B,23736,178,0.89 [0.69-1.15],0.381663932166273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSC,Dipeptidyl peptidase 1,23630,178,1.18 [0.88-1.57],0.2605631928598376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSD,Cathepsin D,22202,160,1.18 [0.85-1.63],0.3341613014048247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSE,Cathepsin E,20082,158,0.91 [0.68-1.22],0.5252897176936826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSF,Cathepsin F,23774,174,1.20 [0.86-1.67],0.2864161877823417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSH,Pro-cathepsin H,23193,173,1.10 [0.92-1.32],0.2766037919413209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSL,Cathepsin L1,23713,172,1.80 [1.06-3.06],0.0302620294545176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSO,Cathepsin O,23989,179,1.53 [1.02-2.31],0.0418865595348739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSS,Cathepsin S,18664,128,1.34 [0.66-2.74],0.4172548563754491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSV,Cathepsin L2,23831,179,0.88 [0.63-1.22],0.4380231579471394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSZ,Cathepsin Z,23751,176,1.41 [0.93-2.12],0.1014288079277311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19997,159,0.85 [0.56-1.30],0.4591567107763046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CWC15,Spliceosome-associated protein CWC15 homolog,20365,161,0.95 [0.74-1.22],0.6912698887589297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CX3CL1,Fractalkine,23507,174,1.25 [0.85-1.86],0.259877145366494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXADR,Coxsackievirus and adenovirus receptor,23685,176,1.12 [0.85-1.46],0.4193009521770037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL1,Growth-regulated alpha protein,23646,177,1.04 [0.90-1.19],0.6181420633434893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL10,C-X-C motif chemokine 10,23798,178,1.20 [0.99-1.44],0.0576734776293928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL11,C-X-C motif chemokine 11,23926,178,1.12 [0.96-1.31],0.1515753704786727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL12,Stromal cell-derived factor 1,23300,174,1.54 [1.11-2.14],0.010247190579153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL13,C-X-C motif chemokine 13,23926,178,1.22 [1.02-1.44],0.0255363530473608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL14,C-X-C motif chemokine 14,23300,174,0.86 [0.66-1.12],0.2671778068130784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL16,C-X-C motif chemokine 16,23972,179,1.09 [0.62-1.92],0.7644547153952131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL17,C-X-C motif chemokine 17,23989,179,1.05 [0.78-1.42],0.7535694863900663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL3,C-X-C motif chemokine 3,23684,177,1.07 [0.93-1.23],0.3673634989259968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL5,C-X-C motif chemokine 5,23634,172,1.08 [0.96-1.21],0.2166784874549068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL6,C-X-C motif chemokine 6,23989,179,1.14 [0.96-1.35],0.1464083268840986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL8,Interleukin-8,23551,177,1.01 [0.83-1.23],0.9116234031300756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL9,C-X-C motif chemokine 9,23798,178,1.21 [1.01-1.46],0.0412692788336022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5A,Cytochrome b5,19825,157,0.96 [0.76-1.20],0.6977446563745298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5R2,NADH-cytochrome b5 reductase 2,20268,163,1.18 [0.91-1.53],0.2014924502080576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19847,157,1.08 [0.91-1.27],0.3691306219181639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTH3,Cytohesin-3,19825,157,0.95 [0.77-1.19],0.6732327072145023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTL1,Cytokine-like protein 1,20552,162,0.90 [0.50-1.62],0.714994734217413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAAM1,Disheveled-associated activator of morphogenesis 1,20082,158,1.17 [0.98-1.41],0.0858651109607839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAB2,Disabled homolog 2,23920,179,1.11 [0.98-1.25],0.0956697675581908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAG1,Dystroglycan,23798,178,1.30 [0.99-1.71],0.0636131586986983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAND5,DAN domain family member 5,19940,158,0.91 [0.70-1.19],0.5025680794958083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPK2,Death-associated protein kinase 2,19940,158,0.99 [0.76-1.30],0.9410970704721612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,23685,176,1.08 [0.96-1.21],0.1880623833625178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DARS1,"Aspartate--tRNA ligase, cytoplasmic",23474,174,1.16 [0.96-1.40],0.1159165587487447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBH,Dopamine beta-hydroxylase,20536,165,0.87 [0.78-0.97],0.0158733725882944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBI,Acyl-CoA-binding protein,23609,173,1.24 [1.05-1.46],0.0132445276991694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBN1,Drebrin,19940,158,1.09 [0.81-1.47],0.5496123492859589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBNL,Drebrin-like protein,23798,178,1.12 [0.97-1.29],0.1196206157357844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23774,174,1.12 [0.77-1.64],0.5593331985204874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCC,Netrin receptor DCC,19997,159,1.14 [0.60-2.14],0.6893480219242978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCDC2C,Doublecortin domain-containing protein 2C,19825,157,0.96 [0.74-1.24],0.7370164305109426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCLRE1C,Protein artemis,19825,157,1.34 [0.84-2.13],0.2244458332501659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCN,Decorin,23281,173,1.10 [0.62-1.97],0.7397404323537504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTD,Deoxycytidylate deaminase,20082,158,1.14 [0.97-1.34],0.1143767134829913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN1,Dynactin subunit 1,23920,179,1.17 [0.95-1.44],0.1294640800994235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN2,Dynactin subunit 2,23599,177,1.08 [0.94-1.24],0.2885945365166422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN6,Dynactin subunit 6,23189,175,1.10 [0.92-1.31],0.284479734087917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTPP1,dCTP pyrophosphatase 1,23713,172,1.01 [0.66-1.55],0.964459921958906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D1,DCN1-like protein 1,19888,158,0.85 [0.67-1.07],0.1670408290012476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D2,DCN1-like protein 2,19825,157,0.94 [0.76-1.15],0.5224493713828872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCXR,L-xylulose reductase,23774,174,1.07 [0.83-1.38],0.5910690405842003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDA1,DET1- and DDB1-associated protein 1,19847,157,1.10 [0.75-1.60],0.635878169903537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",23599,177,1.43 [1.09-1.88],0.0108107801021643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDC,Aromatic-L-amino-acid decarboxylase,23682,172,0.99 [0.74-1.31],0.9231892490060424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDHD2,Phospholipase DDHD2,20505,164,1.10 [0.87-1.38],0.4233962222899606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDI2,Protein DDI1 homolog 2,20082,158,0.92 [0.75-1.13],0.4213179321951837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDR1,Epithelial discoidin domain-containing receptor 1,23926,178,1.79 [1.05-3.08],0.0340217668887736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDT,D-dopachrome decarboxylase,20552,162,1.22 [0.86-1.72],0.2607627703637514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX1,ATP-dependent RNA helicase DDX1,20481,163,0.97 [0.70-1.33],0.8339876302034224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX25,ATP-dependent RNA helicase DDX25,19997,159,1.11 [0.74-1.66],0.6157859122402638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX39A,ATP-dependent RNA helicase DDX39A,19940,158,0.41 [0.20-0.87],0.0200308439511319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX4,Probable ATP-dependent RNA helicase DDX4,19940,158,1.17 [0.91-1.49],0.2161840973159325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX53,Probable ATP-dependent RNA helicase DDX53,19997,159,0.84 [0.54-1.30],0.4275982831778794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX58,Antiviral innate immune response receptor RIG-I,23155,169,1.03 [0.82-1.30],0.7807402073322063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",23685,176,1.13 [0.99-1.30],0.0755166373613044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFA1_DEFA1B,Neutrophil defensin 1,23244,174,1.18 [0.94-1.48],0.1563575608462623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB103A_DEFB103B,Beta-defensin 103,19792,158,1.38 [1.05-1.83],0.0222311986316418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB104A_DEFB104B,Beta-defensin 104,19888,158,1.07 [0.82-1.40],0.6229785081727375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB116,Beta-defensin 116,19888,158,1.11 [0.92-1.34],0.273248836926046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB118,Beta-defensin 118,19888,158,0.77 [0.55-1.09],0.1453210288181388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB4A_DEFB4B,Beta-defensin 4A,23364,173,1.08 [0.99-1.19],0.0832301112733245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENND2B,DENN domain-containing protein 2B,19847,157,1.13 [0.85-1.50],0.4022439875421562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENR,Density-regulated protein,19940,158,1.26 [0.99-1.59],0.0606638580240844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DFFA,DNA fragmentation factor subunit alpha,23989,179,1.21 [1.00-1.47],0.0443032943326448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGCR6,Protein DGCR6,19888,158,0.99 [0.68-1.43],0.9405389200324582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKA,Diacylglycerol kinase alpha,19940,158,1.12 [0.85-1.48],0.4110789191261775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKZ,Diacylglycerol kinase zeta,23300,174,1.22 [0.85-1.74],0.2818333341004561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHODH,Dihydroorotate dehydrogenase,19847,157,0.80 [0.55-1.16],0.2335691714114361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHPS,Deoxyhypusine synthase,20474,161,0.87 [0.59-1.30],0.5015830059551489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,20496,162,1.25 [0.95-1.66],0.1167726045641509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIABLO,"Diablo homolog, mitochondrial",23634,171,1.11 [0.98-1.25],0.1062491007919025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK1C,Divergent protein kinase domain 1C,19997,159,1.13 [0.80-1.60],0.5032155083039265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK2B,Divergent protein kinase domain 2B,20082,158,0.85 [0.50-1.45],0.5514984824075565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK1,Dickkopf-related protein 1,23926,178,1.13 [0.90-1.42],0.2789258866975052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK3,Dickkopf-related protein 3,24010,179,0.79 [0.51-1.24],0.3093463449334075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK4,Dickkopf-related protein 4,23464,174,0.97 [0.73-1.30],0.8554565674192577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKKL1,Dickkopf-like protein 1,23599,177,1.00 [0.85-1.17],0.9763351976296616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLG4,Disks large homolog 4,20496,162,1.07 [0.88-1.32],0.4915878404554931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLGAP5,Disks large-associated protein 5,20505,164,1.06 [0.80-1.40],0.6750396687887004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLK1,Protein delta homolog 1,24010,179,0.98 [0.78-1.23],0.8553821081275392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL1,Delta-like protein 1,23774,174,1.22 [0.79-1.88],0.3701589897574368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL4,Delta-like protein 4,19981,164,0.99 [0.84-1.18],0.9452904583734985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMD,Dystrophin,19981,164,1.40 [1.10-1.77],0.005477454883392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMP1,Dentin matrix acidic phosphoprotein 1,19981,164,0.82 [0.64-1.06],0.1329449410712276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA1,DnaJ homolog subfamily A member 1,19825,157,0.79 [0.54-1.16],0.2238957553504861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA2,DnaJ homolog subfamily A member 2,23911,178,1.13 [0.96-1.33],0.1308161953954959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA4,DnaJ homolog subfamily A member 4,20496,162,0.97 [0.79-1.20],0.8130139442409404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB1,DnaJ homolog subfamily B member 1,23599,177,1.15 [0.98-1.34],0.0819220812993914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB14,DnaJ homolog subfamily B member 14,20481,163,1.10 [0.88-1.38],0.418533132477616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB2,DnaJ homolog subfamily B member 2,20082,158,1.22 [0.92-1.61],0.1669536361374604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB6,DnaJ homolog subfamily B member 6,19900,157,1.14 [0.95-1.37],0.1493556551878427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB8,DnaJ homolog subfamily B member 8,23281,173,1.15 [0.92-1.42],0.2139276067519129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC21,DnaJ homolog subfamily C member 21,20496,162,1.03 [0.71-1.51],0.8674548039773703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19981,164,1.18 [0.99-1.41],0.060289467398546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC9,DnaJ homolog subfamily C member 9,20481,163,1.08 [0.89-1.31],0.4323183555595263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNER,Delta and Notch-like epidermal growth factor-related receptor,23642,178,0.66 [0.39-1.11],0.1154657692943973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNLZ,DNL-type zinc finger protein,19888,158,0.96 [0.79-1.16],0.6493170614874576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM1,Dynamin-1,20481,163,1.11 [0.97-1.27],0.130878177515573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM3,Dynamin-3,20505,164,1.05 [0.80-1.37],0.7309280018645083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNMBP,Dynamin-binding protein,23507,174,1.02 [0.82-1.27],0.8778231955229538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPEP,Aspartyl aminopeptidase,20496,162,0.97 [0.74-1.26],0.7958240071637857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,23753,178,1.10 [0.85-1.42],0.4805529909204441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOC2B,Double C2-like domain-containing protein beta,19997,159,0.91 [0.58-1.43],0.6752858417262532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOCK9,Dedicator of cytokinesis protein 9,19888,158,1.03 [0.91-1.17],0.649926696113543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK1,Docking protein 1,20496,162,1.06 [0.95-1.19],0.2938745892766287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK2,Docking protein 2,23713,172,1.08 [0.97-1.21],0.1595438591134448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP1,Dipeptidase 1,23474,174,1.24 [0.92-1.67],0.1580710356970476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP2,Dipeptidase 2,23599,177,1.61 [1.05-2.47],0.029898657071319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP10,Inactive dipeptidyl peptidase 10,23685,176,0.98 [0.68-1.43],0.9298114335876178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP4,Dipeptidyl peptidase 4,23285,171,1.34 [0.82-2.20],0.2475329093651768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP6,Dipeptidyl aminopeptidase-like protein 6,23599,177,0.93 [0.63-1.38],0.7149151658909174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP7,Dipeptidyl peptidase 2,23533,171,1.03 [0.83-1.28],0.7796041681652911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPT,Dermatopontin,24010,179,0.94 [0.56-1.57],0.8143107039167474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPY30,Protein dpy-30 homolog,23855,176,1.07 [0.87-1.33],0.5200860636591327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRAXIN,Draxin,23507,174,1.04 [0.76-1.43],0.801841678663433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRG2,Developmentally-regulated GTP-binding protein 2,23599,177,1.15 [0.91-1.44],0.2377899553212184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSC2,Desmocollin-2,23436,174,1.18 [0.81-1.74],0.3854892386401443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSCAM,Down syndrome cell adhesion molecule,20505,164,1.10 [0.72-1.66],0.661021941174055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG2,Desmoglein-2,23722,175,1.03 [0.63-1.70],0.9022812343772756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG3,Desmoglein-3,23840,178,1.03 [0.71-1.50],0.8894845927390111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG4,Desmoglein-4,23523,177,1.13 [0.86-1.48],0.3818139498579493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTD1,D-aminoacyl-tRNA deacylase 1,20082,158,1.19 [1.00-1.41],0.0558176928069745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTNB,Dystrobrevin beta,20430,161,1.76 [1.34-2.31],4.106584577114895e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19997,159,1.03 [0.80-1.32],0.8346857904495306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX3,Probable E3 ubiquitin-protein ligase DTX3,23599,177,1.14 [0.67-1.95],0.6213110572539675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTYMK,Thymidylate kinase,20545,162,1.19 [0.96-1.48],0.1183251321442678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUOX2,Dual oxidase 2,23281,173,1.04 [0.86-1.25],0.6960862688685707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP13,Dual specificity protein phosphatase 13 isoform A,20474,161,0.78 [0.54-1.13],0.1825456180690039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP29,Dual specificity phosphatase 29,19997,159,1.17 [0.96-1.43],0.1162290389586202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP3,Dual specificity protein phosphatase 3,23189,175,0.97 [0.82-1.14],0.707098534387345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",20481,163,1.08 [0.93-1.24],0.3239582611967295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DXO,Decapping and exoribonuclease protein,20496,162,1.28 [0.93-1.77],0.1278058153522256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,20474,161,1.06 [0.78-1.43],0.7320631433625697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT1,Dynein light chain Tctex-type 1,19997,159,1.06 [0.88-1.27],0.5652111881391564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT3,Dynein light chain Tctex-type 3,20474,161,1.19 [0.85-1.66],0.3143858057997479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,23507,174,1.10 [0.95-1.26],0.1983225674627454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBI3_IL27,Interleukin-27,23892,177,1.25 [0.81-1.92],0.3103451951773237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECE1,Endothelin-converting enzyme 1,23189,175,0.78 [0.53-1.14],0.206128191568364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20545,162,0.96 [0.78-1.18],0.7013525621280603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19981,164,1.11 [0.95-1.29],0.2048838991399583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECI2,Enoyl-CoA delta isomerase 2,19847,157,1.09 [0.86-1.39],0.4744548697769642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECM1,Extracellular matrix protein 1,20034,159,0.87 [0.58-1.30],0.4973118296399222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECSCR,Endothelial cell-specific chemotaxis regulator,19888,158,0.95 [0.69-1.30],0.7399605467833003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDA2R,Tumor necrosis factor receptor superfamily member 27,23920,179,2.16 [1.63-2.88],1.1719303498967969e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDAR,Tumor necrosis factor receptor superfamily member EDAR,23685,176,1.13 [0.98-1.31],0.0992113334988693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDDM3B,Epididymal secretory protein E3-beta,20474,161,0.98 [0.76-1.25],0.8440298459950683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19847,157,1.05 [0.70-1.58],0.8223689122171838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDF1,Endothelial differentiation-related factor 1,20505,164,1.05 [0.85-1.30],0.6325186781896843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,23281,173,1.04 [0.71-1.53],0.822610972347985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDN1,Endothelin-1,19981,164,1.09 [0.65-1.82],0.7354872830928807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDNRB,Endothelin receptor type B,19940,158,0.74 [0.49-1.13],0.1672764960543407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EEF1D,Elongation factor 1-delta,20545,162,1.05 [0.89-1.23],0.5678774837414777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB14,EF-hand calcium-binding domain-containing protein 14,20481,163,0.85 [0.49-1.48],0.5692740748035576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB2,Dynein regulatory complex protein 8,20186,161,1.14 [0.75-1.75],0.5361201421571231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23787,176,1.16 [0.77-1.77],0.4768417020777413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFHD1,EF-hand domain-containing protein D1,20505,164,0.81 [0.52-1.26],0.3528125105949334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA1,Ephrin-A1,23679,173,1.21 [0.77-1.89],0.4181891214777657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA4,Ephrin-A4,23464,174,1.20 [0.79-1.81],0.3885980726288094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNB2,Ephrin-B2,19997,159,1.04 [0.80-1.35],0.7790600386882023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGF,Pro-epidermal growth factor,23643,177,1.12 [0.98-1.27],0.0929258948920934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFL7,Epidermal growth factor-like protein 7,23155,169,0.96 [0.67-1.37],0.8274469087610425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFLAM,Pikachurin,20481,163,0.62 [0.37-1.03],0.0624247040612096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFR,Epidermal growth factor receptor,24010,179,0.70 [0.31-1.57],0.3826013930931904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGLN1,Egl nine homolog 1,23685,176,1.13 [0.92-1.38],0.2539016894536099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHBP1,EH domain-binding protein 1,20545,162,1.12 [0.92-1.36],0.2546889732113151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHD3,EH domain-containing protein 3,19981,164,1.10 [0.97-1.26],0.1456607651746257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",20496,162,0.93 [0.70-1.23],0.6035797729282664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",20402,162,1.07 [0.93-1.22],0.334915580384108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19847,157,1.04 [0.82-1.31],0.7443136761647082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19981,164,0.96 [0.67-1.37],0.8022082826944985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4B,Eukaryotic translation initiation factor 4B,23507,174,1.14 [0.89-1.45],0.2921190727516966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4E,Eukaryotic translation initiation factor 4E,19940,158,1.11 [0.93-1.31],0.2494896501791738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,23713,172,1.11 [0.90-1.36],0.3324397871738385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,23989,179,1.10 [0.96-1.26],0.1738202668473208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,20505,164,1.03 [0.82-1.29],0.8213420561311174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5,Eukaryotic translation initiation factor 5,19847,157,1.28 [0.94-1.74],0.1143315920017578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5A,Eukaryotic translation initiation factor 5A-1,23300,174,1.46 [1.04-2.05],0.0298113481522689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAC1,Zinc phosphodiesterase ELAC protein 1,20505,164,1.10 [0.93-1.32],0.2708330748088211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAVL4,ELAV-like protein 4,19888,158,1.05 [0.88-1.26],0.564977718927338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELN,Elastin,20545,162,1.56 [1.02-2.39],0.0413697039779001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOA,Elongin-A,23599,177,1.06 [0.85-1.32],0.6333575495373784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOB,Elongin-B,19847,157,1.27 [0.91-1.77],0.1628785012619037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENAH,Protein enabled homolog,23300,174,1.33 [1.02-1.72],0.0319350207383532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENDOU,Poly(U)-specific endoribonuclease,18963,154,0.96 [0.73-1.27],0.798163973653938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENG,Endoglin,24010,179,0.84 [0.39-1.81],0.6554666385279901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO1,Alpha-enolase,23704,176,1.17 [0.99-1.39],0.0717022155098286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO2,Gamma-enolase,23926,178,1.16 [0.95-1.42],0.139126600748518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO3,Beta-enolase,19981,164,1.20 [0.96-1.51],0.1130558705471959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOPH1,Enolase-phosphatase E1,20474,161,1.02 [0.77-1.35],0.8844917074865102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19847,157,1.33 [0.80-2.22],0.2645099301239226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPEP,Glutamyl aminopeptidase,19847,157,1.01 [0.71-1.45],0.9367972270767202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24010,179,1.40 [0.83-2.38],0.21191020622164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,23798,178,0.97 [0.72-1.30],0.8336784856118203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19981,164,0.77 [0.51-1.16],0.2137578446937621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22991,173,0.99 [0.84-1.17],0.9146991845839204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENSA,Alpha-endosulfine,20474,161,1.31 [1.02-1.68],0.0323915413501414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23155,169,1.22 [0.89-1.68],0.2110653829164124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,23281,173,1.26 [0.68-2.35],0.461798994820865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,23281,173,1.01 [0.62-1.64],0.9614314723789972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTR1,Endosome-associated-trafficking regulator 1,19981,164,1.05 [0.82-1.34],0.7117400562799301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EP300,Histone acetyltransferase p300,19940,158,0.92 [0.56-1.52],0.7574616201581871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPB41L5,Band 4.1-like protein 5,19997,159,1.04 [0.82-1.31],0.7425700896929717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPCAM,Epithelial cell adhesion molecule,23674,177,0.96 [0.83-1.10],0.5350576117424023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPGN,Epigen,20474,161,1.28 [1.01-1.62],0.0444284384222429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA1,Ephrin type-A receptor 1,23753,178,0.69 [0.46-1.03],0.0674668152899775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA10,Ephrin type-A receptor 10,23189,175,0.98 [0.79-1.21],0.8434804934074606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA2,Ephrin type-A receptor 2,22836,175,1.07 [0.70-1.64],0.755389640516479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA4,Ephrin type-A receptor 4,20082,158,0.86 [0.51-1.46],0.5883733680356804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB4,Ephrin type-B receptor 4,24010,179,1.07 [0.64-1.80],0.7934129130639308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB6,Ephrin type-B receptor 6,23474,174,1.23 [0.82-1.84],0.3252117521554043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHX2,Bifunctional epoxide hydrolase 2,23281,173,1.18 [0.97-1.43],0.0973002950545784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPN1,Epsin-1,20186,161,0.90 [0.62-1.32],0.591089858167281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPO,Erythropoietin,23685,176,0.98 [0.82-1.18],0.8481916747387331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPPK1,Epiplakin,19981,164,1.09 [0.89-1.34],0.3870660840062813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23883,178,0.68 [0.43-1.08],0.0996478293297237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB2,Receptor tyrosine-protein kinase erbB-2,23774,174,0.87 [0.50-1.52],0.6346083950900044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB3,Receptor tyrosine-protein kinase erbB-3,23592,177,1.31 [0.67-2.54],0.4285169664409242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB4,Receptor tyrosine-protein kinase erbB-4,23774,174,1.38 [0.78-2.44],0.2668894824828511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBIN,Erbin,23599,177,1.09 [0.96-1.25],0.1773753072746787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERC2,ERC protein 2,19997,159,0.86 [0.68-1.09],0.2149609168362201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERCC1,DNA excision repair protein ERCC-1,19825,157,1.35 [0.97-1.87],0.073111481173024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EREG,Proepiregulin,23474,174,1.14 [0.97-1.34],0.1173956206681475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERI1,3'-5' exoribonuclease 1,20186,161,0.97 [0.62-1.52],0.9098931945066652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERMAP,Erythroid membrane-associated protein,19940,158,1.22 [0.87-1.71],0.2580054107768607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,20474,161,1.15 [0.77-1.72],0.4889214123187417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP29,Endoplasmic reticulum resident protein 29,20082,158,1.12 [0.99-1.28],0.0788477851034018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP44,Endoplasmic reticulum resident protein 44,23563,177,1.40 [0.84-2.32],0.1958007655959279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19847,157,0.74 [0.50-1.11],0.1454935724223206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESAM,Endothelial cell-selective adhesion molecule,24010,179,1.12 [0.74-1.67],0.5929526336861143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESM1,Endothelial cell-specific molecule 1,23679,178,0.94 [0.64-1.38],0.750794796517845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESPL1,Separin,19825,157,0.85 [0.62-1.17],0.3145754500931821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESR1,Estrogen receptor,19940,158,0.82 [0.60-1.12],0.2173201178569664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESYT2,Extended synaptotagmin-2,20496,162,1.09 [0.91-1.31],0.3326591552191989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI2B,Protein EVI2B,19825,157,0.76 [0.48-1.20],0.240680827575594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI5,Ecotropic viral integration site 5 protein homolog,19940,158,0.98 [0.83-1.17],0.842394887029695
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVPL,Envoplakin,20186,161,0.85 [0.52-1.39],0.5237307948891434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXOSC10,Exosome component 10,19847,157,1.01 [0.77-1.32],0.9437563358189788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXTL1,Exostosin-like 1,19847,157,0.85 [0.59-1.21],0.3614948767963466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EZR,Ezrin,23926,178,0.86 [0.50-1.48],0.5761048926898826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F10,Coagulation factor X,20572,165,1.10 [0.66-1.84],0.7000651001553935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11,Coagulation factor XI,20276,162,1.45 [1.03-2.03],0.0310047200756304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11R,Junctional adhesion molecule A,23722,175,1.24 [0.98-1.56],0.0743375137282971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F12,Coagulation factor XII,20568,163,1.13 [0.78-1.64],0.5316179748574262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F13B,Coagulation factor XIII B chain,20465,163,1.08 [0.60-1.94],0.8049176523796298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2,Prothrombin,20568,163,1.07 [0.40-2.91],0.8891653137399667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2R,Proteinase-activated receptor 1,23762,178,1.15 [0.92-1.45],0.221052651655423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F3,Tissue factor,23767,176,0.95 [0.56-1.59],0.8403504391573434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F7,Coagulation factor VII,23782,175,1.44 [0.93-2.23],0.1060210901386973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F9,Coagulation factor IX,23789,176,1.74 [0.84-3.59],0.1354664357018111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP1,"Fatty acid-binding protein, liver",23679,178,0.87 [0.75-1.00],0.0532166956087313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP2,"Fatty acid-binding protein, intestinal",23713,172,0.83 [0.69-0.99],0.0377670476515006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP3,"Fatty acid-binding protein, heart",20545,162,1.44 [1.13-1.84],0.0029189017806882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP4,"Fatty acid-binding protein, adipocyte",24010,179,1.15 [0.89-1.49],0.2971530613620562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP5,Fatty acid-binding protein 5,23847,177,1.22 [1.01-1.47],0.0427236208471659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP6,Gastrotropin,23246,173,0.86 [0.67-1.10],0.2279175643803911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP9,Fatty acid-binding protein 9,23685,176,0.96 [0.75-1.22],0.7174841630105274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FADD,FAS-associated death domain protein,23713,172,1.16 [0.98-1.38],0.0930541555184316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM13A,Protein FAM13A,20481,163,0.99 [0.79-1.23],0.9121439591814744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171A2,Protein FAM171A2,20505,164,0.99 [0.90-1.09],0.8491048530573972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171B,Protein FAM171B,20474,161,0.93 [0.52-1.66],0.799545781301972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM172A,Cotranscriptional regulator FAM172A,19981,164,1.13 [0.89-1.45],0.3141953595723452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM20A,Pseudokinase FAM20A,20545,162,1.64 [0.99-2.72],0.0557556255499414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3B,Protein FAM3B,23599,177,0.87 [0.59-1.27],0.4605738661409322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3C,Protein FAM3C,23682,172,0.86 [0.55-1.35],0.5108186739074061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3D,Protein FAM3D,20481,163,1.01 [0.85-1.20],0.9259909398311388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAP,Prolyl endopeptidase FAP,24010,179,1.73 [1.06-2.83],0.0280341004254631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FARSA,Phenylalanine--tRNA ligase alpha subunit,19997,159,1.12 [0.91-1.37],0.285151325207071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAS,Tumor necrosis factor receptor superfamily member 6,23930,178,1.01 [0.68-1.49],0.9683426657491268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FASLG,Tumor necrosis factor ligand superfamily member 6,23989,179,0.93 [0.65-1.32],0.6745426808997022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBLN2,Fibulin-2,20552,162,0.90 [0.56-1.46],0.6796256037667849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBN2,Fibrillin-2,19997,159,1.05 [0.81-1.37],0.68781840967065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBP1,"Fructose-1,6-bisphosphatase 1",23713,172,1.03 [0.85-1.24],0.7707509313900853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,20545,162,0.93 [0.76-1.15],0.515456466894586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAR,Immunoglobulin alpha Fc receptor,23685,176,1.19 [0.91-1.57],0.2002370393180837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,20505,164,0.63 [0.34-1.18],0.1486561239861188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER2,Low affinity immunoglobulin epsilon Fc receptor,23722,175,1.06 [0.83-1.35],0.6298634865861079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,23628,173,1.11 [0.87-1.42],0.3966559451313104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23155,169,1.05 [0.83-1.33],0.6835352959950665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,23746,174,0.90 [0.69-1.18],0.4440676335993144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN1,Ficolin-1,20536,165,1.16 [0.87-1.54],0.3072402552330144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN2,Ficolin-2,23630,176,1.21 [0.86-1.70],0.270564654518319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL1,Fc receptor-like protein 1,23713,172,1.09 [0.82-1.45],0.5608790607400271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL2,Fc receptor-like protein 2,23875,179,1.00 [0.78-1.30],0.972152862499561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL3,Fc receptor-like protein 3,23300,174,1.14 [0.90-1.46],0.2761565873838832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL5,Fc receptor-like protein 5,23722,175,0.97 [0.78-1.22],0.8098636150788227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL6,Fc receptor-like protein 6,23685,176,1.00 [0.82-1.21],0.9947629855460992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRLB,Fc receptor-like B,23155,169,1.11 [0.91-1.36],0.3057313150682059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX1,"Adrenodoxin, mitochondrial",19847,157,1.03 [0.81-1.31],0.8016082147867236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX2,"Ferredoxin-2, mitochondrial",19847,157,1.15 [0.89-1.48],0.2821618972904307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FEN1,Flap endonuclease 1,23155,169,0.91 [0.73-1.14],0.409401772966418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FES,Tyrosine-protein kinase Fes/Fps,23155,169,1.16 [0.90-1.51],0.2515816325154926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FETUB,Fetuin-B,23789,176,1.23 [0.80-1.88],0.3535445897828229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGA,Fibrinogen alpha chain,20097,157,1.27 [0.78-2.07],0.3435597040410183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",20505,164,1.13 [0.94-1.35],0.2009471418785019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF12,Fibroblast growth factor 12,19940,158,0.93 [0.65-1.34],0.7054802448352111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF16,Fibroblast growth factor 16,19940,158,0.85 [0.60-1.22],0.3783030651722887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF19,Fibroblast growth factor 19,23798,178,0.98 [0.83-1.16],0.8468136837090438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF2,Fibroblast growth factor 2,23685,176,1.14 [0.94-1.37],0.1806701925303783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF20,Fibroblast growth factor 20,19940,158,0.97 [0.67-1.40],0.8607929322977758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF21,Fibroblast growth factor 21,23892,177,1.12 [1.01-1.25],0.0340182624932525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF23,Fibroblast growth factor 23,23879,178,1.11 [0.87-1.42],0.387622662829623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF3,Fibroblast growth factor 3,19940,158,0.75 [0.42-1.34],0.3347827347520738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF5,Fibroblast growth factor 5,23300,174,1.65 [1.15-2.36],0.0064699052960732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF6,Fibroblast growth factor 6,19940,158,1.12 [0.78-1.61],0.5284461044908315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF7,Fibroblast growth factor 7,19825,157,0.96 [0.78-1.18],0.703424567733487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF9,Fibroblast growth factor 9,19789,157,0.91 [0.62-1.33],0.6229772339877471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP1,Fibroblast growth factor-binding protein 1,23774,174,1.03 [0.68-1.55],0.8911771498922131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP2,Fibroblast growth factor-binding protein 2,20552,162,0.99 [0.74-1.34],0.9730883978194282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP3,Fibroblast growth factor-binding protein 3,20496,162,0.87 [0.58-1.30],0.4974075313685069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR2,Fibroblast growth factor receptor 2,23774,174,0.95 [0.51-1.74],0.8572026578047911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR4,Fibroblast growth factor receptor 4,20082,158,1.12 [0.83-1.50],0.4607887367409177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGL1,Fibrinogen-like protein 1,20572,165,1.19 [0.95-1.49],0.1313536631712933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGR,Tyrosine-protein kinase Fgr,23189,175,1.09 [0.89-1.32],0.4153588805821463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FH,"Fumarate hydratase, mitochondrial",19888,158,1.11 [0.94-1.30],0.2155161649588886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19847,157,0.78 [0.54-1.11],0.1614032263660049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIT,Bis(5'-adenosyl)-triphosphatase,23189,175,1.19 [0.99-1.44],0.066315422959886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FIS1,Mitochondrial fission 1 protein,23675,177,1.22 [1.03-1.44],0.0201697440335162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,20505,164,1.11 [0.96-1.29],0.1691550862973483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,23799,176,1.10 [0.98-1.23],0.1146803515654031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,23507,174,1.43 [1.05-1.97],0.0251751179853113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,23507,174,1.13 [0.98-1.31],0.0916218203984184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23156,175,1.14 [0.89-1.46],0.3050110793900037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBPL,FK506-binding protein-like,20481,163,1.20 [0.94-1.54],0.1484894217710688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLI1,Friend leukemia integration 1 transcription factor,23155,169,1.07 [0.95-1.21],0.2427568926670058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,23507,174,1.40 [0.88-2.22],0.1591855122821328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT1,Vascular endothelial growth factor receptor 1,23558,177,0.80 [0.43-1.50],0.4830979902710475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3,Receptor-type tyrosine-protein kinase FLT3,23155,169,0.89 [0.56-1.40],0.6032869821459701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3LG,Fms-related tyrosine kinase 3 ligand,23989,179,1.06 [0.73-1.54],0.753544842776141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT4,Vascular endothelial growth factor receptor 3,23774,174,1.21 [0.81-1.80],0.3465465716514946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMNL1,Formin-like protein 1,23189,175,0.98 [0.79-1.20],0.81203777226456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMR1,Synaptic functional regulator FMR1,23155,169,1.28 [0.88-1.86],0.2044388659709721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FN1,Fibronectin,20568,163,0.82 [0.47-1.44],0.4999954187447414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNDC1,Fibronectin type III domain-containing protein 1,20496,162,1.64 [1.19-2.27],0.0023710143111341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,20474,161,1.40 [0.97-2.01],0.0696469524703841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLH1,Glutamate carboxypeptidase 2,19940,158,0.91 [0.77-1.08],0.2652720416617717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR1,Folate receptor alpha,23674,174,1.33 [0.86-2.06],0.2069689975302399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR2,Folate receptor beta,23926,178,1.46 [0.93-2.29],0.0957533166242613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR3,Folate receptor gamma,23699,172,0.98 [0.91-1.05],0.5227152163753455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOS,Proto-oncogene c-Fos,19789,157,1.19 [0.78-1.81],0.424859916926125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOSB,Protein fosB,23189,175,0.95 [0.66-1.36],0.7839793299339604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXJ3,Forkhead box protein J3,19940,158,1.17 [0.85-1.59],0.3342908933682402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO1,Forkhead box protein O1,23685,176,1.07 [0.92-1.24],0.3984284671916459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO3,Forkhead box protein O3,23155,169,0.98 [0.84-1.13],0.7368038090632705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD4B,FERM domain-containing protein 4B,19847,157,1.11 [0.89-1.37],0.3480303927059328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD7,FERM domain-containing protein 7,19997,159,1.01 [0.65-1.59],0.9526726363647666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRZB,Secreted frizzled-related protein 3,23434,174,1.03 [0.60-1.78],0.9167273753118236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSHB,Follitropin subunit beta,19981,164,1.07 [0.76-1.52],0.6965096056330213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FST,Follistatin,23762,178,0.98 [0.74-1.28],0.8609509640719571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL1,Follistatin-related protein 1,19981,164,1.24 [0.64-2.38],0.5236282754878682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL3,Follistatin-related protein 3,23645,178,1.21 [0.81-1.81],0.3525886170042095
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FTCD,Formimidoyltransferase-cyclodeaminase,20452,162,1.00 [0.84-1.20],0.970831888299988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUCA1,Tissue alpha-L-fucosidase,23846,178,1.05 [0.90-1.24],0.5173223087860294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUOM,Fucose mutarotase,20082,158,1.04 [0.81-1.33],0.7763279479143476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FURIN,Furin,23774,174,1.26 [0.84-1.89],0.272207399116133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUS,RNA-binding protein FUS,23114,168,1.21 [0.87-1.67],0.2560146595778239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20152,161,1.13 [0.92-1.41],0.2495107346763316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23926,178,0.95 [0.72-1.27],0.7497706179641297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT8,"Alpha-(1,6)-fucosyltransferase",23507,174,1.11 [0.89-1.40],0.3504290047340405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXN,"Frataxin, mitochondrial",23920,179,1.22 [1.02-1.45],0.030953861709434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXYD5,FXYD domain-containing ion transport regulator 5,23300,174,1.15 [0.94-1.41],0.1606349515846293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FYB1,FYN-binding protein 1,23678,175,1.11 [0.96-1.28],0.1712317213617001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD10,Frizzled-10,19997,159,0.75 [0.54-1.04],0.0826056725185345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD8,Frizzled-8,19888,158,0.95 [0.66-1.38],0.7933486407709488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAP,Gamma-aminobutyric acid receptor-associated protein,20474,161,0.95 [0.68-1.31],0.7396966698062711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20186,161,0.78 [0.59-1.03],0.0811849711106543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19888,158,0.87 [0.67-1.15],0.3338680463266865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD1,Glutamate decarboxylase 1,19825,157,0.79 [0.44-1.43],0.43650878820128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD2,Glutamate decarboxylase 2,19940,158,0.79 [0.54-1.17],0.2412440234493864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20186,161,0.90 [0.63-1.29],0.5726116571344785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19981,164,1.17 [0.89-1.54],0.2641698121105194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAGE2A,G antigen 2A,19825,157,0.92 [0.71-1.20],0.5510985851728001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAL,Galanin peptides,23798,178,1.06 [0.87-1.29],0.5961882676721131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,23599,177,1.21 [0.75-1.95],0.4300181580891691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23920,179,0.43 [0.27-0.70],0.000731395761419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,23300,174,1.20 [0.88-1.62],0.2521001864184826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,20545,162,1.44 [0.86-2.40],0.1657388659537597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT7,N-acetylgalactosaminyltransferase 7,23599,177,1.05 [0.56-1.99],0.8740086003722736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAMT,Guanidinoacetate N-methyltransferase,19847,157,1.02 [0.65-1.59],0.9371362419245955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,19640,155,1.48 [0.86-2.56],0.1548151571676261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GART,Trifunctional purine biosynthetic protein adenosine-3,20505,164,0.74 [0.39-1.39],0.3420869699625333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS2,Growth arrest-specific protein 2,20186,161,0.90 [0.66-1.24],0.5259452889114893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS6,Growth arrest-specific protein 6,23863,178,1.05 [0.61-1.78],0.8701022776719846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GASK1A,Golgi-associated kinase 1A,19847,157,1.26 [0.88-1.80],0.211660388620918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAST,Gastrin,20496,162,1.13 [1.03-1.25],0.0136476013420247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19825,157,1.03 [0.58-1.84],0.9121864961681626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19981,164,1.18 [0.97-1.43],0.0894954866001186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBA,Lysosomal acid glucosylceramidase,19997,159,0.86 [0.65-1.15],0.3193662441048466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP1,Guanylate-binding protein 1,20456,161,0.97 [0.77-1.22],0.7848580374831071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP2,Guanylate-binding protein 2,23300,174,1.03 [0.82-1.28],0.8273173978994639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP4,Guanylate-binding protein 4,23189,175,1.09 [0.83-1.42],0.5390538297978225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP6,Guanylate-binding protein 6,19847,157,0.91 [0.63-1.32],0.6330118554344892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GC,Vitamin D-binding protein,20568,163,1.25 [0.71-2.22],0.4405093863284698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCC1,GRIP and coiled-coil domain-containing protein 1,20496,162,1.09 [0.94-1.25],0.2524610748186541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCG,Pro-glucagon,23155,169,0.99 [0.89-1.11],0.891654161514811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19577,157,0.95 [0.69-1.31],0.7768247730728574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCLM,Glutamate--cysteine ligase regulatory subunit,19847,157,1.12 [0.81-1.56],0.4795867284166415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",23599,177,0.87 [0.59-1.29],0.4909606312451939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF15,Growth/differentiation factor 15,24010,179,1.35 [1.03-1.76],0.0281665313973762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF2,Growth/differentiation factor 2,23713,172,1.18 [0.81-1.72],0.3880421005531129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDNF,Glial cell line-derived neurotrophic factor,23189,175,1.07 [0.75-1.52],0.7214877047271588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GET3,ATPase GET3,20545,162,1.24 [0.97-1.58],0.0923566373588112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFAP,Glial fibrillary acidic protein,23117,169,1.15 [0.86-1.53],0.3560693361474715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFER,FAD-linked sulfhydryl oxidase ALR,23155,169,1.24 [1.01-1.52],0.0432582589252677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23155,169,0.91 [0.80-1.04],0.176671623898156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA1,GDNF family receptor alpha-1,23892,177,2.12 [1.39-3.25],0.0005291860053754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA2,GDNF family receptor alpha-2,23599,177,1.15 [0.61-2.19],0.6621931868372022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA3,GDNF family receptor alpha-3,23434,173,1.11 [0.69-1.81],0.6622624891922211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRAL,GDNF family receptor alpha-like,19901,157,0.95 [0.74-1.22],0.6722927085316975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGA1,ADP-ribosylation factor-binding protein GGA1,23189,175,0.99 [0.81-1.21],0.9259368439121244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGACT,Gamma-glutamylaminecyclotransferase,20545,162,1.09 [0.88-1.34],0.4376189944014205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGCT,Gamma-glutamylcyclotransferase,20511,162,1.27 [0.95-1.72],0.1112431000197662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGH,Gamma-glutamyl hydrolase,23327,172,1.43 [0.99-2.08],0.0591116164869312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT1,Glutathione hydrolase 1 proenzyme,23679,173,1.18 [0.92-1.52],0.1893708127320344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT5,Glutathione hydrolase 5 proenzyme,23507,174,1.70 [0.98-2.96],0.0585744329715257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH1,Somatotropin,23682,172,1.08 [1.00-1.16],0.037518631113019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH2,Growth hormone variant,23155,169,0.98 [0.89-1.07],0.5781662245256531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHR,Growth hormone receptor,20082,158,1.17 [0.68-2.03],0.5683061394938391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRHR,Growth hormone-releasing hormone receptor,23189,175,1.08 [0.86-1.37],0.5093477070103729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRL,Appetite-regulating hormone,23713,172,1.02 [0.87-1.20],0.7858686332425502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GID8,Glucose-induced degradation protein 8 homolog,20505,164,1.07 [0.70-1.64],0.7394574536085544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIGYF2,GRB10-interacting GYF protein 2,20505,164,1.08 [0.89-1.31],0.4278106780282549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP7,GTPase IMAP family member 7,20082,158,1.03 [0.64-1.65],0.913649784695733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP8,GTPase IMAP family member 8,19825,157,1.23 [0.94-1.63],0.1333146759658597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIP,Gastric inhibitory polypeptide,19981,164,1.24 [0.95-1.62],0.1149750274328614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC2,PDZ domain-containing protein GIPC2,20496,162,1.05 [0.65-1.71],0.8421966795687774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC3,PDZ domain-containing protein GIPC3,20481,163,1.09 [0.93-1.27],0.2829460691034883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPR,Gastric inhibitory polypeptide receptor,19940,158,0.93 [0.65-1.34],0.7092067830204218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIT1,ARF GTPase-activating protein GIT1,19940,158,1.07 [0.91-1.25],0.4271210994898534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GJA8,Gap junction alpha-8 protein,19825,157,1.12 [0.90-1.40],0.2984079543105166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GKN1,Gastrokine-1,22754,171,0.87 [0.53-1.43],0.5950682088620756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLA,Alpha-galactosidase A,20050,158,1.17 [0.79-1.74],0.4274097191569356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLB1,Beta-galactosidase,23507,174,1.17 [0.86-1.59],0.3196813660874026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLI2,Zinc finger protein GLI2,19940,158,0.75 [0.45-1.26],0.2803494248117143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLO1,Lactoylglutathione lyase,23281,173,1.18 [0.93-1.48],0.1691918683387489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLOD4,Glyoxalase domain-containing protein 4,23639,177,1.50 [1.02-2.21],0.0378391515807793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLP1R,Glucagon-like peptide 1 receptor,19888,158,1.06 [0.71-1.60],0.7633336466681453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX,Glutaredoxin-1,23562,170,1.13 [0.90-1.43],0.2929713872281836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20082,158,1.16 [0.98-1.37],0.0903156017434215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23189,175,1.03 [0.76-1.38],0.8683818378982276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLYR1,Putative oxidoreductase GLYR1,20474,161,0.90 [0.68-1.19],0.4674124366847051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GM2A,Ganglioside GM2 activator,20055,159,1.29 [0.92-1.81],0.1349532421334966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMFG,Glia maturation factor gamma,20545,162,1.13 [0.91-1.39],0.2643541866067117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR,GMP reductase 1,23989,179,1.11 [0.84-1.47],0.4556220681158716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR2,GMP reductase 2,20082,158,1.27 [1.01-1.59],0.0414359523604729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNAS,Neuroendocrine secretory protein 55,20505,164,1.08 [0.91-1.27],0.3803119108997956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23155,169,1.20 [0.99-1.47],0.0690524630772908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19997,159,0.70 [0.48-1.02],0.0633954786347132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNLY,Granulysin,23722,175,0.87 [0.68-1.12],0.2768176663210022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA1,Glucosamine-6-phosphate isomerase 1,19981,164,0.84 [0.51-1.37],0.485227742349731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA2,Glucosamine-6-phosphate isomerase 2,20082,158,1.10 [0.73-1.66],0.6502004425624877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLGA3,Golgin subfamily A member 3,20505,164,1.16 [0.96-1.40],0.1212387943191853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLM2,Protein GOLM2,23926,178,1.33 [0.76-2.32],0.3219217391387158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,23685,176,1.11 [0.97-1.26],0.1261402842700695
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GORASP2,Golgi reassembly-stacking protein 2,20481,163,1.03 [0.75-1.41],0.8729184611147366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOT1,"Aspartate aminotransferase, cytoplasmic",20552,162,1.11 [0.78-1.56],0.5659456346794418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BA,Platelet glycoprotein Ib alpha chain,23633,176,1.36 [0.92-2.02],0.1187381969787506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BB,Platelet glycoprotein Ib beta chain,19847,157,1.08 [0.86-1.35],0.4934677161636401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22977,169,0.96 [0.81-1.13],0.6114284669412812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP5,Platelet glycoprotein V,20082,158,1.34 [0.87-2.06],0.1895709839461739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP6,Platelet glycoprotein VI,23678,175,1.14 [0.98-1.32],0.100197877288707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPA33,Cell surface A33 antigen,23599,177,0.99 [0.90-1.10],0.9159459123634306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC1,Glypican-1,23920,179,1.09 [0.70-1.70],0.7062941090124624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC5,Glypican-5,23507,174,0.88 [0.69-1.12],0.2867110884081774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPD1,Glycerol-3-phosphate dehydrogenase,20474,161,1.16 [0.87-1.53],0.3074293469025692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPHA2,Glycoprotein hormone alpha-2,20481,163,0.77 [0.51-1.16],0.2062608292849181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPI,Glucose-6-phosphate isomerase,20572,165,1.14 [0.84-1.55],0.3867776598487727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,20481,163,1.03 [0.84-1.28],0.7580264185590673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPKOW,G-patch domain and KOW motifs-containing protein,23189,175,1.03 [0.67-1.58],0.9008345102642022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPNMB,Transmembrane glycoprotein NMB,23072,168,1.36 [0.84-2.18],0.2108936262051523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR101,Probable G-protein coupled receptor 101,19888,158,1.05 [0.81-1.36],0.7122389779083533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR158,Probable G-protein coupled receptor 158,20505,164,0.67 [0.40-1.10],0.1112277203702506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR15L,Protein GPR15L,20481,163,1.09 [0.86-1.39],0.473131497925734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR37,Prosaposin receptor GPR37,23281,173,1.18 [0.96-1.46],0.1109683575236104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPRC5C,G-protein coupled receptor family C group 5 member C,20474,161,1.13 [0.88-1.46],0.3386599520393619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRAP2,GRB2-related adapter protein 2,23713,172,1.08 [0.97-1.19],0.1724846488401153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,20545,162,1.19 [0.94-1.52],0.1463827228550424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIK2,"Glutamate receptor ionotropic, kainate 2",20505,164,0.97 [0.68-1.38],0.8498349911324318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19888,158,1.23 [0.99-1.53],0.0565437126790401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRK5,G protein-coupled receptor kinase 5,23281,173,0.96 [0.73-1.26],0.7499960564469215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRN,Progranulin,23594,173,1.12 [0.65-1.93],0.6757949897947457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRP,Gastrin-releasing peptide,19981,164,0.83 [0.63-1.10],0.1932242142487515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRPEL1,"GrpE protein homolog 1, mitochondrial",23599,177,1.19 [0.96-1.46],0.1104042894012688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRSF1,G-rich sequence factor 1,19715,156,0.95 [0.78-1.15],0.5812498084791926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSAP,Gamma-secretase-activating protein,23155,169,1.11 [0.96-1.28],0.1622379825260527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSN,Gelsolin,20486,163,0.66 [0.30-1.46],0.3021885453479079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSR,"Glutathione reductase, mitochondrial",20462,165,1.41 [0.74-2.72],0.2981695005634805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA1,Glutathione S-transferase A1,23676,172,0.93 [0.79-1.10],0.4139224650225612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA3,Glutathione S-transferase A3,23155,169,0.97 [0.81-1.17],0.7501820079685143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTM4,Glutathione S-transferase Mu 4,19847,157,1.00 [0.81-1.24],0.9890611787426348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTP1,Glutathione S-transferase P,23039,174,1.16 [0.97-1.39],0.1145296619627358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTT2B,Glutathione S-transferase theta-2B,20496,162,1.01 [0.95-1.07],0.7868119300965126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20186,161,0.98 [0.78-1.23],0.8411033446734807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTPBP2,GTP-binding protein 2,19997,159,1.07 [0.89-1.29],0.4887577111320121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCA2A,Guanylin,23598,175,1.11 [0.75-1.62],0.6023215919912706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCY2C,Heat-stable enterotoxin receptor,20186,161,0.93 [0.76-1.14],0.4697713042746323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUK1,Guanylate kinase,19847,157,0.95 [0.63-1.43],0.8150865956379679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUSB,Beta-glucuronidase,23811,178,0.93 [0.75-1.16],0.5161211440657543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GYS1,"Glycogen [starch] synthase, muscle",23281,173,1.14 [0.99-1.32],0.0758934177566406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMA,Granzyme A,23989,179,1.09 [0.74-1.60],0.6544349670025671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMB,Granzyme B,23685,176,0.87 [0.71-1.08],0.2041292514601552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMH,Granzyme H,23281,173,0.93 [0.78-1.12],0.4580666808549528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,H2AP,Huntingtin-interacting protein M,19825,157,1.05 [0.78-1.40],0.7654223913040056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19847,157,1.12 [0.92-1.36],0.2449936332659808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23856,177,1.01 [0.83-1.21],0.9531749402462832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAO1,Hydroxyacid oxidase 1,23920,179,0.95 [0.85-1.06],0.3561083559044211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HARS1,"Histidine--tRNA ligase, cytoplasmic",23722,175,1.16 [0.97-1.38],0.0990614505505407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR1,Hepatitis A virus cellular receptor 1,23884,179,1.21 [1.00-1.48],0.0537434132695172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR2,Hepatitis A virus cellular receptor 2,23722,175,1.14 [0.79-1.66],0.4873986654751149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBEGF,Proheparin-binding EGF-like growth factor,23856,177,1.13 [0.94-1.35],0.1993798071031717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBQ1,Hemoglobin subunit theta-1,23920,179,0.95 [0.77-1.18],0.646978633888097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBZ,Hemoglobin subunit zeta,20545,162,1.06 [0.93-1.22],0.3817843362178331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCG22,Protein PBMUCL2,19847,157,1.08 [0.84-1.39],0.5369297578399237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCLS1,Hematopoietic lineage cell-specific protein,23989,179,1.19 [0.94-1.51],0.1570810924201527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC8,Histone deacetylase 8,19940,158,0.86 [0.64-1.15],0.3100856992376998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC9,Histone deacetylase 9,19888,158,1.03 [0.82-1.28],0.8095627864397504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDDC2,5'-deoxynucleotidase HDDC2,20481,163,1.25 [0.90-1.73],0.1755069869029908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGF,Hepatoma-derived growth factor,23880,179,0.99 [0.86-1.14],0.8841268018524786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGFL2,Hepatoma-derived growth factor-related protein 2,20496,162,1.14 [0.92-1.42],0.2394247711438827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEBP1,Heme-binding protein 1,23281,173,1.12 [0.89-1.43],0.3333331641521263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEG1,Protein HEG homolog 1,20082,158,1.07 [0.61-1.88],0.8150061210087531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPACAM2,HEPACAM family member 2,20496,162,1.02 [0.72-1.44],0.9233483974881684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPH,Hephaestin,20545,162,0.95 [0.56-1.62],0.847717527373339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEXIM1,Protein HEXIM1,23685,176,1.16 [0.98-1.36],0.0797332632312166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGF,Hepatocyte growth factor,23989,179,1.43 [1.00-2.05],0.0521667638990001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGFAC,Hepatocyte growth factor activator,20387,164,0.66 [0.39-1.13],0.127670626174368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23155,169,1.17 [0.99-1.39],0.0689616219048726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HHEX,Hematopoietically-expressed homeobox protein HHEX,20496,162,1.19 [0.98-1.44],0.0772117560894521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIF1A,Hypoxia-inducible factor 1-alpha,19940,158,0.92 [0.70-1.20],0.5203298627436121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1,Huntingtin-interacting protein 1,19847,157,0.64 [0.37-1.10],0.1076451192527524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1R,Huntingtin-interacting protein 1-related protein,20455,162,0.96 [0.68-1.34],0.7965608555489839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HJV,Hemojuvelin,20505,164,1.00 [0.70-1.43],0.9888094780818212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HK2,Hexokinase-2,23281,173,1.17 [0.71-1.91],0.5367127698232886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",20505,164,1.14 [0.72-1.80],0.5675619381337869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23606,176,1.03 [0.72-1.49],0.8629002011041719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",23685,176,0.96 [0.61-1.53],0.8794642060755675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMBS,Porphobilinogen deaminase,23920,179,0.86 [0.63-1.19],0.3600649977513501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMCN2,Hemicentin-2,20046,158,1.04 [0.80-1.36],0.7564000054873327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19981,164,1.11 [0.83-1.50],0.4801448084541888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19847,157,1.09 [0.78-1.53],0.6147285164556239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMMR,Hyaluronan mediated motility receptor,19781,157,1.14 [0.86-1.51],0.3739624578140319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX1,Heme oxygenase 1,23451,169,1.07 [0.81-1.41],0.6468897526133544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX2,Heme oxygenase 2,23189,175,0.99 [0.75-1.32],0.9699537374944092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNF1A,Hepatocyte nuclear factor 1-alpha,19997,159,0.91 [0.72-1.16],0.4624252860402765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNMT,Histamine N-methyltransferase,23400,173,1.05 [0.79-1.40],0.7195118429487051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23200,172,1.17 [0.99-1.38],0.0668885616560437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,20505,164,1.27 [0.99-1.64],0.058146626060543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPCAL1,Hippocalcin-like protein 1,23989,179,1.18 [0.98-1.42],0.0743090140290113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPGDS,Hematopoietic prostaglandin D synthase,23155,169,0.79 [0.55-1.14],0.2098630255518863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPSE,Heparanase,20298,160,1.21 [1.03-1.42],0.0202817970968169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRAS,GTPase Hras,20150,160,0.92 [0.77-1.10],0.3835176306370357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19981,164,1.23 [0.81-1.88],0.334535896513107
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRG,Histidine-rich glycoprotein,20465,163,0.89 [0.55-1.42],0.6206351536584419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS1BP3,HCLS1-binding protein 3,19981,164,1.10 [0.93-1.30],0.2488594850570957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,23599,177,1.16 [0.82-1.66],0.4038312599162782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23920,179,1.00 [0.68-1.47],0.9825598849886054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19940,158,2.07 [1.46-2.93],3.9818051796077705e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSBP1,Heat shock factor-binding protein 1,19981,164,1.10 [0.94-1.28],0.2455734451011391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,23685,176,0.93 [0.67-1.30],0.6649279460202842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,20496,162,1.02 [0.80-1.30],0.882746389279393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19847,157,1.18 [0.88-1.57],0.2692027786372166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19981,164,1.01 [0.74-1.38],0.9644481421838992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSP90B1,Endoplasmin,23078,174,0.83 [0.65-1.07],0.1445922717304283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA1A,Heat shock 70 kDa protein 1A,23753,178,1.15 [0.96-1.38],0.1182985592712855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA2,Heat shock-related 70 kDa protein 2,20474,161,1.59 [1.17-2.17],0.003392697595961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB1,Heat shock protein beta-1,23345,169,1.19 [0.97-1.46],0.0928539355364123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB6,Heat shock protein beta-6,23920,179,1.93 [1.45-2.56],5.794985778121925e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23557,173,1.28 [0.79-2.08],0.3236324188325406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1A,5-hydroxytryptamine receptor 1A,19888,158,1.09 [0.89-1.32],0.4095837498012061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1B,5-hydroxytryptamine receptor 1B,19888,158,0.77 [0.52-1.14],0.1907455829777234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTRA2,"Serine protease HTRA2, mitochondrial",23774,174,1.22 [0.99-1.52],0.0640678028311099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYAL1,Hyaluronidase-1,23610,175,1.20 [0.67-2.15],0.5302634164459039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYOU1,Hypoxia up-regulated protein 1,24010,179,1.15 [0.65-2.02],0.6351449615706305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICA1,Islet cell autoantigen 1,23300,174,1.15 [0.98-1.36],0.0956733782642646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM1,Intercellular adhesion molecule 1,23626,175,1.68 [1.08-2.62],0.0223743917223681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM2,Intercellular adhesion molecule 2,24010,179,1.14 [0.76-1.71],0.529108388330686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM3,Intercellular adhesion molecule 3,24010,179,0.98 [0.60-1.59],0.9227802640009056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM4,Intercellular adhesion molecule 4,23685,176,1.13 [0.88-1.46],0.3467744784009937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM5,Intercellular adhesion molecule 5,23713,172,0.95 [0.71-1.27],0.7498091924226864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICOSLG,ICOS ligand,23599,177,0.87 [0.43-1.74],0.6900659030800119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ID4,DNA-binding protein inhibitor ID-4,20186,161,0.82 [0.55-1.23],0.3371777965992302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDI2,Isopentenyl-diphosphate delta-isomerase 2,23189,175,1.15 [0.88-1.50],0.2987942681424861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDO1,"Indoleamine 2,3-dioxygenase 1",19981,164,0.97 [0.76-1.24],0.820171496139672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDS,Iduronate 2-sulfatase,23989,179,3.98 [1.39-11.34],0.0098555321524202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDUA,Alpha-L-iduronidase,23920,179,1.03 [0.78-1.36],0.8530742763010833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19994,161,0.97 [0.66-1.42],0.8638689964126058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20186,161,1.00 [0.74-1.35],0.9996239603447392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20186,161,1.16 [0.80-1.69],0.4230201826621441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNAR1,Interferon alpha/beta receptor 1,20481,163,0.98 [0.54-1.79],0.9545918144547322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNG,Interferon gamma,23300,174,1.03 [0.92-1.16],0.624844283068613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR1,Interferon gamma receptor 1,23798,178,1.01 [0.54-1.88],0.9765440707445168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR2,Interferon gamma receptor 2,23507,174,1.04 [0.80-1.34],0.789614265934724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL1,Interferon lambda-1,23189,175,1.00 [0.74-1.34],0.9772322077213924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL2,Interferon lambda-2,19888,158,0.90 [0.68-1.20],0.4720047784473868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNLR1,Interferon lambda receptor 1,23685,176,0.92 [0.62-1.36],0.676894735660941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNW1,Interferon omega-1,19847,157,0.96 [0.62-1.51],0.8735575237392476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFT20,Intraflagellar transport protein 20 homolog,19997,159,0.96 [0.68-1.37],0.8320295181377141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGBP1,Immunoglobulin-binding protein 1,20505,164,1.16 [0.91-1.48],0.2373396580165758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19888,158,1.18 [0.91-1.52],0.2174207793218276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20552,162,2.28 [1.38-3.75],0.0012042397181839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF1R,Insulin-like growth factor 1 receptor,23599,177,0.85 [0.45-1.59],0.6010515613898911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19847,157,0.94 [0.67-1.33],0.7325979701263821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2R,Cation-independent mannose-6-phosphate receptor,23722,175,1.36 [0.78-2.38],0.2813641541046651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP1,Insulin-like growth factor-binding protein 1,23976,179,0.97 [0.87-1.07],0.5271261529106092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP2,Insulin-like growth factor-binding protein 2,23975,179,1.20 [0.96-1.51],0.1091568999935856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP3,Insulin-like growth factor-binding protein 3,23824,176,1.51 [0.97-2.34],0.067074598672079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP4,Insulin-like growth factor-binding protein 4,23437,174,1.29 [0.97-1.70],0.0775614622488237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP6,Insulin-like growth factor-binding protein 6,23630,175,0.96 [0.62-1.47],0.8467638388994645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP7,Insulin-like growth factor-binding protein 7,24010,179,1.02 [0.67-1.57],0.919691840665362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBPL1,Insulin-like growth factor-binding protein-like 1,23713,172,0.99 [0.66-1.49],0.9604514867125544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFL4,Insulin growth factor-like family member 4,19940,158,0.94 [0.75-1.18],0.607483623125847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGHMBP2,DNA-binding protein SMUBP-2,19847,157,0.96 [0.72-1.26],0.7486758132409307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLC2,Immunoglobulin lambda constant 2,20540,163,1.20 [0.72-1.99],0.4911239658097811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLON5,IgLON family member 5,19825,157,0.94 [0.78-1.13],0.511768949296117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF21,Immunoglobulin superfamily member 21,19981,164,1.04 [0.71-1.51],0.8578081461153386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF3,Immunoglobulin superfamily member 3,23599,177,1.09 [0.76-1.57],0.6334760602868035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF8,Immunoglobulin superfamily member 8,23713,172,1.66 [1.12-2.45],0.0112019516187789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF9,Protein turtle homolog A,20545,162,1.13 [0.95-1.34],0.1713485388496244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKBKG,NF-kappa-B essential modulator,23685,176,1.06 [0.92-1.23],0.432198046323399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKZF2,Zinc finger protein Helios,23155,169,0.94 [0.80-1.12],0.4962884310435408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10,Interleukin-10,23300,174,1.07 [0.91-1.26],0.4273530424807481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RA,Interleukin-10 receptor subunit alpha,23300,174,0.79 [0.59-1.05],0.1064900080289835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RB,Interleukin-10 receptor subunit beta,23798,178,1.10 [0.70-1.72],0.6776036916830346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL11,Interleukin-11,23300,174,1.17 [0.97-1.42],0.0967782776817517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12A_IL12B,Interleukin-12,23599,177,1.00 [0.84-1.19],0.9613254481309644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12B,Interleukin-12 subunit beta,23989,179,1.04 [0.82-1.32],0.7710162480833362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB1,Interleukin-12 receptor subunit beta-1,23300,174,1.13 [0.79-1.61],0.5188151208501847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB2,Interleukin-12 receptor subunit beta-2,19940,158,0.98 [0.68-1.43],0.9283185504023156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13,Interleukin-13,23300,174,0.96 [0.72-1.29],0.801417452916313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA1,Interleukin-13 receptor subunit alpha-1,23413,169,0.89 [0.50-1.58],0.7009139240201019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA2,Interleukin-13 receptor subunit alpha-2,19888,158,0.96 [0.57-1.63],0.8749169495608909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15,Interleukin-15,23685,176,1.47 [1.00-2.16],0.048682659288051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15RA,Interleukin-15 receptor subunit alpha,23300,174,0.92 [0.63-1.36],0.6904335880584096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL16,Pro-interleukin-16,23989,179,1.08 [0.81-1.45],0.6060249609506196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17A,Interleukin-17A,23252,174,0.92 [0.67-1.27],0.6114864106033397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17C,Interleukin-17C,23300,174,1.02 [0.85-1.23],0.8182852515434368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17D,Interleukin-17D,23300,174,0.84 [0.54-1.30],0.4323470485928814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17F,Interleukin-17F,23300,174,1.16 [1.00-1.36],0.0543870223365793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RA,Interleukin-17 receptor A,23722,175,1.19 [0.88-1.61],0.2685710056940374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RB,Interleukin-17 receptor B,23390,175,1.04 [0.81-1.34],0.7667259866603517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18,Interleukin-18,23599,178,1.03 [0.76-1.38],0.865838342913859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18BP,Interleukin-18-binding protein,23824,176,1.29 [0.85-1.96],0.2283945968842302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18R1,Interleukin-18 receptor 1,23989,179,1.09 [0.73-1.63],0.6744563597193832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18RAP,Interleukin-18 receptor accessory protein,23356,174,1.00 [0.93-1.09],0.9320972978403304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL19,Interleukin-19,23124,163,1.27 [1.07-1.51],0.0073210578408023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1A,Interleukin-1 alpha,23300,174,1.08 [0.88-1.33],0.4447748398996309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1B,Interleukin-1 beta,23190,173,1.18 [0.95-1.47],0.1307952896257981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R1,Interleukin-1 receptor type 1,23679,173,1.27 [0.71-2.27],0.4134981990667398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R2,Interleukin-1 receptor type 2,23637,177,0.81 [0.42-1.58],0.5383296985909374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RAP,Interleukin-1 receptor accessory protein,23722,175,0.91 [0.67-1.22],0.5088808316514525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL1,Interleukin-1 receptor-like 1,23930,178,1.06 [0.80-1.40],0.6782654725192623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL2,Interleukin-1 receptor-like 2,23300,174,0.95 [0.66-1.36],0.7773181205991296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RN,Interleukin-1 receptor antagonist protein,23638,177,1.23 [0.98-1.54],0.0756649856550902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2,Interleukin-2,23300,174,1.08 [0.71-1.64],0.720580984581114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20,Interleukin-20,23300,174,0.86 [0.63-1.17],0.3437111114896171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RA,Interleukin-20 receptor subunit alpha,23300,174,0.90 [0.65-1.25],0.5314874535929657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RB,Interleukin-20 receptor subunit beta,19940,158,0.67 [0.46-0.98],0.0390431652185575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL21R,Interleukin-21 receptor,19940,158,0.78 [0.55-1.10],0.1609914009769243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22,Interleukin-22,20474,161,1.22 [1.00-1.49],0.0451849195646712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22RA1,Interleukin-22 receptor subunit alpha-1,23300,174,0.82 [0.58-1.17],0.2740039752215051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL24,Interleukin-24,23300,174,0.90 [0.67-1.20],0.4617673269805249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL25,Interleukin-25,19752,157,0.63 [0.41-0.98],0.0424337948911395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RA,Interleukin-2 receptor subunit alpha,23562,176,1.45 [1.08-1.95],0.0137939399310829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RB,Interleukin-2 receptor subunit beta,23300,174,1.16 [0.82-1.62],0.4018552690224017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RG,Cytokine receptor common subunit gamma,20474,161,1.41 [1.01-1.98],0.0435981265400465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3,Interleukin-3,19825,157,1.09 [0.84-1.41],0.5225705736340696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31,Interleukin-31,19940,158,0.94 [0.70-1.26],0.6573904668469555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31RA,Interleukin-31 receptor subunit alpha,19869,156,0.82 [0.54-1.24],0.3517541469678062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL32,Interleukin-32,23685,176,1.24 [0.92-1.67],0.1501037778397542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL33,Interleukin-33,23300,174,1.21 [0.86-1.70],0.281330678357532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL34,Interleukin-34,23146,175,1.01 [0.69-1.47],0.96673724912467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36A,Interleukin-36 alpha,19940,158,0.84 [0.61-1.14],0.2617565311239961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36G,Interleukin-36 gamma,19871,158,1.25 [1.04-1.50],0.0153950419780828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3RA,Interleukin-3 receptor subunit alpha,23300,174,1.00 [0.65-1.53],0.9975184839130852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4,Interleukin-4,23300,174,1.16 [0.98-1.38],0.0822366882871956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4R,Interleukin-4 receptor subunit alpha,23685,176,1.21 [0.85-1.72],0.2939236316000744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5,Interleukin-5,23300,174,0.99 [0.90-1.09],0.8613361970042082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5RA,Interleukin-5 receptor subunit alpha,23685,176,0.84 [0.66-1.07],0.1657714754296256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6,Interleukin-6,23599,177,1.21 [1.05-1.39],0.0094724066637098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6R,Interleukin-6 receptor subunit alpha,23594,175,1.13 [0.77-1.67],0.524056430424467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6ST,Interleukin-6 receptor subunit beta,23713,172,1.45 [0.68-3.13],0.3382970875856438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7,Interleukin-7,23685,176,1.06 [0.86-1.30],0.5872173330565197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7R,Interleukin-7 receptor subunit alpha,23722,175,0.88 [0.69-1.14],0.3365403963188484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL9,Interleukin-9,20186,161,1.08 [0.83-1.39],0.5807570207474617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23148,175,1.14 [0.92-1.42],0.2260755597466016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMMT,MICOS complex subunit MIC60,20474,161,1.26 [0.93-1.71],0.128334764222634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPA1,Inositol monophosphatase 1,23507,174,1.22 [0.98-1.52],0.0689067372383103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPACT,Protein IMPACT,20496,162,1.17 [0.89-1.53],0.2662259052682005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPG1,Interphotoreceptor matrix proteoglycan 1,19888,158,0.98 [0.58-1.63],0.9277781970681804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ING1,Inhibitor of growth protein 1,23156,175,1.06 [0.81-1.38],0.6783740817299202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBB,Inhibin beta B chain,20082,158,0.92 [0.69-1.24],0.6022419135553111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBC,Inhibin beta C chain,23722,175,1.10 [0.79-1.55],0.5689526185005284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP1,Inositol polyphosphate 1-phosphatase,23599,177,1.16 [0.91-1.47],0.2413244411805774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19981,164,1.08 [0.83-1.40],0.5692515158477474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",20505,164,1.11 [0.79-1.57],0.5305369743595256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",23599,177,1.10 [0.96-1.27],0.1512746287169482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL3,Insulin-like 3,20496,162,0.97 [0.83-1.15],0.7491002273644483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL4,Early placenta insulin-like peptide,20474,161,0.81 [0.57-1.17],0.2630624784381606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL5,Insulin-like peptide INSL5,20481,163,0.85 [0.73-1.00],0.0487814786018952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSR,Insulin receptor,19940,158,0.91 [0.37-2.26],0.8430889211235432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IPCEF1,Interactor protein for cytohesin exchange factors 1,23464,174,1.10 [0.95-1.28],0.1944410465965254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IQGAP2,Ras GTPase-activating-like protein IQGAP2,23599,177,1.03 [0.81-1.32],0.8084650982878775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",23281,173,0.96 [0.82-1.12],0.6089892844354704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK1,Interleukin-1 receptor-associated kinase 1,23300,174,1.14 [0.94-1.38],0.1764951830472212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK4,Interleukin-1 receptor-associated kinase 4,23685,176,1.13 [0.99-1.29],0.0691173619419824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,22847,174,1.04 [0.72-1.48],0.8483599095447192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM1,Isthmin-1,23685,176,1.00 [0.71-1.41],0.9958179940342724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM2,Isthmin-2,20552,162,0.99 [0.70-1.41],0.9574773326005278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IST1,IST1 homolog,20325,162,1.15 [0.99-1.35],0.075225081713645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA11,Integrin alpha-11,23685,176,0.76 [0.51-1.13],0.1786576183335061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA2,Integrin alpha-2,20082,158,1.11 [0.71-1.73],0.6378377776223028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA5,Integrin alpha-5,23722,175,0.96 [0.56-1.66],0.8940282014982253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA6,Integrin alpha-6,23685,176,1.19 [0.93-1.53],0.1618562459615671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAL,Integrin alpha-L,19940,158,1.34 [0.93-1.93],0.1215190146100813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAM,Integrin alpha-M,23722,175,0.52 [0.34-0.81],0.0037305338575741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAV,Integrin alpha-V,23920,179,0.47 [0.26-0.85],0.0127569653810155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAX,Integrin alpha-X,20186,161,0.82 [0.60-1.13],0.2173591519034252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1,Integrin beta-1,23709,175,1.67 [0.91-3.06],0.098496205048368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP1,Integrin beta-1-binding protein 1,23155,169,1.01 [0.72-1.42],0.9692871433860778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP2,Integrin beta-1-binding protein 2,23281,173,1.13 [1.00-1.28],0.0456125401735101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB2,Integrin beta-2,23597,177,0.50 [0.31-0.82],0.0056473149141677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB5,Integrin beta-5,23774,174,1.04 [0.73-1.48],0.8277534090785976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB6,Integrin beta-6,23300,174,0.93 [0.60-1.45],0.7564082406834285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB7,Integrin beta-7,23920,179,1.03 [0.78-1.37],0.8380654844131067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGBL1,Integrin beta-like protein 1,20552,162,0.92 [0.61-1.38],0.6785973281158996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,20568,163,0.78 [0.35-1.75],0.5453769956931744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23824,176,1.29 [0.91-1.83],0.1579480261154022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,20568,163,0.95 [0.51-1.76],0.8663652728609312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,20474,161,0.79 [0.55-1.14],0.2083941152636373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITM2A,Integral membrane protein 2A,23685,176,0.91 [0.73-1.13],0.3896753147088071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPA,Inosine triphosphate pyrophosphatase,19847,157,1.04 [0.83-1.31],0.7234330750003521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19981,164,1.20 [1.00-1.45],0.0542923044768293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19888,158,1.23 [0.91-1.66],0.1789958903549323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23189,175,0.88 [0.66-1.17],0.3757692074270956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IZUMO1,Izumo sperm-egg fusion protein 1,19825,157,1.04 [0.75-1.42],0.8300089849459813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM2,Junctional adhesion molecule B,23926,178,1.00 [0.61-1.64],0.9978107451592256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM3,Junctional adhesion molecule C,20082,158,1.22 [0.91-1.63],0.1821801997641507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JCHAIN,Immunoglobulin J chain,23300,174,1.04 [0.84-1.29],0.7423269127524648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19825,157,1.02 [0.78-1.33],0.9061422198951504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JPT2,Jupiter microtubule associated homolog 2,20481,163,1.14 [0.96-1.36],0.1343582123048495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JUN,Transcription factor AP-1,23300,174,0.98 [0.74-1.30],0.8866565234420885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,23599,177,0.98 [0.73-1.32],0.9060259004886058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZN,Kazrin,20481,163,1.06 [0.92-1.22],0.4433787763846669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNC4,Potassium voltage-gated channel subfamily C member 4,19888,158,1.09 [0.84-1.41],0.5167463194224414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNH2,Potassium voltage-gated channel subfamily H member 2,19997,159,0.76 [0.58-1.00],0.0460464833249035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNIP4,Kv channel-interacting protein 4,23189,175,1.07 [0.84-1.38],0.5776800727264921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCTD5,BTB/POZ domain-containing protein KCTD5,20104,161,0.96 [0.69-1.34],0.8122900869422378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDM3A,Lysine-specific demethylase 3A,19940,158,0.80 [0.64-1.00],0.0550847308923053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDR,Vascular endothelial growth factor receptor 2,23774,174,1.31 [0.77-2.24],0.3163188001133649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KEL,Kell blood group glycoprotein,23189,175,0.88 [0.60-1.27],0.4875152891928911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHDC3L,KH domain-containing protein 3,19825,157,0.86 [0.66-1.13],0.2845424006869657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHK,Ketohexokinase,19981,164,1.08 [0.85-1.38],0.5389898404010773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA0319,Dyslexia-associated protein KIAA0319,20496,162,0.76 [0.46-1.27],0.2926184437723788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549,UPF0606 protein KIAA1549,20186,161,0.82 [0.66-1.03],0.0836594680920161
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549L,UPF0606 protein KIAA1549L,20186,161,0.60 [0.34-1.07],0.0858465398183861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA2013,Uncharacterized protein KIAA2013,20474,161,1.02 [0.77-1.34],0.9147709768938042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF1C,Kinesin-like protein KIF1C,19847,157,1.27 [0.87-1.83],0.2109528517123057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF20B,Kinesin-like protein KIF20B,19888,158,0.98 [0.79-1.20],0.8353779260680716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF22,Kinesin-like protein KIF22,19847,157,1.03 [0.91-1.17],0.6526449240028587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIFBP,KIF-binding protein,23599,177,1.10 [0.93-1.29],0.2705765637761202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,20474,161,0.89 [0.75-1.06],0.1938664522914349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23155,169,0.95 [0.80-1.13],0.5711466142445407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,20481,163,1.00 [0.91-1.09],0.9361912208797531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23155,169,0.93 [0.83-1.04],0.1810835653869191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19825,157,1.15 [0.99-1.33],0.0702986922637225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL1,Kin of IRRE-like protein 1,19888,158,0.97 [0.73-1.28],0.8062919905613375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL2,Kin of IRRE-like protein 2,23189,175,1.02 [0.73-1.43],0.9155146559800356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIT,Mast/stem cell growth factor receptor Kit,23789,176,1.11 [0.71-1.74],0.6519363010248194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KITLG,Kit ligand,23713,172,0.90 [0.63-1.28],0.5509170661219454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLB,Beta-klotho,23189,175,0.92 [0.77-1.11],0.3891100661562817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLF4,Krueppel-like factor 4,19888,158,1.16 [0.83-1.63],0.3821493934875716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLHL41,Kelch-like protein 41,20505,164,1.31 [1.02-1.67],0.0335322395320507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK1,Kallikrein-1,23490,173,1.00 [0.90-1.11],0.99681443634571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK10,Kallikrein-10,23708,174,1.01 [0.73-1.40],0.9453669502776644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK11,Kallikrein-11,23547,171,1.17 [0.78-1.74],0.4572342222922418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK12,Kallikrein-12,23155,169,1.09 [0.98-1.21],0.1080259562815765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK13,Kallikrein-13,23172,173,1.50 [1.12-2.00],0.0065248969218979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK14,Kallikrein-14,23920,179,1.43 [1.09-1.88],0.0108966391642527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK15,Kallikrein-15,20433,161,0.86 [0.64-1.14],0.2878485637708106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK3,Prostate-specific antigen,20552,162,0.95 [0.84-1.09],0.4743316023774649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK4,Kallikrein-4,23920,179,1.27 [1.05-1.54],0.0150987531329198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK6,Kallikrein-6,23729,174,1.19 [0.77-1.83],0.4321586609943041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK7,Kallikrein-7,19589,156,1.49 [1.03-2.14],0.0332766153191999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK8,Kallikrein-8,22907,167,1.05 [0.72-1.53],0.7927916407747686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLKB1,Plasma kallikrein,20150,161,2.13 [1.15-3.95],0.0161714963260572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRB1,Killer cell lectin-like receptor subfamily B member 1,23989,179,0.78 [0.55-1.10],0.1524441179539495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19888,158,1.10 [0.87-1.39],0.424498864523793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRD1,Natural killer cells antigen CD94,23989,179,1.03 [0.78-1.36],0.8171759513351232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19940,158,0.82 [0.55-1.21],0.3164585897487859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRK1,NKG2-D type II integral membrane protein,20496,162,1.00 [0.73-1.38],0.98884771430815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT14,"Keratin, type I cytoskeletal 14",22480,167,0.95 [0.59-1.54],0.8379309867451398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT17,"Keratin, type I cytoskeletal 17",19847,157,0.79 [0.52-1.20],0.2633469652229454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT18,"Keratin, type I cytoskeletal 18",23599,177,1.07 [0.91-1.26],0.4196242226389881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT19,"Keratin, type I cytoskeletal 19",23642,176,1.03 [0.84-1.25],0.7997655378158766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT5,"Keratin, type II cytoskeletal 5",23189,175,0.91 [0.70-1.19],0.4909596401030182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT6C,"Keratin, type II cytoskeletal 6C",19847,157,0.82 [0.52-1.29],0.3844706120524728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT8,"Keratin, type II cytoskeletal 8",19888,158,0.97 [0.78-1.19],0.7447184265359144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYAT1,Kynurenine--oxoglutarate transaminase 1,23675,172,1.14 [0.91-1.44],0.2615386552071331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYNU,Kynureninase,23989,179,1.05 [0.78-1.41],0.7575086912873465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L1CAM,Neural cell adhesion molecule L1,23774,174,0.76 [0.48-1.19],0.2340603933518698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,20545,162,1.08 [0.91-1.27],0.3883414085568942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACRT,Extracellular glycoprotein lacritin,20434,161,0.79 [0.54-1.15],0.2194891191388429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACTB2,Endoribonuclease LACTB2,23713,172,1.22 [1.00-1.49],0.0558580089951172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAG3,Lymphocyte activation gene 3 protein,23599,177,0.84 [0.60-1.19],0.3293761257854007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23679,178,1.12 [0.80-1.56],0.5246373171985039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,23507,174,0.94 [0.83-1.06],0.3283571943521349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA1,Laminin subunit alpha-1,19847,157,1.04 [0.78-1.39],0.8005542791332427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA4,Laminin subunit alpha-4,23798,178,1.23 [0.84-1.81],0.2916641889586741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMB1,Laminin subunit beta-1,19981,164,1.21 [0.74-1.97],0.453312492799844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP1,Lysosome-associated membrane glycoprotein 1,19989,157,1.07 [0.64-1.79],0.7837422498140058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP2,Lysosome-associated membrane glycoprotein 2,22992,174,1.01 [0.53-1.94],0.9787491335560502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP3,Lysosome-associated membrane glycoprotein 3,23950,178,1.16 [0.91-1.49],0.2411609714250406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMTOR5,Ragulator complex protein LAMTOR5,20474,161,1.04 [0.72-1.50],0.8417514203160126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAP3,Cytosol aminopeptidase,23300,174,1.15 [0.88-1.51],0.3028624297177494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LARP1,La-related protein 1,20474,161,1.02 [0.80-1.29],0.8831925138764641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT,Linker for activation of T-cells family member 1,23989,179,1.18 [0.99-1.41],0.0698692564152791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT2,Linker for activation of T-cells family member 2,23599,177,1.11 [1.00-1.23],0.0538586329742962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LATS1,Serine/threonine-protein kinase LATS1,19940,158,1.05 [0.87-1.25],0.627508803093066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAYN,Layilin,23474,174,1.11 [0.76-1.62],0.574490989031901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBP,Lipopolysaccharide-binding protein,23824,176,1.10 [0.87-1.38],0.4228450511029499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBR,Delta(14)-sterol reductase LBR,23926,178,1.06 [0.89-1.27],0.5047957335090678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCAT,Phosphatidylcholine-sterol acyltransferase,20572,165,0.73 [0.37-1.44],0.3642953468252229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN15,Lipocalin-15,20505,164,0.97 [0.75-1.24],0.8015056801858367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN2,Neutrophil gelatinase-associated lipocalin,23011,169,1.22 [0.87-1.69],0.2464109638980693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCP1,Plastin-2,20552,162,0.95 [0.70-1.30],0.7617682569354771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLR,Low-density lipoprotein receptor,23777,177,1.12 [0.87-1.46],0.3755686415373238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLRAP1,Low density lipoprotein receptor adapter protein 1,20505,164,1.10 [0.95-1.28],0.2179687657201849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LECT2,Leukocyte cell-derived chemotaxin-2,20545,162,0.90 [0.72-1.14],0.3960411600201857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEFTY2,Left-right determination factor 2,23892,177,0.84 [0.65-1.08],0.1726949290537315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEG1,Protein LEG1 homolog,19424,151,0.82 [0.64-1.03],0.0922568615116771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LELP1,Late cornified envelope-like proline-rich protein 1,19888,158,1.05 [0.85-1.29],0.6465233869098983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEO1,RNA polymerase-associated protein LEO1,20505,164,1.01 [0.62-1.64],0.9822173520664408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEP,Leptin,23713,172,1.07 [0.88-1.30],0.4936282757192977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEPR,Leptin receptor,23713,172,0.78 [0.50-1.21],0.2680261223104792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LETM1,Mitochondrial proton/calcium exchanger protein,20505,164,1.36 [1.06-1.74],0.0167061549923416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS1,Galectin-1,23713,172,1.16 [0.80-1.69],0.4306187358594529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3,Galectin-3,23786,178,0.85 [0.54-1.32],0.465530003174489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3BP,Galectin-3-binding protein,20568,163,1.21 [0.76-1.92],0.4277798487730295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS4,Galectin-4,23679,178,1.02 [0.81-1.29],0.8693555238259982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS7_LGALS7B,Galectin-7,23653,177,1.23 [0.92-1.63],0.1635487405626548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS8,Galectin-8,23926,178,1.12 [0.90-1.39],0.2992411378965639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS9,Galectin-9,23684,177,0.98 [0.64-1.51],0.9324396940566728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGMN,Legumain,23798,178,1.21 [0.84-1.73],0.3024941064548389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHB,Lutropin subunit beta,23155,169,1.04 [0.90-1.21],0.570794838950463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,23716,178,1.12 [0.90-1.39],0.3151515001975954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIF,Leukemia inhibitory factor,23189,175,1.04 [0.80-1.35],0.7593975047663029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIFR,Leukemia inhibitory factor receptor,23685,176,1.59 [0.92-2.76],0.0947146621525066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,23722,175,1.16 [0.79-1.69],0.4533165259193881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,20552,162,1.08 [0.95-1.22],0.2323102654346344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19847,157,0.89 [0.64-1.24],0.4964302930763349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,23682,172,1.10 [0.73-1.67],0.6365702332411303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,20545,162,1.03 [0.84-1.26],0.803385509784192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24010,179,1.23 [0.76-1.99],0.3895227720025606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23895,178,1.29 [0.87-1.90],0.1998411974293886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,23300,174,1.36 [1.01-1.82],0.0423287438317909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24010,179,0.84 [0.70-1.00],0.04854335792785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIPF,Gastric triacylglycerol lipase,19981,164,0.82 [0.64-1.05],0.1233087857245037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB1,Lamin-B1,20444,163,0.94 [0.74-1.20],0.6334247008092646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB2,Lamin-B2,20496,162,1.56 [0.96-2.54],0.0717341212948795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD1,Leiomodin-1,20505,164,0.69 [0.43-1.11],0.1278552144289515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD2,Leiomodin-2,19888,158,0.94 [0.72-1.22],0.6315066955370917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LONP1,"Lon protease homolog, mitochondrial",19981,164,1.11 [0.93-1.31],0.2393214795115593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPA,Apolipoprotein(a),20105,159,1.02 [0.94-1.11],0.6384931475541611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPCAT2,Lysophosphatidylcholine acyltransferase 2,23599,177,1.03 [0.77-1.37],0.8510825548415306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPL,Lipoprotein lipase,23713,172,0.92 [0.70-1.21],0.5384170918935776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPO,Lactoperoxidase,22873,171,0.91 [0.72-1.14],0.3986601386689022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPP,Lipoma-preferred partner,19847,157,1.07 [0.85-1.35],0.5627985517872546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19847,157,1.08 [0.87-1.34],0.4992074269371886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19997,159,0.90 [0.63-1.30],0.5819829223434805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRG1,Leucine-rich alpha-2-glycoprotein,20568,163,1.42 [0.82-2.46],0.2115367673036904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23856,177,0.89 [0.61-1.29],0.5259110297958827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19878,158,0.93 [0.52-1.65],0.7987877159990956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP1,Prolow-density lipoprotein receptor-related protein 1,23599,177,1.05 [0.64-1.72],0.856281301481126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP11,Low-density lipoprotein receptor-related protein 11,23713,172,1.42 [0.99-2.03],0.0564358518086072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2,Low-density lipoprotein receptor-related protein 2,19997,159,0.63 [0.39-1.01],0.0534600341693097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2BP,LRP2-binding protein,19997,159,0.78 [0.61-1.00],0.0455482839038937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23926,178,1.25 [1.03-1.53],0.0247201095351676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC25,Leucine-rich repeat-containing protein 25,23599,177,0.94 [0.66-1.33],0.7192049425641571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC37A2,Leucine-rich repeat-containing protein 37A2,20481,163,0.63 [0.45-0.89],0.0081583842064378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC38,Leucine-rich repeat-containing protein 38,19997,159,0.65 [0.46-0.93],0.0177631583477694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC59,Leucine-rich repeat-containing protein 59,20545,162,1.23 [0.92-1.65],0.1600335169960421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,20474,161,1.17 [0.87-1.57],0.3059999319126327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRN1,Leucine-rich repeat neuronal protein 1,23300,174,0.77 [0.55-1.08],0.1292029176410686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19997,159,0.84 [0.56-1.25],0.3904503458560678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,20505,164,1.10 [0.62-1.95],0.7334733360707915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM1,U6 snRNA-associated Sm-like protein LSm1,23155,169,1.23 [1.00-1.52],0.048277512140927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM8,U6 snRNA-associated Sm-like protein LSm8,20186,161,1.02 [0.85-1.22],0.8672699065331081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSP1,Lymphocyte-specific protein 1,23685,176,1.15 [0.84-1.58],0.390957652381416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA,Lymphotoxin-alpha,23685,176,1.08 [0.77-1.51],0.6656206428874167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA4H,Leukotriene A-4 hydrolase,23920,179,1.08 [0.87-1.34],0.4826088043906462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTB,Lymphotoxin-beta,20474,161,1.25 [0.86-1.80],0.2451078789752949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP2,Latent-transforming growth factor beta-binding protein 2,24010,179,1.03 [0.67-1.58],0.8810911225580267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP3,Latent-transforming growth factor beta-binding protein 3,23155,169,0.91 [0.70-1.19],0.5071925165917918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBR,Tumor necrosis factor receptor superfamily member 3,23556,177,1.19 [0.76-1.85],0.451469590900629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTO1,Protein LTO1 homolog,23300,174,1.20 [0.91-1.58],0.2059937199181244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LUZP2,Leucine zipper protein 2,20474,161,0.79 [0.55-1.14],0.20833656172517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LXN,Latexin,23393,174,1.08 [0.90-1.30],0.4179855199757807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY6D,Lymphocyte antigen 6D,23563,177,1.03 [0.73-1.44],0.8820746661489263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY75,Lymphocyte antigen 75,23685,176,1.02 [0.73-1.44],0.8948600426186123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY9,T-lymphocyte surface antigen Ly-9,23411,176,1.25 [0.81-1.93],0.316316451262792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY96,Lymphocyte antigen 96,23507,174,1.13 [0.79-1.62],0.5046216834272252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYAR,Cell growth-regulating nucleolar protein,23155,169,1.06 [0.84-1.33],0.6308640508435984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYN,Tyrosine-protein kinase Lyn,23599,177,1.15 [0.98-1.34],0.0832458263387127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD1,Ly6/PLAUR domain-containing protein 1,23189,175,0.83 [0.64-1.08],0.168415221303139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD3,Ly6/PLAUR domain-containing protein 3,23593,172,1.28 [0.86-1.90],0.2225763998043783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD8,Ly6/PLAUR domain-containing protein 8,23155,169,0.93 [0.71-1.23],0.6235121009208356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPLA2,Acyl-protein thioesterase 2,19888,158,1.10 [0.97-1.25],0.1429802581558741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19997,159,1.07 [0.93-1.23],0.3355887744978497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20568,163,0.99 [0.45-2.14],0.9731145853945924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYZL2,Lysozyme-like protein 2,19825,157,0.86 [0.55-1.33],0.4940100782536145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LZTFL1,Leucine zipper transcription factor-like protein 1,20082,158,1.19 [0.97-1.47],0.0999587600889585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,M6PR,Cation-dependent mannose-6-phosphate receptor,19981,164,0.91 [0.60-1.38],0.6537328017223348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,23434,173,1.17 [0.93-1.46],0.1810572141291818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAEA,E3 ubiquitin-protein transferase MAEA,23155,169,1.24 [0.90-1.71],0.1828301019275541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAG,Myelin-associated glycoprotein,19997,159,0.97 [0.71-1.33],0.8674021833962263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGEA3,Melanoma-associated antigen 3,20186,161,0.90 [0.77-1.06],0.2107223989339032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGED1,Melanoma-associated antigen D1,23155,169,1.22 [0.94-1.59],0.1411524381624822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC2,MAM domain-containing protein 2,20545,162,0.70 [0.45-1.08],0.1100143108611294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC4,Apical endosomal glycoprotein,20474,161,1.15 [0.89-1.49],0.2930468311185064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19981,164,1.25 [0.69-2.26],0.4617900111036274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN2B2,Epididymis-specific alpha-mannosidase,20545,162,1.32 [1.03-1.70],0.0310353103285983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19825,157,0.79 [0.58-1.07],0.1286934568399751
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANF,Mesencephalic astrocyte-derived neurotrophic factor,23798,178,1.10 [0.98-1.24],0.0937982045669518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC1,MANSC domain-containing protein 1,23774,174,1.03 [0.64-1.68],0.8929669697405982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC4,MANSC domain-containing protein 4,19847,157,0.81 [0.64-1.03],0.086148889795022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19888,158,1.36 [0.85-2.18],0.2021432772738619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19847,157,1.19 [1.00-1.43],0.0555239758975516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2,Microtubule-associated protein 2,20496,162,1.12 [0.82-1.53],0.4661395448591812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,20481,163,1.20 [0.95-1.51],0.1171798697352972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,23685,176,1.11 [0.97-1.27],0.1348071696790333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23155,169,0.99 [0.86-1.14],0.9298559720007072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,23474,174,1.08 [0.95-1.21],0.2324212615374029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK13,Mitogen-activated protein kinase 13,19825,157,0.99 [0.69-1.41],0.9398092175117264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK9,Mitogen-activated protein kinase 9,23685,176,1.18 [0.87-1.61],0.2840846781374053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPKAPK2,MAP kinase-activated protein kinase 2,20186,161,1.12 [0.91-1.36],0.2841472435376848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPRE3,Microtubule-associated protein RP/EB family member 3,19825,157,0.92 [0.82-1.04],0.1945695616076164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPT,Microtubule-associated protein tau,23189,175,0.93 [0.72-1.20],0.5694419663055013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARCO,Macrophage receptor MARCO,23713,172,1.16 [0.69-1.95],0.5805180215686734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARS1,"Methionine--tRNA ligase, cytoplasmic",20050,158,1.12 [0.94-1.34],0.2000516225868768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MASP1,Mannan-binding lectin serine protease 1,23474,174,1.09 [0.61-1.97],0.7619425690136543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN2,Matrilin-2,23715,178,1.50 [0.96-2.35],0.0761432564126371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN3,Matrilin-3,23464,174,1.38 [0.93-2.04],0.1107192226230204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAVS,Mitochondrial antiviral-signaling protein,23155,169,1.12 [0.97-1.30],0.1276224636114587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAX,Protein max,23189,175,1.09 [0.96-1.24],0.1641260855971863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MB,Myoglobin,24010,179,1.53 [1.25-1.87],3.7018356569627615e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MBL2,Mannose-binding protein C,20284,161,0.85 [0.74-0.97],0.0157291353643432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCAM,Cell surface glycoprotein MUC18,23824,176,1.23 [0.82-1.85],0.321720040348314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",20505,164,1.45 [1.11-1.88],0.0059695651497943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEMP1,Mast cell-expressed membrane protein 1,19940,158,0.97 [0.82-1.16],0.7516885573023988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCFD2,Multiple coagulation factor deficiency protein 2,23590,172,1.18 [0.88-1.59],0.2782368308116819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCTS1,Malignant T-cell-amplified sequence 1,20481,163,1.05 [0.60-1.82],0.8666288199357315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,23507,174,0.99 [0.81-1.20],0.9160139632590256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDH1,"Malate dehydrogenase, cytoplasmic",20466,165,1.24 [0.87-1.78],0.2400616365306419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDK,Midkine,23696,174,1.33 [1.05-1.67],0.0158979923626918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDM1,Nuclear protein MDM1,19997,159,0.81 [0.49-1.34],0.4173702606153316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19981,164,1.11 [0.94-1.30],0.214433486428679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED18,Mediator of RNA polymerase II transcription subunit 18,23155,169,1.13 [0.94-1.35],0.1935483549230796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED21,Mediator of RNA polymerase II transcription subunit 21,19847,157,0.94 [0.68-1.31],0.7174096859468607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF10,Multiple epidermal growth factor-like domains protein 10,23679,178,2.11 [1.52-2.91],6.773685929643082e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF11,Multiple epidermal growth factor-like domains protein 11,19847,157,1.14 [0.72-1.79],0.5741729152341672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF9,Multiple epidermal growth factor-like domains protein 9,23930,178,1.46 [0.76-2.81],0.2525072023508702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MELTF,Melanotransferrin,20545,162,1.30 [0.80-2.11],0.2850695852215645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MENT,Protein MENT,20082,158,0.58 [0.30-1.10],0.0923666716684502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1A,Meprin A subunit alpha,20481,163,0.97 [0.79-1.19],0.7876406954064071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1B,Meprin A subunit beta,23713,172,0.92 [0.82-1.03],0.1628333031918362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEPE,Matrix extracellular phosphoglycoprotein,23679,178,0.91 [0.52-1.58],0.7285513627838478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MERTK,Tyrosine-protein kinase Mer,23989,179,1.47 [0.87-2.49],0.1547890603701368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MESD,LRP chaperone MESD,23722,175,1.10 [0.99-1.23],0.082732342741508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MET,Hepatocyte growth factor receptor,23773,177,0.74 [0.37-1.47],0.3875835616440106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1,Methionine aminopeptidase 1,23189,175,1.14 [0.73-1.78],0.5575131432360123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",23685,176,1.19 [1.02-1.40],0.0280697944456697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP2,Methionine aminopeptidase 2,23892,177,1.22 [0.96-1.55],0.1051884174036403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3,Microfibril-associated glycoprotein 3,23281,173,1.02 [0.77-1.35],0.894813174016958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3L,Microfibrillar-associated protein 3-like,19997,159,0.94 [0.74-1.21],0.653163886659199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP4,Microfibril-associated glycoprotein 4,20082,158,0.60 [0.37-0.97],0.0360630641748608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP5,Microfibrillar-associated protein 5,24010,179,0.98 [0.71-1.36],0.8993996311279144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFGE8,Lactadherin,23722,175,1.00 [0.74-1.34],0.9795166820606648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGLL,Monoglyceride lipase,23762,178,1.11 [0.96-1.30],0.1680500202550883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGMT,Methylated-DNA--protein-cysteine methyltransferase,23685,176,1.12 [1.00-1.26],0.0489783099931967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIA,Melanoma-derived growth regulatory protein,23774,174,0.95 [0.66-1.36],0.7624840902170441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICALL2,MICAL-like protein 2,19997,159,1.05 [0.85-1.31],0.6435148710185191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,23685,176,0.98 [0.90-1.07],0.6797565569733521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIF,Macrophage migration inhibitory factor,23676,175,1.26 [1.03-1.54],0.0245772696625854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MILR1,Allergin-1,23300,174,1.36 [1.06-1.75],0.0158362679824948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,20474,161,1.04 [0.90-1.19],0.6181741095908675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINK1,Misshapen-like kinase 1,20496,162,1.07 [0.91-1.26],0.3953566966127497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MITD1,MIT domain-containing protein 1,23507,174,1.12 [0.97-1.29],0.1141507910965552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MKI67,Proliferation marker protein Ki-67,19940,158,0.82 [0.54-1.26],0.3675560176808847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLLT1,Protein ENL,19825,157,0.72 [0.54-0.95],0.0201508841666855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLN,Promotilin,23685,176,1.01 [0.87-1.17],0.9095561691283512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MME,Neprilysin,23599,177,1.05 [0.88-1.24],0.5858192814948718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP1,Interstitial collagenase,22921,171,1.11 [0.95-1.30],0.1746841791450158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP10,Stromelysin-2,23636,178,0.75 [0.59-0.95],0.0174813980146373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP12,Macrophage metalloelastase,23746,176,1.13 [0.89-1.43],0.3102051427952497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP13,Collagenase 3,23189,175,1.00 [0.66-1.52],0.995620749232175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP15,Matrix metalloproteinase-15,20545,162,0.77 [0.52-1.14],0.1882300402602728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP3,Stromelysin-1,23722,175,0.92 [0.70-1.21],0.5581893486197566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP7,Matrilysin,23249,172,1.12 [0.85-1.48],0.4249297530689446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP8,Neutrophil collagenase,23889,177,1.26 [1.06-1.50],0.007340790562308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP9,Matrix metalloproteinase-9,23687,175,1.34 [1.07-1.67],0.0098532031294502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19847,157,1.15 [0.86-1.54],0.3539772744555047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MN1,Transcriptional activator MN1,19997,159,0.74 [0.54-1.01],0.0576690144928531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNAT1,CDK-activating kinase assembly factor MAT1,20186,161,0.94 [0.66-1.34],0.7315727205463267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNDA,Myeloid cell nuclear differentiation antigen,23676,172,0.98 [0.85-1.12],0.7297725219421629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOCS2,Molybdopterin synthase catalytic subunit,20082,158,1.27 [1.01-1.58],0.0371116527801386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOG,Myelin-oligodendrocyte glycoprotein,23920,179,1.08 [0.73-1.60],0.6923926213948741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORC3,MORC family CW-type zinc finger protein 3,20496,162,1.17 [0.71-1.94],0.5327603781579106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L1,Mortality factor 4-like protein 1,20186,161,1.08 [0.75-1.56],0.6772422313565921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L2,Mortality factor 4-like protein 2,19825,157,0.77 [0.49-1.21],0.259670138823159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORN4,MORN repeat-containing protein 4,19825,157,0.84 [0.67-1.06],0.1404743060680115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPHOSPH8,M-phase phosphoprotein 8,23281,173,1.09 [0.92-1.29],0.3334196523850611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPI,Mannose-6-phosphate isomerase,23599,177,1.18 [1.01-1.37],0.0325149887005407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,23762,178,1.19 [0.99-1.43],0.0668745643522841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPO,Myeloperoxidase,23722,175,1.27 [0.98-1.65],0.0688961942597105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPRIP,Myosin phosphatase Rho-interacting protein,20440,161,1.22 [0.89-1.68],0.2128261516665893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRC1,Macrophage mannose receptor 1,20572,165,1.17 [0.69-1.97],0.5591083450669583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRI1,Methylthioribose-1-phosphate isomerase,19997,159,0.98 [0.78-1.23],0.8576810969974981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL24,"39S ribosomal protein L24, mitochondrial",19847,157,1.12 [0.77-1.62],0.55927050800608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL28,"39S ribosomal protein L28, mitochondrial",20505,164,1.02 [0.69-1.51],0.91998940010359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL46,"39S ribosomal protein L46, mitochondrial",23189,175,0.82 [0.49-1.37],0.4554906569654702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL52,"39S ribosomal protein L52, mitochondrial",19781,157,1.05 [0.60-1.85],0.8572775803682395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",20505,164,0.91 [0.73-1.14],0.4185006709615487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPS16,"28S ribosomal protein S16, mitochondrial",19940,158,0.60 [0.31-1.16],0.1314461438542286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLN,Mesothelin,23559,177,1.00 [0.80-1.25],0.9990237839053906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLNL,Mesothelin-like protein,19997,159,0.86 [0.56-1.32],0.4941546536767757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSMB,Beta-microseminoprotein,23693,177,1.02 [0.85-1.23],0.8221106045344964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSR1,Macrophage scavenger receptor types I and II,23926,178,0.97 [0.74-1.28],0.8435926108707192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSRA,Mitochondrial peptide methionine sulfoxide reductase,23774,174,1.16 [0.97-1.40],0.1054710802313016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MST1,Hepatocyte growth factor-like protein,20271,162,0.93 [0.76-1.13],0.448434098881263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSTN,Growth/differentiation factor 8,23281,173,0.91 [0.71-1.17],0.4455783343357046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTDH,Protein LYRIC,19940,158,1.07 [0.91-1.25],0.4362528494816268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",20496,162,1.10 [0.62-1.97],0.7342148809589101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20186,161,1.12 [0.98-1.28],0.0845642147817518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTIF3,"Translation initiation factor IF-3, mitochondrial",20481,163,1.13 [0.96-1.34],0.1529423063930271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTPN,Myotrophin,23281,173,1.07 [0.71-1.60],0.7568384284698269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTR,Methionine synthase,19847,157,1.08 [0.87-1.34],0.5121078399171028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS1,Protein MTSS 1,20481,163,1.01 [0.88-1.15],0.929126356801052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS2,Protein MTSS 2,20474,161,1.11 [0.96-1.29],0.158804452200669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTUS1,Microtubule-associated tumor suppressor 1,20186,161,1.23 [0.96-1.58],0.1088082969663205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC13,Mucin-13,23189,175,0.80 [0.61-1.05],0.1060869798823985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC16,Mucin-16,23599,177,1.01 [0.94-1.08],0.8034986892275073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC2,Mucin-2,20552,162,0.90 [0.76-1.05],0.1840390045132887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUCL3,Mucin-like protein 3,19825,157,0.92 [0.62-1.36],0.6707589392895683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MVK,Mevalonate kinase,23300,174,1.19 [1.01-1.39],0.0328760830686853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MXRA8,Matrix remodeling-associated protein 8,20082,158,0.87 [0.53-1.44],0.5883190600122642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC1,"Myosin-binding protein C, slow-type",20545,162,1.44 [1.22-1.70],2.099962340300048e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC2,"Myosin-binding protein C, fast-type",19981,164,1.31 [1.14-1.49],8.31055923217282e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,20505,164,1.10 [0.88-1.37],0.39758047333337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYDGF,Myeloid-derived growth factor,20545,162,1.13 [0.97-1.31],0.1220587925530473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH4,Myosin-4,19847,157,1.11 [0.81-1.54],0.5097593654418735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH7B,Myosin-7B,19825,157,0.95 [0.65-1.38],0.7898013633479153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH9,Myosin-9,20552,162,1.12 [0.98-1.28],0.0925485936534211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19847,157,1.50 [1.12-1.99],0.006022524095689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL3,Myosin light chain 3,19981,164,1.31 [1.09-1.58],0.0040582684822326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL4,Myosin light chain 4,19981,164,1.10 [0.84-1.44],0.5063981363707526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL6B,Myosin light chain 6B,19997,159,0.95 [0.80-1.13],0.5881415786594627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19997,159,1.60 [1.34-1.91],1.6936741295515453e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO6,Unconventional myosin-VI,20505,164,1.07 [0.73-1.56],0.7241454140692105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO9B,Unconventional myosin-IXb,23300,174,0.93 [0.75-1.15],0.5058892551214103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOC,Myocilin,23722,175,0.85 [0.63-1.15],0.3033194840411755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM1,Myomesin-1,19888,158,1.12 [0.84-1.50],0.4340692994946767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM2,Myomesin-2,19847,157,1.47 [1.18-1.83],0.0005136565604026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM3,Myomesin-3,20082,158,1.32 [1.13-1.55],0.0004242236040871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZB1,Marginal zone B- and B1-cell-specific protein,23751,178,1.26 [0.98-1.61],0.0703514229686951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZT1,Mitotic-spindle organizing protein 1,23155,169,1.06 [0.81-1.37],0.6817144646356531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA10,N-alpha-acetyltransferase 10,19847,157,1.25 [0.93-1.70],0.1412561514151579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA80,N-alpha-acetyltransferase 80,19997,159,1.05 [0.93-1.19],0.4184619364817883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAAA,N-acylethanolamine-hydrolyzing acid amidase,23399,173,1.00 [0.80-1.25],0.9696259593196258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NACC1,Nucleus accumbens-associated protein 1,20474,161,1.10 [0.85-1.43],0.4680942825921925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NADK,NAD kinase,23713,172,1.05 [0.83-1.32],0.6860797726117511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGA,Alpha-N-acetylgalactosaminidase,19906,157,0.88 [0.65-1.18],0.3786386713494394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGK,N-acetyl-D-glucosamine kinase,19947,164,1.17 [0.90-1.52],0.2382637892083444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20082,158,2.12 [1.04-4.31],0.0380823732473817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAMPT,Nicotinamide phosphoribosyltransferase,23155,169,1.18 [0.95-1.45],0.136345688474193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAP1L4,Nucleosome assembly protein 1-like 4,20437,163,1.21 [0.83-1.77],0.3169944439887192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAPRT,Nicotinate phosphoribosyltransferase,20496,162,1.04 [0.66-1.62],0.8725269117935568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NARS1,"Asparagine--tRNA ligase, cytoplasmic",20505,164,1.16 [0.84-1.61],0.3631176226667849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBL1,Neuroblastoma suppressor of tumorigenicity 1,23774,174,1.39 [0.86-2.25],0.1789055842635975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBN,Nibrin,23300,174,1.10 [0.88-1.36],0.4004709895517682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM1,Neural cell adhesion molecule 1,23824,176,1.30 [0.87-1.94],0.1938006333134438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM2,Neural cell adhesion molecule 2,23722,175,1.12 [0.69-1.84],0.6413193462134994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAN,Neurocan core protein,23926,178,0.75 [0.53-1.05],0.0956349817067345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCF2,Neutrophil cytosol factor 2,23638,176,1.03 [0.89-1.20],0.6626181139955417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCK2,Cytoplasmic protein NCK2,23798,178,1.11 [0.98-1.25],0.1031455483472231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCLN,Nicalin,23300,174,0.77 [0.55-1.07],0.1206535779010938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR1,Natural cytotoxicity triggering receptor 1,23652,176,0.88 [0.62-1.25],0.4746234816436896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20481,163,0.89 [0.58-1.36],0.5841469974730233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCS1,Neuronal calcium sensor 1,23920,179,1.55 [0.98-2.44],0.0630175343863964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDRG1,Protein NDRG1,23189,175,1.02 [0.83-1.25],0.839319324153277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,20474,161,0.80 [0.59-1.08],0.1453615059940609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19909,158,1.18 [0.78-1.81],0.432974834863112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,20481,163,1.13 [0.96-1.34],0.1401645283305805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23155,169,1.11 [0.95-1.29],0.2024236494080747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEB,Nebulin,19847,157,1.57 [1.18-2.07],0.0017135416834179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECAP2,Adaptin ear-binding coat-associated protein 2,19847,157,1.21 [0.98-1.50],0.0708163433738459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN1,Nectin-1,19940,158,1.10 [0.71-1.70],0.6756873648329832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN2,Nectin-2,23682,172,1.38 [0.90-2.11],0.1381111471975496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN4,Nectin-4,23774,174,1.03 [0.69-1.55],0.8692692911587407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19940,158,0.81 [0.60-1.10],0.1875960167783769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD9,Enhancer of filamentation 1,19940,158,0.98 [0.63-1.52],0.9162339254412092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEFL,Neurofilament light polypeptide,23119,174,2.91 [2.53-3.35],9.288306486401149e-50
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEK7,Serine/threonine-protein kinase Nek7,20186,161,0.89 [0.71-1.11],0.3072902892056718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL1,Protein kinase C-binding protein NELL1,23774,174,1.02 [0.74-1.41],0.8805765641780293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL2,Protein kinase C-binding protein NELL2,23798,178,0.49 [0.31-0.79],0.0033151592421264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NENF,Neudesin,20474,161,0.92 [0.79-1.07],0.2550963563136416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEO1,Neogenin,20505,164,0.77 [0.39-1.53],0.4555519588954818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEXN,Nexilin,20572,165,1.12 [0.91-1.37],0.2979350768203322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFASC,Neurofascin,23989,179,0.70 [0.44-1.13],0.1443148252655846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFAT5,Nuclear factor of activated T-cells 5,19940,158,0.93 [0.77-1.13],0.4696970352521933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",23685,176,1.02 [0.90-1.17],0.7222515185944955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",23300,174,1.03 [0.83-1.28],0.7855590786528417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFE2,Transcription factor NF-E2 45 kDa subunit,19981,164,1.11 [0.90-1.35],0.3237690758055027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFIC,Nuclear factor 1 C-type,20505,164,0.95 [0.66-1.36],0.7895759759530335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19847,157,1.09 [0.88-1.34],0.4344853288870424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB2,Nuclear factor NF-kappa-B p100 subunit,20186,161,1.10 [0.87-1.40],0.4161282097818846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKBIE,NF-kappa-B inhibitor epsilon,23155,169,1.06 [0.81-1.40],0.6562427828140771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",20481,163,1.15 [1.00-1.33],0.0570622585608804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFX1,Transcriptional repressor NF-X1,19847,157,0.99 [0.79-1.24],0.9256881945839516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFYA,Nuclear transcription factor Y subunit alpha,19847,157,1.14 [0.80-1.61],0.4670731420948942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGF,Beta-nerve growth factor,23507,174,1.00 [0.34-2.99],0.9942956920506052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGFR,Tumor necrosis factor receptor superfamily member 16,20545,162,0.76 [0.44-1.31],0.3221240171303798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGRN,Neugrin,20496,162,1.56 [0.89-2.73],0.1215487837557311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NHLRC3,NHL repeat-containing protein 3,19607,155,1.24 [0.76-2.03],0.3916517349764261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID1,Nidogen-1,23751,176,1.27 [0.88-1.82],0.1998167282217484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID2,Nidogen-2,23722,175,1.14 [0.96-1.37],0.1423891068410804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NINJ1,Ninjurin-1,23155,169,1.06 [0.84-1.35],0.6187462446646479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT1,Deaminated glutathione amidase,19981,164,1.15 [0.81-1.62],0.4272485384565214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT2,Omega-amidase NIT2,20461,160,1.22 [0.99-1.51],0.0560183495946655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN1,Neuroligin-1,19997,159,1.07 [0.86-1.32],0.5433546900063043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN2,Neuroligin-2,19888,158,0.88 [0.62-1.27],0.5054171768975413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME1,Nucleoside diphosphate kinase A,19940,158,1.24 [0.62-2.50],0.5447024006893826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME3,Nucleoside diphosphate kinase 3,23715,178,1.04 [0.60-1.82],0.8828108921648117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMI,N-myc-interactor,20390,161,1.03 [0.84-1.27],0.7755510833886212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,23507,174,1.01 [0.85-1.20],0.9107442171470992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMRK2,Nicotinamide riboside kinase 2,19825,157,0.89 [0.58-1.36],0.5837170876708212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,20505,164,1.06 [0.85-1.31],0.6155457927506378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOMO1,Nodal modulator 1,23722,175,0.72 [0.41-1.29],0.2729289632533105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOP56,Nucleolar protein 56,19847,157,1.02 [0.89-1.17],0.7396365071728306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS1,"Nitric oxide synthase, brain",23189,175,1.37 [1.11-1.69],0.0029030278834253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS2,"Nitric oxide synthase, inducible",19847,157,1.06 [0.73-1.53],0.7638425013633616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS3,"Nitric oxide synthase, endothelial",23189,175,1.09 [0.85-1.40],0.4913841513221567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH1,Neurogenic locus notch homolog protein 1,24010,179,0.99 [0.43-2.25],0.9765352815986558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH2,Neurogenic locus notch homolog protein 2,20552,162,1.09 [0.54-2.18],0.8116554083398886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH3,Neurogenic locus notch homolog protein 3,24010,179,0.76 [0.51-1.13],0.1747146917385711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPC2,NPC intracellular cholesterol transporter 2,20207,160,1.47 [0.97-2.22],0.0689246329479613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPDC1,Neural proliferation differentiation and control protein 1,23713,172,1.44 [0.99-2.09],0.0544791057833671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS1,Nephrin,19940,158,1.13 [0.73-1.75],0.5926887087369626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS2,Podocin,19940,158,0.93 [0.80-1.09],0.3966929117273973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPL,N-acetylneuraminate lyase,20545,162,0.91 [0.66-1.27],0.5958069668511756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPB,Natriuretic peptides B,23281,173,1.00 [0.90-1.10],0.9293866342983756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPC,C-type natriuretic peptide,23685,176,1.13 [0.89-1.45],0.319680927896448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPR1,Atrial natriuretic peptide receptor 1,19847,157,0.83 [0.55-1.24],0.3616406690855818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTN,Neuroplastin,23155,169,1.13 [0.97-1.31],0.1068147152461538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX1,Neuronal pentraxin-1,23722,175,1.06 [0.77-1.46],0.7250049810018588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX2,Neuronal pentraxin-2,20552,162,1.06 [0.68-1.65],0.796084252125258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTXR,Neuronal pentraxin receptor,23713,172,0.89 [0.59-1.34],0.5808848219644377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPY,Pro-neuropeptide Y,23920,179,0.92 [0.75-1.13],0.4422762658053948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRCAM,Neuronal cell adhesion molecule,23713,172,1.27 [0.79-2.02],0.322358761971458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRGN,Neurogranin,20572,165,1.11 [0.94-1.30],0.2111401880526242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRN1,Neuritin,20505,164,1.00 [0.66-1.51],0.9966613522447352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP1,Neuropilin-1,23862,176,0.94 [0.58-1.55],0.8184963973084691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP2,Neuropilin-2,23722,175,0.99 [0.62-1.59],0.968808110093101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRTN,Neurturin,23300,174,0.94 [0.71-1.24],0.6490575902738593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRXN3,Neurexin-3,19997,159,0.71 [0.43-1.18],0.1862620554674616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NSFL1C,NSFL1 cofactor p47,23926,178,1.13 [0.92-1.39],0.2406999706346589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",20545,162,1.27 [1.04-1.56],0.0205740247850453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C1A,Cytosolic 5'-nucleotidase 1A,20496,162,1.49 [1.02-2.19],0.0390132066793086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C3A,Cytosolic 5'-nucleotidase 3A,23642,176,1.15 [0.98-1.34],0.0924069464736433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5E,5'-nucleotidase,23774,174,1.00 [0.78-1.28],0.9992791425670006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF3,Neurotrophin-3,23685,176,0.85 [0.58-1.25],0.4094883575162802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF4,Neurotrophin-4,23155,169,0.79 [0.52-1.21],0.2823371713375511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK2,BDNF/NT-3 growth factors receptor,23713,172,1.42 [0.83-2.42],0.1953861404140148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK3,NT-3 growth factor receptor,23926,178,1.14 [0.61-2.12],0.681325742159353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTproBNP,N-terminal prohormone of brain natriuretic peptide,23713,172,0.99 [0.88-1.12],0.892465037945853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUB1,NEDD8 ultimate buster 1,23685,176,1.11 [0.95-1.29],0.1950133232339812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,20474,161,0.96 [0.82-1.12],0.6118074937633617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUCB2,Nucleobindin-2,23885,179,1.33 [0.95-1.88],0.100818978449568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDC,Nuclear migration protein nudC,23989,179,1.15 [0.93-1.41],0.2021963385771541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19981,164,0.80 [0.41-1.54],0.4960661243620272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19847,157,0.90 [0.64-1.25],0.5171825123328707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT16,U8 snoRNA-decapping enzyme,20447,163,1.07 [0.90-1.27],0.4380160692347709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],23599,177,1.21 [0.97-1.51],0.0833313129627995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT5,ADP-sugar pyrophosphatase,23722,175,1.23 [0.95-1.60],0.1188464975127239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUMB,Protein numb homolog,19940,158,1.04 [0.87-1.25],0.6702985041298144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUP50,Nuclear pore complex protein Nup50,19847,157,0.95 [0.58-1.56],0.8506741758117202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPE4,NXPE family member 4,19847,157,1.29 [0.86-1.93],0.219911696029755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH1,Neurexophilin-1,23189,175,1.12 [0.80-1.56],0.5045321153516502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH3,Neurexophilin-3,19940,158,0.89 [0.54-1.47],0.6414811992262455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OBP2B,Odorant-binding protein 2b,23425,174,0.88 [0.70-1.11],0.2858180360031154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OCLN,Occludin,20505,164,0.89 [0.62-1.28],0.5333637557462753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ODAM,Odontogenic ameloblast-associated protein,23146,175,1.00 [0.78-1.28],0.98129818454663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OFD1,Oral-facial-digital syndrome 1 protein,20186,161,0.87 [0.66-1.13],0.298448734562889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGA,Protein O-GlcNAcase,20481,163,1.14 [0.93-1.41],0.207333543803593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGFR,Opioid growth factor receptor,23599,177,1.11 [0.74-1.66],0.6250765396032049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGN,Mimecan,23722,175,1.31 [0.97-1.77],0.0762619489621371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20186,161,0.79 [0.60-1.05],0.1071781114473743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLFM4,Olfactomedin-4,19336,152,1.02 [0.90-1.16],0.7502223268931061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLR1,Oxidized low-density lipoprotein receptor 1,23479,171,1.26 [1.03-1.54],0.0244162757358346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMD,Osteomodulin,23798,178,0.97 [0.70-1.33],0.8311091233517477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMG,Oligodendrocyte-myelin glycoprotein,23599,177,0.91 [0.75-1.10],0.3364630585791039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMP,Olfactory marker protein,19888,158,1.03 [0.75-1.41],0.8747804103620684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPHN1,Oligophrenin-1,20496,162,1.10 [0.95-1.26],0.1904800607909839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPLAH,5-oxoprolinase,19981,164,1.04 [0.84-1.29],0.714746588345371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPTC,Opticin,23599,177,1.04 [0.78-1.39],0.7787940880748971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ORM1,Alpha-1-acid glycoprotein 1,20492,163,1.54 [0.74-3.20],0.2469772457884183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSBPL2,Oxysterol-binding protein-related protein 2,20496,162,0.86 [0.55-1.34],0.5108659316027455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSCAR,Osteoclast-associated immunoglobulin-like receptor,23715,178,1.43 [0.98-2.11],0.0660153825201124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSM,Oncostatin-M,23569,175,1.30 [1.08-1.57],0.0064767770886554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSMR,Oncostatin-M-specific receptor subunit beta,23862,176,2.91 [1.50-5.62],0.0015149857378491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSTN,Osteocrin,19997,159,1.00 [0.69-1.46],0.9991088869868342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTOA,Otoancorin,19888,158,0.79 [0.56-1.12],0.1930175317267351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD6B,Deubiquitinase OTUD6B,20481,163,1.21 [0.94-1.56],0.1378312222249519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD7B,OTU domain-containing protein 7B,20505,164,1.24 [0.98-1.57],0.0672151596033377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19981,164,1.20 [0.97-1.47],0.0887950787237427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXT,Oxytocin-neurophysin 1,23926,178,0.96 [0.88-1.05],0.3763674705345555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,P4HB,Protein disulfide-isomerase,23585,174,1.13 [0.80-1.59],0.4864023899194549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PACS2,Phosphofurin acidic cluster sorting protein 2,19847,157,1.28 [1.01-1.62],0.045242412094762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI2,Protein-arginine deiminase type-2,23300,174,1.11 [0.91-1.36],0.2860010800039442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI4,Protein-arginine deiminase type-4,23146,175,1.02 [0.86-1.21],0.812863830331049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAEP,Glycodelin,23507,174,1.12 [0.99-1.26],0.0719756025294071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20505,164,0.95 [0.83-1.09],0.4870741808688427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20186,161,1.27 [0.96-1.67],0.0957076310692564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,23281,173,1.01 [0.80-1.29],0.9122615205235746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAGR1,PAXIP1-associated glutamate-rich protein 1,19981,164,1.00 [0.70-1.42],0.989924177505252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19789,157,0.90 [0.66-1.21],0.4713840542982308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAK4,Serine/threonine-protein kinase PAK 4,23189,175,1.00 [0.80-1.24],0.9655475925747822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALLD,Palladin,19940,158,0.66 [0.41-1.07],0.0933919562823919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM,Paralemmin-1,20362,163,0.71 [0.46-1.12],0.1395899853439267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM2,Paralemmin-2,20496,162,1.16 [0.78-1.71],0.4663921620368455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM3,Paralemmin-3,19847,157,0.93 [0.75-1.16],0.5244305050684888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAM,Peptidyl-glycine alpha-amidating monooxygenase,23910,179,1.08 [0.68-1.73],0.7451912064952562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAMR1,Inactive serine protease PAMR1,23722,175,1.02 [0.62-1.69],0.9355342691798078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAPPA,Pappalysin-1,23300,174,1.05 [0.79-1.39],0.757284963354426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARD3,Partitioning defective 3 homolog,20186,161,1.00 [0.81-1.22],0.9693763067964144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARK7,Parkinson disease protein 7,23722,175,1.35 [1.04-1.74],0.0230041999317113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARP1,Poly [ADP-ribose] polymerase 1,23685,176,1.12 [0.93-1.36],0.2308022614914892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAXX,Protein PAXX,20082,158,1.22 [0.89-1.68],0.2218702682399949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19825,157,0.98 [0.60-1.60],0.9354496225821152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBLD,Phenazine biosynthesis-like domain-containing protein,23189,175,1.03 [0.79-1.34],0.816078132945784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,20481,163,0.84 [0.50-1.42],0.5167774207734608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCARE,Photoreceptor cilium actin regulator,19888,158,0.96 [0.78-1.16],0.65192659494448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20043,158,1.29 [0.95-1.76],0.1079107419105398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBP2,Poly(rC)-binding protein 2,20505,164,1.17 [0.95-1.43],0.1406744960318296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH1,Protocadherin-1,23911,178,0.69 [0.35-1.35],0.27485399123662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH12,Protocadherin-12,20505,164,1.11 [0.61-2.00],0.7389959848875527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH17,Protocadherin-17,23713,172,1.09 [0.76-1.57],0.6366879083740045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH7,Protocadherin-7,20481,163,1.10 [0.74-1.62],0.6410071757295163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH9,Protocadherin-9,20481,163,0.89 [0.58-1.38],0.6142367014495759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDHB15,Protocadherin beta-15,20474,161,0.94 [0.64-1.38],0.755866408057151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCNA,Proliferating cell nuclear antigen,19825,157,0.95 [0.74-1.22],0.6638698387379889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK7,Proprotein convertase subtilisin/kexin type 7,20474,161,0.97 [0.69-1.36],0.8639140793094643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK9,Proprotein convertase subtilisin/kexin type 9,24010,179,0.98 [0.70-1.36],0.8820679185400704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCYT2,Ethanolamine-phosphate cytidylyltransferase,20481,163,1.17 [0.96-1.43],0.1137283728643366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDAP1,28 kDa heat- and acid-stable phosphoprotein,20545,162,1.10 [0.94-1.28],0.2469123894388402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1,Programmed cell death protein 1,23876,177,1.22 [0.90-1.66],0.1922844341873907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1LG2,Programmed cell death 1 ligand 2,23599,177,1.54 [1.02-2.31],0.0389164447171457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD5,Programmed cell death protein 5,23926,178,1.25 [1.00-1.56],0.0482783692160705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD6,Programmed cell death protein 6,23713,172,1.04 [0.85-1.26],0.7183560135218048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCL2,Phosducin-like protein 2,19825,157,1.11 [0.85-1.45],0.4532231392589486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19825,157,0.79 [0.56-1.12],0.1926162228845346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19847,157,0.84 [0.62-1.13],0.25715451088065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20082,158,1.07 [0.92-1.24],0.3990969432325378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFA,Platelet-derived growth factor subunit A,24010,179,1.13 [0.94-1.35],0.1982828312524239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFB,Platelet-derived growth factor subunit B,23798,178,1.13 [0.97-1.32],0.1241306888268501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFC,Platelet-derived growth factor C,23155,169,1.42 [0.89-2.26],0.1419707129647924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRA,Platelet-derived growth factor receptor alpha,23713,172,0.94 [0.58-1.53],0.8118434548246968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRB,Platelet-derived growth factor receptor beta,24010,179,1.04 [0.71-1.52],0.8341921272044077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA2,Protein disulfide-isomerase A2,19825,157,1.09 [0.76-1.57],0.6423447241727612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA3,Protein disulfide-isomerase A3,20082,158,1.55 [0.90-2.67],0.1171252345790688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA4,Protein disulfide-isomerase A4,20552,162,1.29 [1.02-1.63],0.0322700975415006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA5,Protein disulfide-isomerase A5,19825,157,0.96 [0.74-1.24],0.7425250540697423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM5,PDZ and LIM domain protein 5,20505,164,1.10 [0.97-1.25],0.1350765211888919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM7,PDZ and LIM domain protein 7,23798,178,1.10 [0.99-1.22],0.0696959352943199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23155,169,0.98 [0.74-1.29],0.8625580928822436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDRG1,p53 and DNA damage-regulated protein 1,19997,159,0.93 [0.68-1.27],0.6378502795616885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19825,157,1.08 [0.85-1.38],0.5291855595205659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZD2,PDZ domain-containing protein 2,19847,157,1.15 [0.90-1.47],0.2578910542355963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19940,158,0.93 [0.65-1.33],0.6901707613103715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEAR1,Platelet endothelial aggregation receptor 1,24010,179,1.40 [0.78-2.51],0.2536958321747948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEBP1,Phosphatidylethanolamine-binding protein 1,23722,175,1.27 [1.01-1.59],0.0381327089648035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECAM1,Platelet endothelial cell adhesion molecule,23722,175,1.39 [0.91-2.15],0.1303607801897727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19981,164,1.55 [1.00-2.39],0.0513829687825098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PENK,Proenkephalin-A,20082,158,0.93 [0.56-1.54],0.7799888104221219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEPD,Xaa-Pro dipeptidase,20572,165,0.72 [0.41-1.27],0.2583150988032662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PER3,Period circadian protein homolog 3,19940,158,0.95 [0.84-1.08],0.4384247215965183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PF4,Platelet factor 4,20411,163,1.09 [0.93-1.27],0.2964364833300741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN2,Prefoldin subunit 2,23189,175,1.20 [0.95-1.51],0.1338519930423413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN4,Prefoldin subunit 4,19825,157,1.13 [0.86-1.49],0.3908579083433692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN6,Prefoldin subunit 6,19997,159,1.11 [0.90-1.37],0.3352017573543687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",23563,177,1.12 [0.95-1.33],0.1833493551525123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGA4,Pepsin A-4,20572,165,1.06 [0.87-1.29],0.5636263635922929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",20545,162,1.30 [0.99-1.70],0.0609284933585142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGF,Placenta growth factor,23989,179,1.54 [0.96-2.48],0.0735706015209494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP1,Peptidoglycan recognition protein 1,23895,178,1.47 [1.11-1.95],0.0073975560932133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,20313,162,0.90 [0.54-1.50],0.6871970838554295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP4,Peptidoglycan recognition protein 4,19847,157,1.00 [0.77-1.30],0.9745262888210487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGM2,Phosphoglucomutase-2,19997,159,1.13 [0.90-1.41],0.3018290230017982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGR,Progesterone receptor,19940,158,0.86 [0.71-1.04],0.117798022168175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHACTR2,Phosphatase and actin regulator 2,20505,164,1.09 [0.95-1.24],0.2089380086837674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB1,Pleckstrin homology-like domain family B member 1,20481,163,1.16 [0.87-1.54],0.3010678137466244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB2,Pleckstrin homology-like domain family B member 2,19825,157,0.90 [0.74-1.08],0.2507892933407493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,23507,174,1.42 [0.90-2.24],0.1265316964858542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20082,158,1.17 [0.81-1.69],0.4007396996061186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI16,Peptidase inhibitor 16,20572,165,0.94 [0.51-1.74],0.8376567929314667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI3,Elafin,23408,175,1.36 [1.10-1.69],0.004831500075076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",20505,164,1.08 [0.89-1.31],0.427766116807964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIGR,Polymeric immunoglobulin receptor,23413,174,0.99 [0.69-1.43],0.9708894432682424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,23685,176,1.05 [0.85-1.30],0.6264742524848961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,23722,175,1.03 [0.65-1.64],0.9029429744063064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19940,158,0.97 [0.73-1.28],0.8084097186126266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRA,Paired immunoglobulin-like type 2 receptor alpha,23722,175,0.92 [0.67-1.26],0.6077308130649524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRB,Paired immunoglobulin-like type 2 receptor beta,23713,172,0.96 [0.76-1.21],0.7306889228992767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20082,158,1.14 [0.91-1.42],0.2568646553956965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PITHD1,PITH domain-containing protein 1,19789,157,1.08 [0.90-1.30],0.3892773169652224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD1,Polycystin-1,20545,162,1.30 [0.73-2.29],0.3698487852021757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD2,Polycystin-2,19847,157,1.05 [0.81-1.36],0.6939313196915755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKLR,Pyruvate kinase PKLR,23717,178,0.97 [0.79-1.20],0.8048671721977178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKN3,Serine/threonine-protein kinase N3,20186,161,0.98 [0.80-1.21],0.8696329222063153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G10,Group 10 secretory phospholipase A2,23507,174,1.12 [0.88-1.41],0.3511924563338429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G15,Phospholipase A2 group XV,23774,174,1.69 [1.06-2.70],0.0287480188958911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G1B,Phospholipase A2,23976,179,1.13 [0.84-1.52],0.4215256374020599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G2A,"Phospholipase A2, membrane associated",23695,175,0.98 [0.76-1.26],0.8595834508352469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G4A,Cytosolic phospholipase A2,23798,178,1.12 [0.97-1.30],0.1328463471789325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G7,Platelet-activating factor acetylhydrolase,23722,175,1.12 [0.74-1.70],0.578725290842238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAT,Tissue-type plasminogen activator,23930,178,0.99 [0.77-1.28],0.9491467770052484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAU,Urokinase-type plasminogen activator,23722,175,1.09 [0.70-1.72],0.6927354508903706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAUR,Urokinase plasminogen activator surface receptor,23521,176,1.85 [1.19-2.89],0.0067033232355228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLB1,"Phospholipase B1, membrane-associated",20496,162,0.99 [0.77-1.28],0.935802066542012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19940,158,0.81 [0.54-1.22],0.3160471378625345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",20496,162,1.08 [0.93-1.26],0.2966762224628497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLEKHO1,Pleckstrin homology domain-containing family O member 1,20496,162,1.11 [0.90-1.37],0.3426113372723459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLG,Plasminogen,20061,159,1.11 [0.55-2.23],0.7779078417359009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN1,Perilipin-1,23189,175,1.04 [0.71-1.54],0.8238161299455115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN3,Perilipin-3,23713,172,1.21 [0.89-1.64],0.2218039394490162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLPBP,Pyridoxal phosphate homeostasis protein,23713,172,1.20 [0.99-1.46],0.0658637218207134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLSCR3,Phospholipid scramblase 3,20451,162,1.18 [0.91-1.53],0.2126584712075396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLTP,Phospholipid transfer protein,23942,179,1.16 [0.81-1.66],0.4155815777248061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC1,Plexin domain-containing protein 1,23155,169,0.53 [0.32-0.88],0.0147876209470173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC2,Plexin domain-containing protein 2,20496,162,1.06 [0.61-1.83],0.8479632731805136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNA4,Plexin-A4,23685,176,1.09 [0.93-1.29],0.2926581998147888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB2,Plexin-B2,23891,178,1.10 [0.64-1.91],0.7291976016105775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB3,Plexin-B3,23634,171,1.25 [0.95-1.65],0.1110342445169989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,23609,171,1.03 [0.96-1.11],0.4562914141360897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMCH,Pro-MCH,19847,157,1.07 [0.90-1.27],0.4619448549823044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMM2,Phosphomannomutase 2,19847,157,1.18 [0.92-1.52],0.2007145181804804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMS1,PMS1 protein homolog 1,19997,159,1.00 [0.74-1.36],0.9795572534007384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMVK,Phosphomevalonate kinase,23153,175,1.07 [0.94-1.22],0.2837924595794053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIP,Pancreatic triacylglycerol lipase,20572,165,0.96 [0.76-1.20],0.7006471659117512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP1,Inactive pancreatic lipase-related protein 1,20496,162,0.89 [0.74-1.07],0.2119683619561651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP2,Pancreatic lipase-related protein 2,23679,178,1.01 [0.97-1.06],0.6401151788130981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA1,Paraneoplastic antigen Ma1,19981,164,1.12 [0.87-1.45],0.3666884460546342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA2,Paraneoplastic antigen Ma2,19888,158,1.09 [0.78-1.51],0.6121746698834125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",23300,174,1.03 [0.92-1.15],0.5946995197095919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL,Podocalyxin,23599,177,0.67 [0.28-1.60],0.3647934387501187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL2,Podocalyxin-like protein 2,23774,174,0.80 [0.50-1.28],0.3525348307762883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POF1B,Protein POF1B,19940,158,1.19 [0.87-1.63],0.2651986195352818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19940,158,0.77 [0.44-1.33],0.345559691988004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",23599,177,1.16 [0.83-1.62],0.3730669305755434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POMC,Pro-opiomelanocortin,19981,164,0.97 [0.79-1.20],0.8032631924486012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON1,Serum paraoxonase/arylesterase 1,20572,165,0.69 [0.41-1.17],0.166511413670471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON2,Serum paraoxonase/arylesterase 2,23281,173,0.83 [0.57-1.22],0.3560225642705897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON3,Serum paraoxonase/lactonase 3,23798,178,0.68 [0.46-1.00],0.0517162929996088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POSTN,Periostin,20552,162,1.14 [0.76-1.70],0.5251732990122236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPBP,Platelet basic protein,20411,163,1.15 [0.97-1.38],0.1164472107136431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPCDC,Phosphopantothenoylcysteine decarboxylase,23926,178,1.24 [0.94-1.64],0.1264013568139053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIB,Peptidyl-prolyl cis-trans isomerase B,23743,177,1.13 [0.98-1.30],0.0866592572102603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIE,Peptidyl-prolyl cis-trans isomerase E,20186,161,1.01 [0.79-1.30],0.93837266165276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",20552,162,1.32 [1.09-1.61],0.0049449574091699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPL,Periplakin,19940,158,1.24 [0.79-1.95],0.3496815836089308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1A,Protein phosphatase 1A,23155,169,1.27 [0.87-1.84],0.2149213199446054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1B,Protein phosphatase 1B,19940,158,0.84 [0.62-1.12],0.2334680932452773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1F,Protein phosphatase 1F,20545,162,1.24 [0.94-1.64],0.1227067580054726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPME1,Protein phosphatase methylesterase 1,23599,177,1.13 [0.90-1.41],0.2929329979290727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,20474,161,1.12 [0.94-1.34],0.2010910948395725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,23774,174,1.12 [0.97-1.28],0.1156580159797731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20186,161,0.99 [0.79-1.23],0.9028115696308802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,20505,164,1.03 [0.85-1.24],0.7933238846704653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,20505,164,0.84 [0.56-1.27],0.4128934963598939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R2,Protein phosphatase inhibitor 2,23713,172,1.15 [0.97-1.35],0.0978258160446717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R9B,Neurabin-2,23989,179,1.09 [0.95-1.25],0.2076977816584871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,20481,163,1.08 [0.95-1.22],0.2319240797640344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP3R1,Calcineurin subunit B type 1,23507,174,1.25 [0.90-1.73],0.184166856745776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPT1,Palmitoyl-protein thioesterase 1,19997,159,1.01 [0.83-1.23],0.8925136264157116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPY,Pancreatic prohormone,23641,174,0.94 [0.82-1.07],0.3409157081243955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PQBP1,Polyglutamine-binding protein 1,23155,169,1.04 [0.83-1.30],0.7579872142809381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAME,Melanoma antigen preferentially expressed in tumors,19825,157,1.10 [0.60-2.02],0.7529404121927057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAP1,Proline-rich acidic protein 1,20552,162,1.16 [0.79-1.72],0.4443163472152921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRC1,Protein regulator of cytokinesis 1,20474,161,1.11 [0.83-1.50],0.4743950188160266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRCP,Lysosomal Pro-X carboxypeptidase,23857,179,1.01 [0.66-1.53],0.970737446634506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX1,Peroxiredoxin-1,23012,171,1.11 [0.96-1.28],0.1723871913494723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX2,Peroxiredoxin-2,20224,160,0.90 [0.70-1.16],0.4286963526419891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",23300,174,1.21 [1.01-1.45],0.0360453922531209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX5,"Peroxiredoxin-5, mitochondrial",23989,179,1.34 [1.08-1.66],0.0073336105220417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX6,Peroxiredoxin-6,23920,179,1.04 [0.84-1.29],0.7324215094958821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PREB,Prolactin regulatory element-binding protein,23300,174,1.57 [1.05-2.35],0.029079682421088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRELP,Prolargin,23679,178,1.75 [0.97-3.14],0.0619262701113373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG2,Bone marrow proteoglycan,20552,162,0.99 [0.74-1.32],0.9299923163779444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG3,Proteoglycan 3,20552,162,0.81 [0.60-1.10],0.1718378451952925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,23300,174,1.11 [0.87-1.41],0.4096538655267749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19997,159,0.79 [0.47-1.32],0.3720527363763112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,23713,172,1.10 [0.93-1.29],0.2547047171848816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,20452,162,1.14 [0.94-1.38],0.1866306469873871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKCQ,Protein kinase C theta type,23300,174,1.06 [0.78-1.44],0.7083184029933904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKD2,Serine/threonine-protein kinase D2,19847,157,0.98 [0.68-1.41],0.9284778034342424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKG1,cGMP-dependent protein kinase 1,20082,158,1.09 [0.97-1.23],0.1640541355872338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23155,169,1.09 [0.89-1.33],0.4095099673695547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRL,Prolactin,23926,178,0.98 [0.82-1.18],0.8480259853946113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRND,Prion-like protein doppel,20496,162,0.92 [0.67-1.26],0.5926508679763095
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROC,Vitamin K-dependent protein C,23789,176,1.59 [0.95-2.68],0.0797341189895858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROCR,Endothelial protein C receptor,19847,157,1.12 [0.73-1.71],0.6175964431830189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROK1,Prokineticin-1,23685,176,1.08 [0.83-1.41],0.5578452241252254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROS1,Vitamin K-dependent protein S,20568,163,1.08 [0.61-1.94],0.7880444776514798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR4,Proline-rich protein 4,19929,157,0.86 [0.69-1.08],0.1963147441449447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR5,Proline-rich protein 5,19940,158,0.71 [0.48-1.04],0.0761322738496999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRRT3,Proline-rich transmembrane protein 3,19981,164,0.56 [0.37-0.84],0.0049572349462723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS2,Trypsin-2,23824,176,1.22 [0.98-1.53],0.0772965010733991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS22,Brain-specific serine protease 4,19940,158,0.71 [0.44-1.16],0.1732005947856974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS27,Serine protease 27,23634,171,1.22 [0.87-1.71],0.2395712994444871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS53,Serine protease 53,20496,162,0.87 [0.59-1.29],0.4961140643693827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS8,Prostasin,23602,177,1.15 [0.84-1.58],0.3749112925844079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23189,175,1.06 [0.94-1.20],0.3216607409281816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTG,Protogenin,23920,179,1.08 [0.63-1.84],0.7897065318547856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTN3,Myeloblastin,23144,172,1.20 [0.93-1.53],0.1552132529263609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRUNE2,Protein prune homolog 2,20186,161,0.68 [0.38-1.21],0.188355641856408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAP,Prosaposin,20363,161,1.41 [0.87-2.30],0.1652556966766729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAPL1,Proactivator polypeptide-like 1,20481,163,0.77 [0.57-1.04],0.0903365426371495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSCA,Prostate stem cell antigen,20481,163,0.96 [0.91-1.01],0.1491202407168032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSG1,Pregnancy-specific beta-1-glycoprotein 1,23507,174,1.01 [0.90-1.14],0.8337906803843159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSIP1,PC4 and SFRS1-interacting protein,23685,176,1.14 [0.95-1.36],0.1595196278777993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMA1,Proteasome subunit alpha type-1,23155,169,1.05 [0.78-1.40],0.7505677786834231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMC3,26S proteasome regulatory subunit 6A,19825,157,0.94 [0.57-1.56],0.811312300555139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD1,26S proteasome non-ATPase regulatory subunit 1,20505,164,1.11 [0.83-1.48],0.4789384455988038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19997,159,0.87 [0.63-1.20],0.4035459528318256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD9,26S proteasome non-ATPase regulatory subunit 9,23599,177,1.06 [0.84-1.34],0.6222098419353042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME1,Proteasome activator complex subunit 1,23463,174,1.36 [0.95-1.94],0.0965891823555869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME2,Proteasome activator complex subunit 2,23401,174,1.32 [0.91-1.90],0.13985529885831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG3,Proteasome assembly chaperone 3,23685,176,1.06 [0.82-1.38],0.651112015309496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG4,Proteasome assembly chaperone 4,19940,158,1.16 [0.90-1.50],0.2424527269320739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSPN,Persephin,23685,176,1.02 [0.88-1.19],0.8135312561641207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSRC1,Proline/serine-rich coiled-coil protein 1,23155,169,1.20 [0.97-1.49],0.0856000468429743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,19380,154,1.12 [0.97-1.31],0.1300340486255902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23189,175,0.95 [0.61-1.48],0.8121183158800381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGDS,Prostaglandin-H2 D-isomerase,23556,175,1.41 [0.95-2.10],0.0860985544019987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGES2,Prostaglandin E synthase 2,19800,156,1.31 [1.00-1.73],0.0489743912047335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGR1,Prostaglandin reductase 1,20545,162,0.97 [0.80-1.16],0.7036699561416111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH,Parathyroid hormone,19997,159,1.03 [0.86-1.24],0.7529246586147396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,23685,176,1.10 [0.79-1.52],0.579489399239967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTK7,Inactive tyrosine-protein kinase 7,23189,175,1.70 [1.20-2.40],0.0027461106967856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTN,Pleiotrophin,23281,173,1.35 [1.05-1.75],0.021420413185577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTP4A3,Protein tyrosine phosphatase type IVA 3,19940,158,1.02 [0.76-1.38],0.8831430893750615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,23507,174,1.09 [0.92-1.29],0.3143791161992795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,23762,178,1.13 [0.97-1.32],0.1076151148551735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19907,158,0.97 [0.65-1.44],0.8757975529184285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRB,Receptor-type tyrosine-protein phosphatase beta,20545,162,0.95 [0.57-1.57],0.8296037933757014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRC,Receptor-type tyrosine-protein phosphatase C,20552,162,1.15 [0.61-2.18],0.6693627153351042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRF,Receptor-type tyrosine-protein phosphatase F,24010,179,0.79 [0.49-1.25],0.3141775166577432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRH,Receptor-type tyrosine-protein phosphatase H,20481,163,1.14 [0.84-1.54],0.4062714042925681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,20481,163,0.66 [0.31-1.40],0.2759425301819318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRM,Receptor-type tyrosine-protein phosphatase mu,23645,175,0.97 [0.56-1.68],0.9035655686641114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,23431,174,0.97 [0.65-1.46],0.8896142440704234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRR,Receptor-type tyrosine-protein phosphatase R,20496,162,0.84 [0.56-1.25],0.3891235120094934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRS,Receptor-type tyrosine-protein phosphatase S,24010,179,1.00 [0.59-1.68],0.9892960138729732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20545,162,0.82 [0.50-1.34],0.4266628103296516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20082,158,1.28 [0.99-1.66],0.0563941381496758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTS,6-pyruvoyl tetrahydrobiopterin synthase,23073,175,1.03 [0.80-1.32],0.8236224041565918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTTG1,Securin,20186,161,1.08 [0.76-1.54],0.6548564535352834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTX3,Pentraxin-related protein PTX3,23685,176,0.97 [0.75-1.26],0.8282536425669609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVALB,Parvalbumin alpha,23819,177,1.13 [1.00-1.28],0.0514199355019818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVR,Poliovirus receptor,23926,178,1.07 [0.75-1.53],0.7066873395352873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXDNL,Peroxidasin-like protein,20474,161,1.00 [0.78-1.30],0.9727234105968778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXN,Paxillin,23189,175,1.10 [0.87-1.40],0.4335258588965779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYDC1,Pyrin domain-containing protein 1,19981,164,1.03 [0.71-1.48],0.8835506988504114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYY,Peptide YY,19847,157,1.03 [0.88-1.20],0.7073798042088191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PZP,Pregnancy zone protein,20568,163,1.59 [1.06-2.39],0.0247394466883389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QDPR,Dihydropteridine reductase,23594,169,1.39 [1.02-1.90],0.0397819551309567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QPCT,Glutaminyl-peptide cyclotransferase,23730,178,1.04 [0.63-1.70],0.8846352152821864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QSOX1,Sulfhydryl oxidase 1,20157,160,0.91 [0.60-1.40],0.6821311183318834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB10,Ras-related protein Rab-10,20545,162,1.25 [0.96-1.65],0.1024914786017057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB11FIP3,Rab11 family-interacting protein 3,20545,162,1.05 [0.92-1.21],0.4560500191312275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB27B,Ras-related protein Rab-27B,20545,162,1.08 [0.89-1.29],0.439886863143158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB2B,Ras-related protein Rab-2B,20474,161,1.28 [1.01-1.62],0.0433230217157555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB33A,Ras-related protein Rab-33A,19847,157,1.23 [1.00-1.52],0.0511269637078913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB37,Ras-related protein Rab-37,23300,174,1.10 [0.94-1.28],0.2236116671397615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB39B,Ras-related protein Rab-39B,19847,157,1.01 [0.86-1.20],0.8817822203295473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19888,158,1.00 [0.77-1.30],0.998769431351724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB44,Ras-related protein Rab-44,20474,161,0.90 [0.63-1.28],0.5649990116445975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6A,Ras-related protein Rab-6A,23685,176,1.03 [0.76-1.38],0.8656167559128443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6B,Ras-related protein Rab-6B,23189,175,0.96 [0.71-1.28],0.7688984895943043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEP1,Rab GTPase-binding effector protein 1,20082,158,1.17 [0.96-1.43],0.1113707645278326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEPK,Rab9 effector protein with kelch motifs,23155,169,0.99 [0.78-1.26],0.943885621389253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABGAP1L,Rab GTPase-activating protein 1-like,23300,174,1.25 [1.01-1.54],0.0403221927387822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAC3,Ras-related C3 botulinum toxin substrate 3,19997,159,0.92 [0.71-1.18],0.4935439163742637
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD23B,UV excision repair protein RAD23 homolog B,23155,169,1.24 [0.94-1.64],0.1320210648024913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD51,DNA repair protein RAD51 homolog 1,20186,161,1.03 [0.78-1.36],0.8362892116025283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALB,Ras-related protein Ral-B,19940,158,0.95 [0.57-1.58],0.8365024007525749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALY,RNA-binding protein Raly,20474,161,0.86 [0.61-1.20],0.3804274053259349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP1,Ran-specific GTPase-activating protein,19981,164,1.03 [0.77-1.37],0.8496583546642842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP2,E3 SUMO-protein ligase RanBP2,19888,158,0.81 [0.50-1.31],0.3919625535519413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANGAP1,Ran GTPase-activating protein 1,23155,169,0.96 [0.71-1.29],0.7734715229620881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAP1A,Ras-related protein Rap-1A,19940,158,0.98 [0.78-1.23],0.8685290208390004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAPGEF2,Rap guanine nucleotide exchange factor 2,20186,161,1.12 [0.85-1.47],0.4389230217414519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES1,Retinoic acid receptor responder protein 1,23155,169,1.08 [0.72-1.61],0.704551910446053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES2,Retinoic acid receptor responder protein 2,23862,176,1.52 [1.21-1.90],0.000278077733696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASA1,Ras GTPase-activating protein 1,23189,175,0.83 [0.54-1.27],0.3899904691996261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19825,157,1.32 [0.96-1.82],0.0828340900949844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASSF2,Ras association domain-containing protein 2,23155,169,0.99 [0.79-1.25],0.9511097858964508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBFOX3,RNA binding protein fox-1 homolog 3,20505,164,1.78 [1.37-2.32],1.8692551043610583e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBKS,Ribokinase,23159,172,1.10 [0.84-1.45],0.4758462446639523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM17,Splicing factor 45,20505,164,1.15 [0.95-1.39],0.1542262912852941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM19,Probable RNA-binding protein 19,19847,157,1.10 [0.80-1.50],0.5596105585466924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM25,RNA-binding protein 25,19825,157,0.93 [0.66-1.30],0.656205542518135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP1,Retinol-binding protein 1,19997,159,1.03 [0.83-1.27],0.8092263288135692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP2,Retinol-binding protein 2,23599,177,0.81 [0.68-0.97],0.0222885657550788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP5,Retinol-binding protein 5,23599,177,1.25 [0.99-1.58],0.0604625252715134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP7,Retinoid-binding protein 7,20481,163,0.95 [0.74-1.21],0.6749886728327827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS,RNA-binding protein with multiple splicing,19940,158,0.89 [0.68-1.16],0.3860823793893393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS2,RNA-binding protein with multiple splicing 2,19981,164,1.06 [0.92-1.23],0.437448580587864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCC1,Regulator of chromosome condensation,20474,161,1.00 [0.75-1.35],0.9802218470532426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCOR1,REST corepressor 1,23281,173,1.04 [0.78-1.40],0.786376253588447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19981,164,0.82 [0.40-1.65],0.5731676320293098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REEP4,Receptor expression-enhancing protein 4,20505,164,1.10 [0.87-1.39],0.406046184166057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1A,Lithostathine-1-alpha,23589,175,1.23 [0.95-1.57],0.1115231420148103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1B,Lithostathine-1-beta,24010,179,1.23 [0.99-1.52],0.0611778452263652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3A,Regenerating islet-derived protein 3-alpha,24010,179,1.02 [0.83-1.25],0.8524665901295516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3G,Regenerating islet-derived protein 3-gamma,20474,161,0.93 [0.63-1.36],0.6947894172109611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG4,Regenerating islet-derived protein 4,23715,178,1.00 [0.77-1.30],0.9817792605073972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELB,Transcription factor RelB,19940,158,1.04 [0.75-1.43],0.8230379156060162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELT,Tumor necrosis factor receptor superfamily member 19L,23722,175,0.83 [0.52-1.32],0.419431076809394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REN,Renin,23713,172,1.03 [0.87-1.21],0.7389426199390263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REPS1,RalBP1-associated Eps domain-containing protein 1,19940,158,0.90 [0.60-1.36],0.6207366760107451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REST,RE1-silencing transcription factor,19825,157,1.09 [0.71-1.68],0.6873731845796915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,23599,177,0.80 [0.56-1.14],0.2106639634295312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RETN,Resistin,23667,177,1.16 [0.86-1.56],0.338989108511905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REXO2,"Oligoribonuclease, mitochondrial",19847,157,1.06 [0.78-1.44],0.7194519184385977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RFC4,Replication factor C subunit 4,20474,161,1.10 [0.56-2.17],0.7758189865946707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGCC,Regulator of cell cycle RGCC,20505,164,1.07 [0.88-1.31],0.4801803999479472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20186,161,1.00 [0.79-1.27],0.99729330677704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMA,Repulsive guidance molecule A,23926,178,0.71 [0.47-1.07],0.1028682105938322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMB,RGM domain family member B,23926,178,0.85 [0.53-1.37],0.5078857581607494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS10,Regulator of G-protein signaling 10,20505,164,1.15 [0.90-1.47],0.2573936051288067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS8,Regulator of G-protein signaling 8,23300,174,1.03 [0.85-1.26],0.7398014285437227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RHOC,Rho-related GTP-binding protein RhoC,23384,173,1.10 [0.98-1.24],0.0958423730080084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RICTOR,Rapamycin-insensitive companion of mTOR,19940,158,1.10 [0.81-1.48],0.54748290388632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20082,158,1.17 [0.87-1.59],0.2974918012556439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILP,Rab-interacting lysosomal protein,23856,177,1.26 [1.01-1.57],0.0413394572231703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILPL2,RILP-like protein 2,20545,162,1.09 [0.93-1.27],0.2953627865967881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19847,157,0.84 [0.64-1.09],0.1946417538023974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN1,Prorelaxin H1,20505,164,0.80 [0.52-1.25],0.3272437840450847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN2,Prorelaxin H2,20045,158,1.18 [0.89-1.55],0.2578084603908589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE1,Ribonuclease pancreatic,20572,165,1.23 [0.70-2.19],0.4724041298205023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE10,Inactive ribonuclease-like protein 10,19981,164,0.88 [0.64-1.22],0.4451071209209445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE3,Eosinophil cationic protein,23597,171,0.99 [0.88-1.11],0.8546721103878527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE4,Ribonuclease 4,19901,159,1.11 [0.64-1.92],0.7094702366191559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE6,Ribonuclease K6,20435,164,1.16 [0.74-1.82],0.5215574440529738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASEH2A,Ribonuclease H2 subunit A,20505,164,0.96 [0.70-1.31],0.7896120317400906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASET2,Ribonuclease T2,23897,179,1.07 [0.66-1.75],0.7862362825909572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF149,E3 ubiquitin-protein ligase RNF149,19981,164,1.12 [0.70-1.80],0.6357344948501831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF168,E3 ubiquitin-protein ligase RNF168,19940,158,0.67 [0.43-1.04],0.0718956934666762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF31,E3 ubiquitin-protein ligase RNF31,19940,158,0.56 [0.33-0.95],0.0302517739026941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF4,E3 ubiquitin-protein ligase RNF4,20186,161,0.80 [0.62-1.05],0.1042210457435604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF41,E3 ubiquitin-protein ligase NRDP1,23155,169,1.08 [0.88-1.32],0.4714878581359103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF43,E3 ubiquitin-protein ligase RNF43,20186,161,1.17 [0.94-1.46],0.1522804952853158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF5,E3 ubiquitin-protein ligase RNF5,19981,164,1.02 [0.83-1.25],0.8811556854690867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO1,Roundabout homolog 1,23715,178,1.38 [0.80-2.38],0.2528908475116361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO2,Roundabout homolog 2,23926,178,1.16 [0.65-2.09],0.6154461805634246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO4,Roundabout homolog 4,19981,164,0.92 [0.40-2.14],0.847592837254856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23713,172,1.29 [0.85-1.96],0.2376115312624234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RP2,Protein XRP2,23599,177,1.25 [0.93-1.68],0.1433614101602771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPA2,Replication protein A 32 kDa subunit,19940,158,1.23 [0.78-1.94],0.3816009036838802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPE,Ribulose-phosphate 3-epimerase,20186,161,0.96 [0.77-1.19],0.689958865042526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPGR,X-linked retinitis pigmentosa GTPase regulator,19997,159,0.71 [0.46-1.09],0.1129381138476465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPL14,60S ribosomal protein L14,19981,164,0.82 [0.54-1.23],0.3392149677514937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPS10,40S ribosomal protein S10,19847,157,1.26 [0.91-1.73],0.1611231422546067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRAS,Ras-related protein R-Ras,19997,159,1.09 [0.97-1.22],0.1474750060442534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2,Ribonucleoside-diphosphate reductase subunit M2,23155,169,1.31 [1.04-1.64],0.0215314062803587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23155,169,1.09 [0.89-1.34],0.3822212019685704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRP15,RRP15-like protein,19888,158,0.95 [0.80-1.12],0.5189220374545651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO1,R-spondin-1,23507,174,1.38 [0.94-2.02],0.1023607193972572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO3,R-spondin-3,23920,179,1.18 [0.74-1.88],0.498503484940127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTBDN,Retbindin,23599,177,0.92 [0.59-1.45],0.7164656978276267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTKN2,Rhotekin-2,19847,157,1.07 [0.80-1.42],0.6584536980047704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",20505,164,1.15 [0.98-1.35],0.0824791117857169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4R,Reticulon-4 receptor,23920,179,1.12 [0.76-1.66],0.5513931945671313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RUVBL1,RuvB-like 1,23155,169,1.12 [0.99-1.27],0.0667593539671439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RWDD1,RWD domain-containing protein 1,23926,178,1.19 [0.96-1.46],0.1129755439351399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RYR1,Ryanodine receptor 1,19847,157,1.01 [0.65-1.57],0.9742699891530164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A11,Protein S100-A11,23535,171,1.08 [0.83-1.41],0.5540965530239284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A12,Protein S100-A12,23361,175,1.29 [1.09-1.54],0.0036938726099224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A13,Protein S100-A13,19940,158,1.20 [0.79-1.81],0.3939681090886054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A14,Protein S100-A14,20505,164,0.85 [0.62-1.15],0.2834401491265619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A16,Protein S100-A16,23146,175,0.91 [0.72-1.14],0.4133538319661469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A3,Protein S100-A3,20474,161,0.94 [0.65-1.36],0.7616345613936428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A4,Protein S100-A4,23774,174,1.28 [1.00-1.63],0.0467755648539384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100G,Protein S100-G,20505,164,0.81 [0.58-1.11],0.1910585258878325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100P,Protein S100-P,23281,173,1.07 [0.86-1.34],0.5472312628763618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAA4,Serum amyloid A-4 protein,20568,163,1.07 [0.69-1.66],0.7492457583426078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAFB2,Scaffold attachment factor B2,20505,164,1.27 [0.79-2.04],0.3206633498812004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAG,S-arrestin,19888,158,1.00 [0.74-1.34],0.991692890579883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAMD9L,Sterile alpha motif domain-containing protein 9-like,23685,176,1.20 [1.01-1.43],0.042389600490642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAP18,Histone deacetylase complex subunit SAP18,20186,161,0.99 [0.80-1.22],0.9271343217575924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SARG,Specifically androgen-regulated gene protein,20472,161,1.05 [0.92-1.21],0.4814803376267804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19847,157,0.97 [0.65-1.45],0.8831051009714158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT1,Diamine acetyltransferase 1,19847,157,0.90 [0.64-1.26],0.5464764616383226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT2,Thialysine N-epsilon-acetyltransferase,20186,161,0.96 [0.76-1.21],0.7480885463479241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SATB1,DNA-binding protein SATB1,20505,164,1.56 [1.07-2.28],0.0210655088716233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SBSN,Suprabasin,20516,162,0.96 [0.63-1.47],0.8606196636574373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCAMP3,Secretory carrier-associated membrane protein 3,23599,177,1.11 [0.95-1.30],0.1820205395657543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARA5,Scavenger receptor class A member 5,23926,178,1.59 [1.03-2.45],0.0347752973889089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB1,Scavenger receptor class B member 1,23189,175,1.10 [0.88-1.38],0.3864996842331936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB2,Lysosome membrane protein 2,23042,171,1.43 [0.96-2.11],0.0753061551003488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF1,Scavenger receptor class F member 1,24010,179,1.31 [0.97-1.77],0.0831118262799451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF2,Scavenger receptor class F member 2,23926,178,1.33 [0.84-2.12],0.2280797825525851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG2,Secretogranin-2,23821,177,0.70 [0.47-1.06],0.0938011287276295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG3,Secretogranin-3,23715,178,0.81 [0.54-1.20],0.290897486797727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB1A1,Uteroglobin,23719,178,0.78 [0.61-0.98],0.0354924435349856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB2A2,Mammaglobin-A,19847,157,1.29 [0.83-2.00],0.2519632841928203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A1,Secretoglobin family 3A member 1,20082,158,0.77 [0.43-1.40],0.3976089162597531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A2,Secretoglobin family 3A member 2,23762,178,0.95 [0.80-1.13],0.5837944271740367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGN,Secretagogin,23300,174,1.13 [0.84-1.52],0.4147842875634379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCIN,Adseverin,19888,158,0.80 [0.63-1.01],0.0606035324135204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCLY,Selenocysteine lyase,23856,177,1.03 [0.77-1.36],0.8570264344132725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2A,Sodium channel protein type 2 subunit alpha,19888,158,1.06 [0.78-1.44],0.701944437479439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2B,Sodium channel subunit beta-2,19997,159,0.48 [0.26-0.87],0.0166267213896247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3A,Sodium channel protein type 3 subunit alpha,19997,159,0.85 [0.54-1.35],0.4865139353690878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3B,Sodium channel subunit beta-3,19888,158,0.90 [0.63-1.27],0.5304161634920641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN4B,Sodium channel subunit beta-4,19981,164,0.80 [0.56-1.14],0.2102003682516642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCP2,Non-specific lipid-transfer protein,23155,169,1.00 [0.83-1.20],0.9971068916540794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCPEP1,Retinoid-inducible serine carboxypeptidase,19915,163,1.16 [0.86-1.55],0.3360201187178932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRG1,Scrapie-responsive protein 1,20545,162,0.83 [0.47-1.47],0.5285244320014724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRIB,Protein scribble homolog,19981,164,0.83 [0.68-1.01],0.0637348825342605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRN1,Secernin-1,23685,176,1.17 [0.93-1.47],0.1816532942038617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCT,Secretin,19997,159,0.69 [0.49-0.96],0.0270677320740359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC1,Syndecan-1,23713,172,1.09 [0.78-1.53],0.6125522683932457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC4,Syndecan-4,23713,172,1.07 [0.80-1.42],0.6567905993548061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDCCAG8,Serologically defined colon cancer antigen 8,20474,161,1.01 [0.89-1.16],0.8644201678249166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDHB,Succinate dehydrogenase,20481,163,1.06 [0.84-1.34],0.6048966342042246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDK2,Protein sidekick-2,20082,158,0.91 [0.61-1.37],0.6558045701993728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEC31A,Protein transport protein Sec31A,19981,164,1.08 [0.89-1.31],0.4527218178801299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEL1L,Protein sel-1 homolog 1,19981,164,0.76 [0.44-1.34],0.350998958586331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELE,E-selectin,24010,179,0.78 [0.60-1.01],0.0598492659254185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELENOP,Selenoprotein P,20568,163,0.67 [0.34-1.31],0.2408315047399056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELL,L-selectin,20568,163,1.39 [0.74-2.58],0.3030300815626668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELP,P-selectin,23824,176,1.19 [0.94-1.50],0.1454392710729417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELPLG,P-selectin glycoprotein ligand 1,23685,176,0.68 [0.43-1.06],0.0918004195337463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3F,Semaphorin-3F,23713,172,2.02 [1.24-3.31],0.0049195155049352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3G,Semaphorin-3G,20082,158,0.84 [0.59-1.20],0.3446233410690187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4C,Semaphorin-4C,23599,177,1.20 [0.77-1.84],0.4206824337274675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4D,Semaphorin-4D,23926,178,1.34 [0.86-2.09],0.1907830633086994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA6C,Semaphorin-6C,19940,158,0.98 [0.55-1.77],0.9568268837949668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA7A,Semaphorin-7A,23930,178,1.09 [0.69-1.73],0.7035155533201964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN3,Neuronal-specific septin-3,20505,164,1.06 [0.88-1.28],0.5512994500839346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN7,Septin-7,20186,161,0.91 [0.66-1.24],0.5322808596900905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN8,Septin-8,20458,162,1.13 [0.72-1.77],0.603675365202372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN9,Septin-9,23599,177,1.39 [0.93-2.09],0.1097121123087757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA1,Alpha-1-antitrypsin,20194,161,1.59 [0.28-9.11],0.6007189971008564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA11,Serpin A11,24010,179,1.34 [0.97-1.85],0.0777072863210881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA12,Serpin A12,23037,169,1.07 [0.94-1.21],0.3170484994602714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA3,Alpha-1-antichymotrypsin,20504,163,2.53 [1.26-5.10],0.0091148293320478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA4,Kallistatin,20204,161,1.18 [0.62-2.25],0.6122440808895923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA5,Plasma serine protease inhibitor,20274,162,0.58 [0.33-1.01],0.0539713499946604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA6,Corticosteroid-binding globulin,20568,163,1.27 [0.49-3.31],0.6261434122400893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA7,Thyroxine-binding globulin,20568,163,0.69 [0.31-1.54],0.3631172455563595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA9,Serpin A9,23502,177,0.86 [0.71-1.04],0.1170910866607465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB1,Leukocyte elastase inhibitor,23641,175,1.11 [0.96-1.29],0.1406563128183212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB5,Serpin B5,23281,173,0.90 [0.68-1.19],0.4621226305010001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB6,Serpin B6,23845,178,1.17 [0.94-1.46],0.1674687985182133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB8,Serpin B8,23989,179,1.00 [0.81-1.24],0.9931089471546334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB9,Serpin B9,23507,174,1.31 [0.87-1.98],0.2003749453654077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINC1,Antithrombin-III,20535,163,1.34 [0.48-3.72],0.5728363890733301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPIND1,Heparin cofactor 2,20535,163,1.62 [0.96-2.72],0.0689605828974799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE1,Plasminogen activator inhibitor 1,24010,179,1.14 [0.94-1.40],0.1855663764277443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE2,Glia-derived nexin,20545,162,1.21 [0.96-1.51],0.1062370148158941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF1,Pigment epithelium-derived factor,20255,160,1.05 [0.59-1.88],0.8612821975303329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF2,Alpha-2-antiplasmin,20185,160,1.03 [0.33-3.19],0.9547013542284752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPING1,Plasma protease C1 inhibitor,20535,163,1.64 [0.73-3.65],0.2292116549343146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINH1,Serpin H1,20186,161,1.08 [0.96-1.22],0.1760521304667029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI1,Neuroserpin,20050,158,1.03 [0.60-1.77],0.9044273484027988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI2,Serpin I2,20481,163,0.97 [0.74-1.27],0.8237206814387953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23189,175,1.05 [0.86-1.30],0.6165132884250992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SETMAR,Histone-lysine N-methyltransferase SETMAR,23421,174,1.45 [0.97-2.18],0.0702175248699605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6,Seizure protein 6 homolog,19997,159,0.46 [0.27-0.79],0.0043292888479959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L,Seizure 6-like protein,23774,174,0.82 [0.50-1.33],0.4238436641142965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L2,Seizure 6-like protein 2,23599,177,1.38 [0.80-2.39],0.2467126808330225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SF3B4,Splicing factor 3B subunit 4,23599,177,1.20 [1.01-1.43],0.0337872053233806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP1,Secreted frizzled-related protein 1,23421,174,1.58 [1.21-2.07],0.0008283137894361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP4,Secreted frizzled-related protein 4,20082,158,1.51 [1.02-2.22],0.037393071203767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA1,Pulmonary surfactant-associated protein A1,23155,169,1.14 [0.92-1.42],0.227201236933084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA2,Pulmonary surfactant-associated protein A2,23155,169,0.99 [0.76-1.28],0.9268021490580408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPD,Pulmonary surfactant-associated protein D,23713,172,1.18 [0.97-1.44],0.1044775278550579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SGSH,N-sulphoglucosamine sulphohydrolase,20217,162,1.18 [0.92-1.53],0.1972033071026048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2B3,SH2B adapter protein 3,23155,169,1.04 [0.91-1.20],0.5568716782090153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2D1A,SH2 domain-containing protein 1A,23685,176,1.16 [0.96-1.41],0.1246111032460213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19888,158,1.00 [0.77-1.28],0.9788607832899406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BP1,SH3 domain-binding protein 1,20481,163,1.04 [0.78-1.38],0.8066450004030895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GL3,Endophilin-A3,20066,160,0.98 [0.82-1.17],0.7899039736687197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GLB2,Endophilin-B2,20496,162,1.04 [0.83-1.30],0.7237624000418235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHBG,Sex hormone-binding globulin,20572,165,0.74 [0.54-1.01],0.0547097037359916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHC1,SHC-transforming protein 1,19825,157,0.94 [0.82-1.09],0.4177880701526799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHD,SH2 domain-containing adapter protein D,19812,156,0.98 [0.81-1.19],0.8758370166414615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHH,Sonic hedgehog protein,19940,158,0.99 [0.69-1.41],0.9347145732860598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHISA5,Protein shisa-5,20552,162,0.92 [0.51-1.66],0.780345047078346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHMT1,"Serine hydroxymethyltransferase, cytosolic",23762,178,1.20 [1.03-1.40],0.0217979554468416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHPK,Sedoheptulokinase,20186,161,0.90 [0.61-1.34],0.617847059010504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIAE,Sialate O-acetylesterase,23734,174,1.29 [0.97-1.71],0.0827839897545924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC1,Sialoadhesin,23798,178,1.02 [0.74-1.41],0.8955002194170613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC10,Sialic acid-binding Ig-like lectin 10,23685,176,1.06 [0.72-1.56],0.7696779783339365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC15,Sialic acid-binding Ig-like lectin 15,23189,175,0.96 [0.79-1.16],0.6524597432442274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC5,Sialic acid-binding Ig-like lectin 5,23722,175,1.04 [0.92-1.17],0.5513881940961349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC6,Sialic acid-binding Ig-like lectin 6,23920,179,1.03 [0.69-1.53],0.8848899869447782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC7,Sialic acid-binding Ig-like lectin 7,23713,172,1.44 [0.90-2.32],0.1291139021019028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19981,164,1.24 [0.89-1.72],0.1977420160179292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC9,Sialic acid-binding Ig-like lectin 9,23884,179,1.31 [0.84-2.04],0.2329293252604153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIL1,Nucleotide exchange factor SIL1,19981,164,0.85 [0.51-1.43],0.551378367631362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,23779,178,0.94 [0.75-1.18],0.5805044070585057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPB1,Signal-regulatory protein beta-1,23634,178,1.23 [0.93-1.61],0.146269990597698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19940,158,0.92 [0.76-1.13],0.4345021037472893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT2,NAD-dependent protein deacetylase sirtuin-2,23599,177,1.17 [1.01-1.37],0.0385850992464072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23189,175,1.08 [0.85-1.37],0.5455616400229479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIT1,Signaling threshold-regulating transmembrane adapter 1,23300,174,1.01 [0.79-1.29],0.9509905896762998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP1,Src kinase-associated phosphoprotein 1,23474,174,1.04 [0.86-1.25],0.6919892729001271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP2,Src kinase-associated phosphoprotein 2,23798,178,1.08 [0.95-1.22],0.2513897810207854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKIV2L,Helicase SKI2W,19847,157,1.06 [0.73-1.56],0.7478585152900212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLA2,Src-like-adapter 2,20505,164,1.07 [0.93-1.23],0.3662753943102089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF1,Signaling lymphocytic activation molecule,23300,174,1.24 [0.99-1.55],0.0642878175405788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF6,SLAM family member 6,23155,169,0.93 [0.65-1.34],0.7101368678823307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF7,SLAM family member 7,23685,176,1.06 [0.85-1.32],0.6236050754827096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF8,SLAM family member 8,23155,169,0.99 [0.77-1.27],0.9256691656083358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC12A2,Solute carrier family 12 member 2,19847,157,1.06 [0.59-1.88],0.8540063258480965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC13A1,Solute carrier family 13 member 1,20474,161,0.98 [0.75-1.27],0.8596170621493251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC16A1,Monocarboxylate transporter 1,23189,175,1.06 [0.84-1.35],0.6129243746934989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC1A4,Neutral amino acid transporter A,19997,159,0.89 [0.64-1.23],0.4716257019912133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC27A4,Long-chain fatty acid transport protein 4,23189,175,1.10 [0.91-1.32],0.3270494294576738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC28A1,Sodium/nucleoside cotransporter 1,19825,157,0.89 [0.67-1.19],0.4386605661732259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC34A3,Sodium-dependent phosphate transport protein 2C,19825,157,0.91 [0.65-1.29],0.610947255130446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A14,Zinc transporter ZIP14,23189,175,0.88 [0.58-1.32],0.5319222490683368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A5,Zinc transporter ZIP5,23685,176,0.99 [0.77-1.28],0.9432420516290336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC44A4,Choline transporter-like protein 4,19997,159,1.01 [0.81-1.26],0.9229873702673292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC4A1,Band 3 anion transport protein,20552,162,1.15 [0.85-1.55],0.3783055395549721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC51B,Organic solute transporter subunit beta,19847,157,0.81 [0.63-1.03],0.0819551890156884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20082,158,1.15 [0.96-1.37],0.1233346098446003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,20481,163,1.09 [0.82-1.43],0.5612262304139493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19825,157,0.98 [0.74-1.29],0.8905565303656042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIT2,Slit homolog 2 protein,23189,175,1.19 [0.95-1.50],0.13700489104654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK1,SLIT and NTRK-like protein 1,19940,158,0.66 [0.41-1.05],0.0808450425226049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK2,SLIT and NTRK-like protein 2,23920,179,1.05 [0.76-1.45],0.7749713923475333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK6,SLIT and NTRK-like protein 6,23281,173,0.96 [0.65-1.42],0.846077679076628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLK,STE20-like serine/threonine-protein kinase,20186,161,0.82 [0.64-1.05],0.109537629067679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLMAP,Sarcolemmal membrane-associated protein,20481,163,1.11 [0.93-1.33],0.2380192204633719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLURP1,Secreted Ly-6/uPAR-related protein 1,20408,162,1.13 [0.76-1.66],0.5532333337218396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD1,Mothers against decapentaplegic homolog 1,23155,169,1.09 [0.92-1.28],0.3141058352341289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD2,Mothers against decapentaplegic homolog 2,20474,161,1.13 [0.92-1.40],0.2424278999415963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD3,Mothers against decapentaplegic homolog 3,20474,161,1.09 [0.82-1.45],0.5572496766826085
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD5,Mothers against decapentaplegic homolog 5,23599,177,0.99 [0.51-1.95],0.9832507213346504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMARCA2,Probable global transcription activator SNF2L2,23189,175,1.13 [0.95-1.35],0.158133828709133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMC3,Structural maintenance of chromosomes protein 3,19825,157,0.93 [0.68-1.26],0.6328734472889959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMNDC1,Survival of motor neuron-related-splicing factor 30,20481,163,1.07 [0.86-1.33],0.5517454848787788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC1,SPARC-related modular calcium-binding protein 1,23920,179,1.06 [0.71-1.59],0.7853907050424684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC2,SPARC-related modular calcium-binding protein 2,23798,178,1.56 [1.13-2.16],0.0073374723565631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD1,Sphingomyelin phosphodiesterase,23808,177,0.97 [0.75-1.26],0.8443306048246435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD3,Sphingomyelin phosphodiesterase 3,19940,158,0.78 [0.56-1.09],0.149123413615635
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,23753,178,1.02 [0.84-1.25],0.8272052294592158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,20474,161,1.16 [0.98-1.37],0.0860396418962326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMS,Spermine synthase,19888,158,1.01 [0.80-1.28],0.924003417669221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMTN,Smoothelin,20454,161,1.06 [0.90-1.25],0.4670623266773385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP23,Synaptosomal-associated protein 23,23713,172,1.09 [0.93-1.28],0.2904428317855707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP25,Synaptosomal-associated protein 25,19888,158,1.14 [0.83-1.56],0.4139104248210122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP29,Synaptosomal-associated protein 29,23774,174,1.12 [0.97-1.30],0.1261420095033568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAPIN,SNARE-associated protein Snapin,20505,164,1.12 [0.87-1.44],0.3726613627193532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCA,Alpha-synuclein,20082,158,1.12 [0.98-1.28],0.0836619203888976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCG,Gamma-synuclein,23507,174,0.94 [0.77-1.15],0.5799748626622752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19981,164,1.21 [0.77-1.90],0.4126453288435584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNRPB2,U2 small nuclear ribonucleoprotein B'',20496,162,1.03 [0.77-1.40],0.8283396345401695
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNU13,NHP2-like protein 1,19847,157,0.91 [0.70-1.18],0.465274295474482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX15,Sorting nexin-15,20082,158,1.20 [0.91-1.58],0.2060378492741515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX18,Sorting nexin-18,20481,163,1.36 [1.02-1.81],0.0368422260905413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX2,Sorting nexin-2,20474,161,1.02 [0.86-1.21],0.8423750797965879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX5,Sorting nexin-5,19981,164,1.14 [0.70-1.87],0.5994316795638196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX9,Sorting nexin-9,23713,172,1.16 [0.96-1.41],0.1318691708709068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD1,Superoxide dismutase [Cu-Zn],23258,171,1.25 [0.95-1.64],0.1094300108181153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD2,"Superoxide dismutase [Mn], mitochondrial",23722,175,1.34 [0.96-1.86],0.0876754080383594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD3,Extracellular superoxide dismutase,20572,165,1.14 [0.93-1.40],0.2034854781251651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORBS1,Sorbin and SH3 domain-containing protein 1,20505,164,1.51 [1.20-1.91],0.0004275220575525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORCS2,VPS10 domain-containing receptor SorCS2,23155,169,1.04 [0.71-1.54],0.8248610551691571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORD,Sorbitol dehydrogenase,23815,176,1.04 [0.85-1.27],0.7091230171595135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORT1,Sortilin,23682,172,1.07 [0.75-1.53],0.7097128138230273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOST,Sclerostin,23682,172,0.79 [0.56-1.12],0.1855702186212573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19997,159,0.97 [0.70-1.34],0.8469674488878169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX2,Transcription factor SOX-2,20461,164,0.88 [0.47-1.67],0.7041361530246569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX9,Transcription factor SOX-9,19997,159,1.13 [0.64-1.99],0.6674253237095529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,20505,164,1.17 [0.74-1.86],0.507078954602065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPAG1,Sperm-associated antigen 1,20505,164,0.99 [0.77-1.29],0.9667606919190916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARC,SPARC,23774,174,1.11 [0.92-1.35],0.2758777517940716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARCL1,SPARC-like protein 1,23742,175,1.35 [0.88-2.06],0.1693110605123561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPART,Spartin,20082,158,1.09 [0.89-1.32],0.4090112846636797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPESP1,Sperm equatorial segment protein 1,20545,162,1.62 [1.07-2.45],0.0212024287023237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK1,Serine protease inhibitor Kazal-type 1,23722,175,1.14 [0.83-1.56],0.4197652578814935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK2,Serine protease inhibitor Kazal-type 2,20082,158,1.08 [0.71-1.66],0.7116007021796775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK4,Serine protease inhibitor Kazal-type 4,23685,176,0.92 [0.75-1.14],0.451488432655081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK5,Serine protease inhibitor Kazal-type 5,23722,175,1.26 [0.87-1.83],0.2179201571432115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK6,Serine protease inhibitor Kazal-type 6,23920,179,1.06 [0.82-1.36],0.6583770094520158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK8,Serine protease inhibitor Kazal-type 8,19847,157,0.91 [0.58-1.43],0.6973817580617475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT1,Kunitz-type protease inhibitor 1,23633,173,1.32 [0.80-2.19],0.2832150142751896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT2,Kunitz-type protease inhibitor 2,23798,178,1.16 [0.83-1.63],0.3791125202835964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT3,Kunitz-type protease inhibitor 3,20481,163,1.02 [0.93-1.11],0.7202119530642741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPOCK1,Testican-1,23507,174,1.28 [0.77-2.15],0.3450443939117479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON1,Spondin-1,23715,178,1.01 [0.68-1.52],0.946966125012632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON2,Spondin-2,23600,172,1.15 [0.77-1.70],0.4980905821788878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPP1,Osteopontin,23975,179,1.09 [0.81-1.48],0.5561029064103724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19940,158,0.85 [0.59-1.23],0.3976859314890286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRING1,SREBP regulating gene protein,19825,157,0.90 [0.68-1.18],0.4450130335343989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR1B,Cornifin-B,20186,161,1.06 [0.89-1.25],0.5270888229709103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR3,Small proline-rich protein 3,20496,162,1.10 [0.87-1.39],0.4362143222019906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRY2,Protein sprouty homolog 2,23300,174,1.13 [0.98-1.30],0.0981884582489601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19888,158,1.07 [0.66-1.73],0.7793496695961978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTLC1,Serine palmitoyltransferase 1,20496,162,1.04 [0.71-1.52],0.844896866820128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRC,Proto-oncogene tyrosine-protein kinase Src,23736,173,1.09 [0.97-1.22],0.1440608081783178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRP14,Signal recognition particle 14 kDa protein,23599,177,1.04 [0.84-1.28],0.7428965219289927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPK2,SRSF protein kinase 2,23685,176,1.11 [0.95-1.29],0.1773466470810935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPX,Sushi repeat-containing protein SRPX,20545,162,0.91 [0.62-1.33],0.6285934915653114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSB,Lupus La protein,23189,175,1.02 [0.81-1.29],0.8616540938874598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19940,158,0.88 [0.55-1.41],0.6069108457745255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,23682,172,0.97 [0.87-1.09],0.603962636102439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23824,176,1.16 [0.85-1.58],0.3497662262991703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSH3,Protein phosphatase Slingshot homolog 3,19825,157,0.66 [0.37-1.18],0.163226064377003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSNA1,Sjoegren syndrome nuclear autoantigen 1,20481,163,1.12 [0.84-1.49],0.4522935313721679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST13,Hsc70-interacting protein,20082,158,1.22 [0.93-1.61],0.156072016709459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",23599,177,0.95 [0.69-1.30],0.7343206375988673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24010,179,1.51 [1.03-2.20],0.0344030092485295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19940,158,0.67 [0.44-1.03],0.0681939134079287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAB2,Stabilin-2,20552,162,1.48 [0.86-2.54],0.1568619798984698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAM,Signal transducing adapter molecule 1,20474,161,1.15 [0.77-1.70],0.4991399482744079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAMBP,STAM-binding protein,23474,174,1.26 [1.02-1.56],0.0301410400462729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT2,Signal transducer and activator of transcription 2,19940,158,1.05 [0.86-1.28],0.6183074176388138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT5B,Signal transducer and activator of transcription 5B,23599,177,1.09 [0.99-1.20],0.0824273080223987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19825,157,0.96 [0.76-1.22],0.7366960859283262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC1,Stanniocalcin-1,23926,178,1.16 [0.88-1.53],0.2937259467760869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC2,Stanniocalcin-2,23690,175,0.91 [0.52-1.59],0.7344404562002896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STEAP4,Metalloreductase STEAP4,19888,158,0.94 [0.74-1.18],0.5717540348167851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STIP1,Stress-induced-phosphoprotein 1,23676,175,1.21 [0.99-1.48],0.0581849697385584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK11,Serine/threonine-protein kinase STK11,23281,173,1.20 [1.00-1.45],0.0462772358584904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK24,Serine/threonine-protein kinase 24,23189,175,1.22 [0.98-1.51],0.0701184412112856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK4,Serine/threonine-protein kinase 4,23713,172,1.07 [0.91-1.24],0.4103646723568218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STOML2,"Stomatin-like protein 2, mitochondrial",19825,157,0.89 [0.75-1.07],0.220296748532614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX16,Syntaxin-16,23155,169,0.93 [0.72-1.20],0.5697158602119808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX1B,Syntaxin-1B,19997,159,0.99 [0.68-1.44],0.9568774848847948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX3,Syntaxin-3,20496,162,0.90 [0.59-1.37],0.6318089600583205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX4,Syntaxin-4,23599,177,1.08 [0.87-1.33],0.5004280936924543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX5,Syntaxin-5,19940,158,0.81 [0.53-1.24],0.3308975949697347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX6,Syntaxin-6,23155,169,0.92 [0.73-1.14],0.4384683169089255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX7,Syntaxin-7,19940,158,1.07 [0.78-1.46],0.6681070166728391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX8,Syntaxin-8,23685,176,0.98 [0.74-1.29],0.8601731057768638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP1,Syntaxin-binding protein 1,20505,164,1.04 [0.86-1.26],0.6827975724029098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP3,Syntaxin-binding protein 3,23155,169,1.07 [0.79-1.46],0.6536977296894139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGP1,SURP and G-patch domain-containing protein 1,20481,163,1.00 [0.69-1.44],0.9788614282165784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGT1,Protein SGT1 homolog,23155,169,1.23 [1.03-1.46],0.019866701581901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT1A1,Sulfotransferase 1A1,23926,178,1.05 [0.95-1.17],0.3425393201788355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT2A1,Bile salt sulfotransferase,23685,176,0.97 [0.76-1.23],0.7793171082734305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF1,Formylglycine-generating enzyme,19940,158,0.98 [0.76-1.26],0.8611413754398793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,23926,178,1.24 [0.96-1.61],0.1065920649934201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUOX,"Sulfite oxidase, mitochondrial",20505,164,0.99 [0.78-1.26],0.936283593893428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD1,Sushi domain-containing protein 1,23281,173,1.33 [1.00-1.76],0.047097391849483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD2,Sushi domain-containing protein 2,23722,175,1.30 [0.82-2.05],0.2595533327327554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD4,Sushi domain-containing protein 4,20474,161,1.22 [0.85-1.75],0.2728172219014089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD5,Sushi domain-containing protein 5,19982,158,0.78 [0.50-1.22],0.2698522840721423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SV2A,Synaptic vesicle glycoprotein 2A,19997,159,1.08 [0.85-1.37],0.5181581835471405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SWAP70,Switch-associated protein 70,20481,163,0.88 [0.57-1.35],0.5486866680002379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYAP1,Synapse-associated protein 1,20082,158,1.24 [0.96-1.59],0.1000630838485687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19888,158,1.40 [1.16-1.70],0.0004594096976066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYT1,Synaptotagmin-1,20496,162,1.12 [0.80-1.56],0.4993014949806922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYTL4,Synaptotagmin-like protein 4,20545,162,1.15 [0.94-1.40],0.1699851229332958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20186,161,1.05 [0.91-1.21],0.5124097211724551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACC3,Transforming acidic coiled-coil-containing protein 3,23599,177,1.09 [0.97-1.22],0.1531917797301513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACSTD2,Tumor-associated calcium signal transducer 2,20996,152,1.29 [0.78-2.12],0.3150867800763938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TADA3,Transcriptional adapter 3,20474,161,1.45 [1.02-2.04],0.0367346219013581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAFA5,Chemokine-like protein TAFA-5,23599,177,0.85 [0.59-1.24],0.404924720093788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAGLN3,Transgelin-3,19825,157,1.00 [0.78-1.30],0.9803195334845616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TALDO1,Transaldolase,20482,162,1.35 [0.98-1.85],0.0664840299325566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TANK,TRAF family member-associated NF-kappa-B activator,23300,174,1.09 [0.90-1.31],0.3799348808405359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAP1,Antigen peptide transporter 1,20186,161,0.75 [0.54-1.04],0.0847529271749005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARBP2,RISC-loading complex subunit TARBP2,23189,175,1.13 [0.95-1.33],0.1658049468001082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19997,159,0.80 [0.62-1.02],0.0710377751213958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",20474,161,1.12 [0.76-1.66],0.5715036913194824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAX1BP1,Tax1-binding protein 1,20496,162,1.06 [0.84-1.35],0.6224705293611271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D17,TBC1 domain family member 17,23189,175,1.06 [0.78-1.43],0.7085878337938867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D23,TBC1 domain family member 23,23599,177,1.07 [0.92-1.24],0.3811910224710199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D5,TBC1 domain family member 5,23685,176,0.99 [0.84-1.17],0.9145466014199138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCA,Tubulin-specific chaperone A,20082,158,1.17 [0.98-1.40],0.0890522268339518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCB,Tubulin-folding cofactor B,23507,174,1.13 [0.98-1.29],0.0863161303468845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCC,Tubulin-specific chaperone C,23507,174,1.19 [1.01-1.41],0.0379583854880513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBL1X,F-box-like/WD repeat-containing protein TBL1X,23155,169,1.04 [0.88-1.22],0.6514030859367816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBR1,T-box brain protein 1,19997,159,1.22 [0.94-1.57],0.1328786409728079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1A,T-cell leukemia/lymphoma protein 1A,23477,173,1.01 [0.89-1.15],0.8402312630489652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1B,T-cell leukemia/lymphoma protein 1B,23281,173,0.89 [0.73-1.09],0.2612567120739067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN1,Transcobalamin-1,20170,161,0.90 [0.57-1.41],0.6415920357269127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN2,Transcobalamin-2,23975,179,0.87 [0.56-1.35],0.5362754935997693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCOF1,Treacle protein,20545,162,1.15 [0.74-1.78],0.5385734950028089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCP11,T-complex protein 11 homolog,20186,161,0.85 [0.61-1.17],0.3082077175058186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCTN3,Tectonic-3,20545,162,1.64 [1.01-2.68],0.047708926108786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDGF1,Teratocarcinoma-derived growth factor 1,23189,175,0.98 [0.90-1.07],0.6823932489406165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDO2,"Tryptophan 2,3-dioxygenase",19997,159,0.69 [0.44-1.09],0.1151800294832935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDP1,Tyrosyl-DNA phosphodiesterase 1,20474,161,0.92 [0.74-1.15],0.4672450019573688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDRKH,Tudor and KH domain-containing protein,23189,175,1.08 [0.92-1.26],0.3434217883687421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEF,Thyrotroph embryonic factor,19847,157,0.95 [0.65-1.37],0.7705456003871292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEK,Angiopoietin-1 receptor,23774,174,1.15 [0.62-2.11],0.6600224975638352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TERF1,Telomeric repeat-binding factor 1,19940,158,0.59 [0.33-1.04],0.0702562453593641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TET2,Methylcytosine dioxygenase TET2,20150,160,0.99 [0.85-1.15],0.8974893822076694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX101,Testis-expressed protein 101,19997,159,0.96 [0.75-1.23],0.7741267086582916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX33,Testis-expressed protein 33,20186,161,0.85 [0.55-1.33],0.480092401903346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TF,Serotransferrin,20568,163,1.16 [0.58-2.31],0.6779033180071283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFAP2A,Transcription factor AP-2-alpha,19888,158,1.13 [0.90-1.43],0.2939930712338715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF1,Trefoil factor 1,23608,175,1.05 [0.89-1.24],0.5537369865076087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF2,Trefoil factor 2,23762,178,1.10 [0.88-1.37],0.4145591792201706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF3,Trefoil factor 3,23707,175,1.25 [0.91-1.70],0.1665011059229568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI,Tissue factor pathway inhibitor,23672,175,1.55 [1.07-2.24],0.0193957705894296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI2,Tissue factor pathway inhibitor 2,23708,174,0.97 [0.69-1.36],0.8432882692277432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFRC,Transferrin receptor protein 1,23818,174,1.17 [0.83-1.66],0.3702663381733867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TG,Thyroglobulin,20474,161,1.00 [0.86-1.15],0.9664837153250212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFA,Protransforming growth factor alpha,23685,176,1.43 [1.09-1.87],0.0092743667040805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB1,Transforming growth factor beta-1 proprotein,23950,178,1.10 [0.79-1.54],0.5765851967372544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB2,Transforming growth factor beta-2 proprotein,20474,161,0.99 [0.74-1.32],0.9245025321732018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBI,Transforming growth factor-beta-induced protein ig-h3,23594,175,0.98 [0.60-1.62],0.9465519999184996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR1,TGF-beta receptor type-1,19940,158,1.14 [0.59-2.21],0.6964261829438743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR2,TGF-beta receptor type-2,23774,174,1.22 [0.84-1.78],0.297854179263854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR3,Transforming growth factor beta receptor type 3,24010,179,0.83 [0.54-1.27],0.3855253239173865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGM2,Protein-glutamine gamma-glutamyltransferase 2,23671,172,0.99 [0.83-1.18],0.8966044168519562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGOLN2,Trans-Golgi network integral membrane protein 2,20572,165,1.09 [0.62-1.91],0.7572627011220622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THAP12,52 kDa repressor of the inhibitor of the protein kinase,19789,157,0.93 [0.77-1.14],0.4966099105048908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBD,Thrombomodulin,23713,172,1.01 [0.64-1.60],0.9726247188571197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS2,Thrombospondin-2,23722,175,1.15 [0.81-1.63],0.4408733206630216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS4,Thrombospondin-4,23751,176,1.72 [1.29-2.28],0.0001888538347176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THOP1,Thimet oligopeptidase,23601,169,1.38 [0.92-2.09],0.1207936980733508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THPO,Thrombopoietin,23281,173,1.19 [0.85-1.68],0.3110089871078093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THRAP3,Thyroid hormone receptor-associated protein 3,19847,157,0.93 [0.79-1.09],0.3623026966191952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THSD1,Thrombospondin type-1 domain-containing protein 1,19795,156,0.76 [0.47-1.23],0.2685731249943605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THTPA,Thiamine-triphosphatase,20427,161,1.13 [0.95-1.34],0.1643577601093678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THY1,Thy-1 membrane glycoprotein,23926,178,1.34 [0.85-2.10],0.2027540883130442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIA1,Nucleolysin TIA-1 isoform p40,23023,170,1.12 [1.01-1.25],0.0353041533917809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIE1,Tyrosine-protein kinase receptor Tie-1,24010,179,1.21 [0.86-1.70],0.2843383251367928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23156,175,0.95 [0.71-1.26],0.7024431022862672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20186,161,0.64 [0.40-1.01],0.057153388478799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,23824,176,1.08 [0.79-1.47],0.6312641342863763
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,20545,162,1.26 [0.88-1.81],0.2044721950432252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,20496,162,1.10 [0.93-1.31],0.2784714507716374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP1,Metalloproteinase inhibitor 1,23481,174,1.65 [1.08-2.54],0.0215451525721229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP2,Metalloproteinase inhibitor 2,20545,162,0.60 [0.30-1.20],0.1448310428763222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP3,Metalloproteinase inhibitor 3,23798,178,1.09 [0.99-1.21],0.0867329266106097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP4,Metalloproteinase inhibitor 4,23722,175,1.41 [1.03-1.93],0.0329116887406264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TINAGL1,Tubulointerstitial nephritis antigen-like,23646,172,1.42 [0.77-2.61],0.2568306987854354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJAP1,Tight junction-associated protein 1,23774,174,1.09 [0.93-1.28],0.2923068881527579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJP3,Tight junction protein ZO-3,19888,158,0.93 [0.64-1.37],0.718234957376404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TK1,"Thymidine kinase, cytosolic",20186,161,0.97 [0.69-1.36],0.8549069142194337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR1,Toll-like receptor 1,19940,158,1.20 [0.68-2.11],0.5302540956659714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR2,Toll-like receptor 2,20186,161,0.90 [0.47-1.74],0.759960214513804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR3,Toll-like receptor 3,23989,179,0.99 [0.80-1.23],0.960736754362236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR4,Toll-like receptor 4,19940,158,0.60 [0.34-1.04],0.0685998617070727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19997,159,1.16 [0.90-1.50],0.2593597686011379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED1,Transmembrane emp24 domain-containing protein 1,20186,161,0.93 [0.69-1.25],0.6249635377636109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED10,Transmembrane emp24 domain-containing protein 10,19847,157,1.15 [0.88-1.51],0.305017404868755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED4,Transmembrane emp24 domain-containing protein 4,19847,157,0.87 [0.64-1.18],0.3700519240348185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED8,Protein TMED8,20481,163,1.11 [0.96-1.28],0.1666850210670221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM106A,Transmembrane protein 106A,20474,161,1.12 [0.91-1.37],0.2755410097113495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM132A,Transmembrane protein 132A,19981,164,0.77 [0.61-0.99],0.0403361577077468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM25,Transmembrane protein 25,20505,164,1.14 [0.86-1.53],0.3651235294873153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMOD4,Tropomodulin-4,19825,157,1.43 [1.01-2.04],0.0445739923469618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11B,Transmembrane protease serine 11B,19888,158,1.11 [0.93-1.33],0.2550184333566996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11D,Transmembrane protease serine 11D,20458,162,0.83 [0.56-1.24],0.3631385844049681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS15,Enteropeptidase,23599,177,0.98 [0.84-1.14],0.7736187981197296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS5,Transmembrane protease serine 5,23391,173,1.36 [0.95-1.94],0.0924667216943546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMSB10,Thymosin beta-10,23722,175,1.23 [1.03-1.46],0.0205437336328281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNC,Tenascin,23824,176,1.38 [1.05-1.81],0.0196144782984909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNF,Tumor necrosis factor,23249,173,1.26 [0.91-1.73],0.158320796236158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,20481,163,1.10 [0.82-1.47],0.5251086812024632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,23300,174,0.93 [0.64-1.35],0.7048312943399714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20082,158,1.21 [0.96-1.53],0.1009385005772972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,23507,174,1.32 [0.91-1.91],0.148867486660176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,23507,174,1.27 [1.05-1.54],0.0145519387485865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,23788,179,1.04 [0.79-1.36],0.788587443903365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23989,179,1.09 [0.78-1.52],0.6037123238344069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,23679,178,1.14 [0.72-1.78],0.5794856823072606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23774,174,1.55 [1.10-2.19],0.0118691100204903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23715,178,0.96 [0.65-1.41],0.8284243524909131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,23300,174,1.10 [0.81-1.49],0.557403202490191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23715,178,1.46 [0.98-2.19],0.064184751616157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20082,158,0.90 [0.62-1.30],0.579010371906655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23920,179,1.20 [0.82-1.77],0.3482602376975053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,23722,175,1.43 [0.95-2.15],0.0851005724119608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,23722,175,1.17 [0.83-1.64],0.3693333440592337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23926,178,0.98 [0.61-1.57],0.9204153166390316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23950,178,1.24 [0.89-1.74],0.2110630011952865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,23507,174,1.04 [0.83-1.32],0.7316704481436569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23926,178,1.03 [0.77-1.39],0.8229941525258485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,23507,174,1.25 [0.94-1.66],0.1307532940842476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF10,Tumor necrosis factor ligand superfamily member 10,23989,179,0.77 [0.46-1.30],0.3312464372740368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF11,Tumor necrosis factor ligand superfamily member 11,23685,176,1.12 [0.90-1.39],0.2973241995252969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF12,Tumor necrosis factor ligand superfamily member 12,23989,179,1.24 [0.77-1.97],0.3757690121353979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13,Tumor necrosis factor ligand superfamily member 13,23798,178,1.92 [1.20-3.05],0.0061822358273736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23972,179,1.61 [1.04-2.48],0.0324323822158791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF14,Tumor necrosis factor ligand superfamily member 14,23507,174,1.20 [0.96-1.50],0.1179405283582975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF8,Tumor necrosis factor ligand superfamily member 8,20552,162,1.00 [0.66-1.52],0.984463822064427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNIP1,TNFAIP3-interacting protein 1,20496,162,1.09 [0.92-1.29],0.3117466277601353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNN,Tenascin-N,20552,162,0.89 [0.63-1.27],0.53375241840081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNNI3,"Troponin I, cardiac muscle",23281,173,1.09 [0.92-1.28],0.3226128527965637
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNPO1,Transportin-1,20186,161,0.68 [0.44-1.05],0.084972172152025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNR,Tenascin-R,23507,174,1.04 [0.76-1.43],0.8039793144818989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNXB,Tenascin-X,23722,175,0.95 [0.56-1.59],0.8368679982833208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,20545,162,1.16 [0.96-1.40],0.1267551957408521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1,DNA topoisomerase 1,20481,163,1.06 [0.93-1.20],0.3887337432934462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1MT,"DNA topoisomerase I, mitochondrial",19825,157,1.10 [0.81-1.49],0.5360555975320704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP2B,DNA topoisomerase 2-beta,19940,158,1.10 [0.91-1.32],0.3304983434811899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOR1AIP1,Torsin-1A-interacting protein 1,19981,164,1.14 [0.88-1.46],0.3186070129497573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53,Cellular tumor antigen p53,23155,169,1.13 [0.83-1.53],0.4286276146978059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53BP1,TP53-binding protein 1,19940,158,0.94 [0.79-1.13],0.5427099312657756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53I3,Quinone oxidoreductase PIG3,19647,153,1.35 [1.01-1.79],0.0401225916851185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53INP1,Tumor protein p53-inducible nuclear protein 1,23281,173,1.15 [0.76-1.73],0.5170526476277624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP73,Tumor protein p73,19997,159,0.74 [0.47-1.16],0.1944807065004761
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPBGL,Trophoblast glycoprotein-like,19997,159,0.93 [0.64-1.37],0.7197520771124908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPD52L2,Tumor protein D54,20082,158,1.15 [1.00-1.33],0.0560602479229127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPK1,Thiamin pyrophosphokinase 1,20545,162,0.84 [0.49-1.45],0.5354683782673075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPM3,Tropomyosin alpha-3 chain,19847,157,1.46 [1.10-1.93],0.0083332592115237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPMT,Thiopurine S-methyltransferase,23155,169,1.20 [1.00-1.42],0.0467406516384066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPP1,Tripeptidyl-peptidase 1,23524,178,1.09 [0.83-1.43],0.5378878073412356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP2,Tubulin polymerization-promoting protein family member 2,20186,161,0.99 [0.81-1.21],0.8985270168776157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP3,Tubulin polymerization-promoting protein family member 3,23189,175,0.99 [0.70-1.40],0.96874320796894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPR,Nucleoprotein TPR,19847,157,1.14 [0.88-1.47],0.3320314945473691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPRKB,EKC/KEOPS complex subunit TPRKB,19825,157,0.81 [0.62-1.08],0.1512485535036418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSAB1,Tryptase alpha/beta-1,23951,179,1.07 [0.83-1.38],0.5979353326588561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSD1,Tryptase delta,20505,164,1.11 [0.76-1.62],0.6001281318160767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSG1,Tryptase gamma,19940,158,0.60 [0.32-1.11],0.1053616203164593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPT1,Translationally-controlled tumor protein,23300,174,0.97 [0.78-1.20],0.7772487728119748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF2,TNF receptor-associated factor 2,23685,176,1.04 [0.86-1.26],0.6721543055715551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19940,158,0.96 [0.64-1.44],0.8527089324890674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19847,157,1.14 [0.86-1.51],0.350612472330955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20186,161,0.98 [0.82-1.17],0.7987810825468771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREH,Trehalase,20552,162,1.03 [0.84-1.26],0.7892406627989523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREM2,Triggering receptor expressed on myeloid cells 2,23679,178,1.04 [0.82-1.33],0.7372443455702453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML1,Trem-like transcript 1 protein,20572,165,1.19 [0.90-1.56],0.2239437804732836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML2,Trem-like transcript 2 protein,23722,175,0.91 [0.62-1.34],0.631190294463302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIAP1,TP53-regulated inhibitor of apoptosis 1,23920,179,1.30 [1.06-1.59],0.0117645132612813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM21,E3 ubiquitin-protein ligase TRIM21,23685,176,1.08 [0.90-1.30],0.3907331412910492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM24,Transcription intermediary factor 1-alpha,20149,161,0.92 [0.73-1.17],0.5041391468919325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,20481,163,1.01 [0.88-1.17],0.836891656195927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM26,Tripartite motif-containing protein 26,19825,157,0.90 [0.67-1.20],0.4721155929001662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM40,E3 ubiquitin ligase TRIM40,19997,159,1.02 [0.83-1.26],0.8616121780024383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM5,Tripartite motif-containing protein 5,23685,176,1.08 [0.93-1.26],0.3127279995201678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM58,E3 ubiquitin-protein ligase TRIM58,20474,161,1.05 [0.88-1.25],0.5921386811823302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRPV3,Transient receptor potential cation channel subfamily V member 3,19847,157,0.77 [0.54-1.10],0.1462259135356595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC1,Hamartin,19940,158,0.82 [0.64-1.05],0.1187693037988608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC22D1,TSC22 domain family protein 1,20505,164,1.15 [0.93-1.44],0.2023315377360638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSHB,Thyrotropin subunit beta,23713,172,1.03 [0.85-1.25],0.7657239062013755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSLP,Thymic stromal lymphopoietin,23281,173,0.77 [0.59-1.01],0.0600173864570739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSNAX,Translin-associated protein X,19847,157,1.19 [0.81-1.74],0.3728244567947613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN1,Tetraspanin-1,23281,173,1.07 [0.91-1.25],0.4253146862486279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN15,Tetraspanin-15,19847,157,1.00 [0.74-1.36],0.9963922760951588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN7,Tetraspanin-7,19888,158,1.00 [0.85-1.17],0.9924431047160932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN8,Tetraspanin-8,20481,163,0.94 [0.80-1.11],0.4617969789362769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPYL1,Testis-specific Y-encoded-like protein 1,19940,158,1.01 [0.69-1.48],0.9563191065392735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TST,Thiosulfate sulfurtransferase,23153,174,1.04 [0.87-1.25],0.65040542145798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTF2,Transcription termination factor 2,19997,159,1.08 [0.80-1.47],0.6027195255996283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTN,Titin,19847,157,1.20 [1.00-1.46],0.055511015189643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTR,Transthyretin,20351,162,0.81 [0.44-1.49],0.4989252120688171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TUBB3,Tubulin beta-3 chain,19888,158,1.34 [0.80-2.23],0.2654341422694177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TWF2,Twinfilin-2,20552,162,1.11 [0.94-1.33],0.2236342627989595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXK,Tyrosine-protein kinase TXK,20186,161,1.18 [0.99-1.39],0.0600054832329303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXLNA,Alpha-taxilin,23507,174,1.12 [0.96-1.30],0.1470926963514041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXN,Thioredoxin,20244,161,1.10 [0.79-1.53],0.5563548271737506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC15,Thioredoxin domain-containing protein 15,23774,174,1.13 [0.70-1.83],0.6137820197439456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC5,Thioredoxin domain-containing protein 5,23926,178,1.15 [0.95-1.38],0.15901261133667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC9,Thioredoxin domain-containing protein 9,20496,162,1.14 [0.87-1.50],0.3519085303646652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNL1,Thioredoxin-like protein 1,19854,158,0.90 [0.76-1.07],0.219197569363524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",23722,175,1.20 [0.90-1.59],0.2175254403059916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYMP,Thymidine phosphorylase,23566,172,1.12 [0.91-1.37],0.2868719083398167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRO3,Tyrosine-protein kinase receptor TYRO3,23713,172,1.12 [0.70-1.81],0.6338957545305237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19940,158,0.88 [0.69-1.12],0.3028169835791645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBAC1,Ubiquitin-associated domain-containing protein 1,23599,177,1.06 [0.71-1.57],0.7736598423073189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2B,Ubiquitin-conjugating enzyme E2 B,20474,161,0.92 [0.54-1.56],0.7514537737503402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,20545,162,1.23 [0.97-1.56],0.0949190813589287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19940,158,1.01 [0.78-1.32],0.912374411916203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBQLN3,Ubiquilin-3,19847,157,1.09 [0.85-1.41],0.4960027008585557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBXN1,UBX domain-containing protein 1,20082,158,1.17 [0.94-1.46],0.1479876538096891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,20481,163,1.10 [0.99-1.22],0.0887068447706494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UGDH,UDP-glucose 6-dehydrogenase,19847,157,0.85 [0.70-1.03],0.0908390033809795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UHRF2,E3 ubiquitin-protein ligase UHRF2,19847,157,1.07 [0.69-1.65],0.771191213852576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ULBP2,UL16-binding protein 2,23507,174,1.24 [0.88-1.74],0.2130413107233012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UMOD,Uromodulin,23928,179,1.14 [0.88-1.47],0.3217902292458834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC5D,Netrin receptor UNC5D,19940,158,0.52 [0.28-0.97],0.0405212155734425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC79,Protein unc-79 homolog,19825,157,0.77 [0.57-1.04],0.0864510833294836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNG,Uracil-DNA glycosylase,20474,161,1.27 [0.87-1.85],0.2109429659404543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPB1,Beta-ureidopropionase,20545,162,0.98 [0.83-1.16],0.8278525068826137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3A,Uroplakin-3a,19888,158,0.82 [0.59-1.14],0.232391705184919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3BL1,Uroplakin-3b-like protein 1,20142,161,0.71 [0.48-1.04],0.0776183535266895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROD,Uroporphyrinogen decarboxylase,20082,158,1.09 [0.87-1.36],0.4643196808722152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROS,Uroporphyrinogen-III synthase,19997,159,1.00 [0.79-1.26],0.971090417877587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USO1,General vesicular transport factor p115,23599,177,1.15 [0.99-1.34],0.0628865031750453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP25,Ubiquitin carboxyl-terminal hydrolase 25,20474,161,1.11 [0.90-1.37],0.3234718829154477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP28,Ubiquitin carboxyl-terminal hydrolase 28,20496,162,1.32 [0.93-1.86],0.1171392359076385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19847,157,1.02 [0.86-1.21],0.8244033164910829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP8,Ubiquitin carboxyl-terminal hydrolase 8,23281,173,1.11 [0.97-1.28],0.1395216008371946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UXS1,UDP-glucuronic acid decarboxylase 1,23155,169,1.12 [0.87-1.44],0.3903717456238103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP5,Vesicle-associated membrane protein 5,23281,173,1.11 [0.88-1.41],0.3789975423336288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP8,Vesicle-associated membrane protein 8,19940,158,1.10 [0.92-1.31],0.2836650328280569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASH1,Tubulinyl-Tyr carboxypeptidase 1,23685,176,1.10 [0.94-1.29],0.2353153976768762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASN,Vasorin,23358,172,1.23 [0.75-2.01],0.4127905848666866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASP,Vasodilator-stimulated phosphoprotein,20572,165,1.10 [0.90-1.35],0.3507831172065387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,23599,177,0.64 [0.32-1.28],0.2101000948581758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAV3,Guanine nucleotide exchange factor VAV3,19888,158,1.06 [0.91-1.24],0.4686683786886991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAM1,Vascular cell adhesion protein 1,23789,176,1.33 [0.83-2.15],0.2349215423555061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAN,Versican core protein,23926,178,1.00 [0.65-1.56],0.9863107800430015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCPKMT,Protein-lysine methyltransferase METTL21D,19825,157,0.96 [0.80-1.16],0.7056387541154456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFA,Vascular endothelial growth factor A,23914,178,1.25 [1.00-1.56],0.0512152785498639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFB,Vascular endothelial growth factor B,19940,158,1.51 [0.91-2.51],0.1133768996935691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFC,Vascular endothelial growth factor C,23774,174,1.18 [0.93-1.51],0.1654268078261718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFD,Vascular endothelial growth factor D,23955,179,1.04 [0.73-1.46],0.8382446595423383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VGF,Neurosecretory protein VGF,20505,164,0.68 [0.41-1.12],0.1253610163671515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIM,Vimentin,23281,173,0.98 [0.88-1.10],0.7475979819558123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIPR1,Vasoactive intestinal polypeptide receptor 1,19981,164,0.92 [0.48-1.74],0.7866071237381072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIT,Vitrin,20545,162,1.21 [0.82-1.80],0.3381264877710422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VMO1,Vitelline membrane outer layer protein 1 homolog,23599,177,1.12 [0.92-1.38],0.2683593764632951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN1,Pantetheinase,20572,165,0.97 [0.79-1.19],0.7641372063187848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN2,Vascular non-inflammatory molecule 2,23599,177,1.07 [0.80-1.42],0.6544911406980389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS28,Vacuolar protein sorting-associated protein 28 homolog,20186,161,1.09 [0.87-1.37],0.445416763985641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS37A,Vacuolar protein sorting-associated protein 37A,23599,177,1.16 [0.99-1.36],0.0748277919467828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS4B,Vacuolar protein sorting-associated protein 4B,20474,161,1.08 [0.93-1.27],0.312847065327845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS53,Vacuolar protein sorting-associated protein 53 homolog,23599,177,1.10 [0.93-1.30],0.2748505347249979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10,V-set and immunoglobulin domain-containing protein 10,20474,161,0.65 [0.40-1.08],0.094576329752345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19847,157,1.10 [0.70-1.72],0.6691297981723299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG2,V-set and immunoglobulin domain-containing protein 2,20474,161,1.17 [0.93-1.46],0.1718471337983426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG4,V-set and immunoglobulin domain-containing protein 4,23690,175,1.18 [0.87-1.61],0.2887288702359679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,23676,172,1.23 [1.00-1.51],0.0512802376264667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSNL1,Visinin-like protein 1,20496,162,1.06 [0.72-1.57],0.7614224214985806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM1,V-set and transmembrane domain-containing protein 1,23189,175,1.06 [0.82-1.38],0.6603632821891379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2B,V-set and transmembrane domain-containing protein 2B,20186,161,0.66 [0.41-1.04],0.0716535227326558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,23281,173,1.07 [0.86-1.34],0.5432915909398244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,23926,178,1.15 [0.96-1.39],0.1366495566952448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTCN1,V-set domain-containing T-cell activation inhibitor 1,23155,169,0.90 [0.57-1.40],0.6283453918155242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20082,158,1.10 [0.85-1.43],0.4541810220729415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA1,von Willebrand factor A domain-containing protein 1,23892,177,1.23 [0.90-1.68],0.1869120293971465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA5A,von Willebrand factor A domain-containing protein 5A,19825,157,0.89 [0.71-1.13],0.3411429551010213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2,Brorin,23431,174,0.93 [0.66-1.30],0.6657449013597075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2L,von Willebrand factor C domain-containing protein 2-like,20505,164,0.66 [0.43-1.01],0.0578499789298142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWF,von Willebrand factor,24010,179,1.00 [0.83-1.19],0.9563114990843128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WARS,"Tryptophan--tRNA ligase, cytoplasmic",23722,175,1.05 [0.74-1.50],0.7670601338359595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WAS,Wiskott-Aldrich syndrome protein,23300,174,1.03 [0.84-1.26],0.7783690181658283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF1,Wiskott-Aldrich syndrome protein family member 1,23281,173,1.08 [0.94-1.25],0.2611119220664201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF3,Wiskott-Aldrich syndrome protein family member 3,23189,175,1.05 [0.89-1.23],0.560416599746163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASHC3,WASH complex subunit 3,20496,162,1.02 [0.84-1.24],0.8614960008501507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASL,Neural Wiskott-Aldrich syndrome protein,19940,158,0.89 [0.67-1.17],0.3953645184153159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WDR46,WD repeat-containing protein 46,20474,161,1.18 [0.81-1.71],0.3847092781946252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC1,WAP four-disulfide core domain protein 1,20050,158,0.90 [0.66-1.22],0.5024699533095165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC12,WAP four-disulfide core domain protein 12,23872,179,0.98 [0.80-1.21],0.8838894565663684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC2,WAP four-disulfide core domain protein 2,22520,165,1.36 [1.00-1.86],0.0508657698899003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",23421,174,0.95 [0.68-1.31],0.7391787723165457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",23715,178,0.80 [0.54-1.19],0.2688284787677643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WIF1,Wnt inhibitory factor 1,23920,179,0.91 [0.62-1.35],0.6416121050960442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WNT9A,Protein Wnt-9a,23300,174,1.13 [0.71-1.78],0.6081338260461144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,23507,174,1.20 [0.94-1.54],0.1442934383783469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XCL1,Lymphotactin,23920,179,0.96 [0.75-1.23],0.7598774855520481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XG,Glycoprotein Xg,23900,179,1.09 [0.74-1.61],0.655085641450944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XIAP,E3 ubiquitin-protein ligase XIAP,19940,158,1.13 [0.87-1.47],0.3457344489424571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XPNPEP2,Xaa-Pro aminopeptidase 2,23774,174,1.00 [0.88-1.13],0.988343950637745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XRCC4,DNA repair protein XRCC4,23189,175,1.16 [0.82-1.64],0.4011791089268918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YAP1,Transcriptional coactivator YAP1,20496,162,1.11 [0.65-1.91],0.7041818752785656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",20481,163,1.07 [0.96-1.18],0.2287239661938765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YES1,Tyrosine-protein kinase Yes,23599,177,1.10 [0.98-1.24],0.0926972394459632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YJU2,Splicing factor YJU2,20474,161,0.82 [0.51-1.32],0.4122124827146077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YOD1,Ubiquitin thioesterase OTU1,19847,157,1.11 [0.86-1.42],0.424419111902547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YTHDF3,YTH domain-containing family protein 3,23300,174,1.12 [0.96-1.31],0.1453944699446364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YWHAQ,14-3-3 protein theta,20082,158,1.19 [0.97-1.46],0.0871222947451967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YY1,Transcriptional repressor protein YY1,19940,158,0.98 [0.57-1.69],0.9478330100444288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBP1,Z-DNA-binding protein 1,19940,158,0.89 [0.60-1.32],0.5600018981180226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB16,Zinc finger and BTB domain-containing protein 16,23155,169,1.05 [0.87-1.26],0.5982546443323596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB17,Zinc finger and BTB domain-containing protein 17,23281,173,0.99 [0.72-1.35],0.928313966400241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19847,157,0.96 [0.73-1.25],0.7509318271843431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZFYVE19,Abscission/NoCut checkpoint regulator,20481,163,1.12 [0.95-1.32],0.1936818333698451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZHX2,Zinc fingers and homeoboxes protein 2,20496,162,1.12 [0.77-1.64],0.5478877746791948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF174,Zinc finger protein 174,19940,158,0.96 [0.62-1.48],0.8500206055406343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF75D,Zinc finger protein 75D,20186,161,0.96 [0.74-1.24],0.7299024929643987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF830,Zinc finger protein 830,20474,161,1.06 [0.88-1.27],0.5631066212517049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRD2,Protein ZNRD2,20481,163,1.15 [0.93-1.42],0.1848879163463639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,20474,161,0.98 [0.74-1.29],0.8626706201584723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP3,Zona pellucida sperm-binding protein 3,19981,164,1.01 [0.96-1.07],0.6907117824092479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP4,Zona pellucida sperm-binding protein 4,19825,157,0.84 [0.49-1.44],0.5201355490062853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZPR1,Zinc finger protein ZPR1,19888,158,0.83 [0.68-1.01],0.0649484665574674
